<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lower Respiratory Disorders - Pharmacology - Diagnostic Exam </title>
    <style>
        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
            background-color: #f0f2f5;
            margin: 0;
            padding: 0;
            color: #333;
            display: flex;
            justify-content: center;
            align-items: center;
            min-height: 100vh;
        }
        .quiz-wrapper {
            width: 100vw;
            height: 100vh;
            background-color: #ffffff;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.1);
            overflow-y: auto;
            display: flex;
            flex-direction: column;
        }
        .quiz-header {
            background-color: #4a5568;
            color: white;
            padding: 1rem 1.5rem;
            text-align: center;
            border-bottom: 4px solid #2c3e50;
            position: relative;
        }
        .logo {
            position: absolute;
            left: 1.5rem;
            top: 50%;
            transform: translateY(-50%);
            font-size: 1.8rem;
            font-weight: 900;
            font-family: "Trebuchet MS", "Lucida Sans Unicode", "Lucida Grande", "Lucida Sans", Arial, sans-serif;
            color: #f6ad55;
            letter-spacing: 1px;
        }
        .quiz-header h1 { margin: 0; font-size: 1.75rem; }
        #timer-display { font-size: 1.25rem; margin-top: 0.5rem; font-weight: bold; color: #f6ad55; }
        .quiz-content { padding: 1.5rem 2rem; flex-grow: 1; }
        #initial-screen { text-align: center; }
        #initial-screen h2 { color: #2c3e50; }
        #initial-screen p { font-size: 1.1rem; line-height: 1.6; max-width: 600px; margin: 1rem auto; }
        #question-container { margin-bottom: 1.5rem; }
        .question-header { font-size: 1.1rem; color: #718096; margin-bottom: 1rem; }
        .question-text { font-size: 1.3rem; font-weight: bold; margin-bottom: 1.5rem; line-height: 1.5; }
        .question-scenario {
            background-color: #f9f9f9;
            border-left: 4px solid #5bc0de;
            padding: 15px;
            margin-bottom: 20px;
            font-style: italic;
            font-size: 1.1rem;
            line-height: 1.6;
        }
        .options-container label { display: block; background-color: #f7fafc; border: 1px solid #e2e8f0; padding: 1rem; margin-bottom: 0.75rem; border-radius: 8px; cursor: pointer; transition: background-color 0.2s, border-color 0.2s; }
        .options-container label:hover { background-color: #e2e8f0; border-color: #cbd5e0; }
        .options-container input[type="radio"], .options-container input[type="checkbox"] { margin-right: 10px; }
        /* Style for text input answers */
        #dosage-input, .text-answer-input {
            width: 100%;
            padding: 1rem;
            font-size: 1.2rem;
            border: 1px solid #cbd5e0;
            border-radius: 8px;
            margin-top: 1rem;
            box-sizing: border-box;
        }
        .flag-container { margin-top: 1.5rem; text-align: right; }
        .flag-container label { cursor: pointer; color: #4a5568; font-weight: bold; }
        .flag-container input[type="checkbox"] { margin-right: 5px; transform: scale(1.2); }
        #navigation-btn, #start-btn, #print-btn { display: block; width: 100%; padding: 1rem; font-size: 1.2rem; font-weight: bold; color: white; background-color: #3182ce; border: none; border-radius: 8px; cursor: pointer; margin-top: 1rem; transition: background-color 0.2s; }
        #navigation-btn:hover, #start-btn:hover, #print-btn:hover { background-color: #2b6cb0; }
        #print-btn { background-color: #68d391; }
        #print-btn:hover { background-color: #48bb78; }
        #results-area { line-height: 1.7; }
        #results-summary { text-align: center; background-color: #ebf8ff; border: 1px solid #90cdf4; padding: 1.5rem; margin-bottom: 2rem; border-radius: 8px; }
        #results-summary h2 { margin-top: 0; }
        .result-question { background: #fff; border: 1px solid #e2e8f0; padding: 1.5rem; margin-bottom: 1.5rem; border-radius: 8px; }
        .result-question p strong { display: block; margin-bottom: 1rem; font-size: 1.2em; }
        .result-question ul { list-style-type: none; padding: 0; margin: 0; }
        .result-question li { padding: 0.75rem; border-radius: 6px; margin-bottom: 0.5rem; border: 1px solid #e2e8f0; }
        .correct-answer-label { background-color: #c6f6d5 !important; border-color: #9ae6b4 !important; }
        .incorrect-answer-label { background-color: #fed7d7 !important; border-color: #feb2b2 !important; }
        .missed-correct-answer-label { border: 2px solid #68d391 !important; }
        .typed-answer-result { margin-top: 1rem; }
        .typed-answer-result .user-answer.correct { color: #38a169; }
        .typed-answer-result .user-answer.incorrect { color: #e53e3e; text-decoration: line-through; }
        .typed-answer-result .correct-answer-text { color: #38a169; font-weight: bold; }
        .rationale { margin-top: 1rem; padding: 1rem; border-radius: 6px; border-left: 5px solid #a0aec0; background-color: #f7fafc; }
        .rationale strong { display: block; margin-bottom: 0.5rem; }
        .time-spent-info { font-style: italic; color: #718096; margin-top: 0.5rem; display: block; }
        .time-flagged-rationale { background-color: #e9d8fd !important; border-left-color: #9f7aea !important; }
        .flagged-rationale { background-color: #fefcbf !important; border-left-color: #f6e05e !important; }
        #study-focus { margin-top: 2.5rem; padding: 1.5rem; background-color: #fefcbf; border: 1px solid #f6e05e; border-radius: 8px; }
        #study-focus h3 { margin-top: 0; color: #2d3748; border-bottom: 2px solid #f6e05e; padding-bottom: 0.5rem; }
        #study-focus ul { list-style-type: '👉'; padding-left: 2rem; }
        #study-focus li { padding-left: 0.5rem; margin-bottom: 0.5rem; font-size: 1.1rem; }
        .hidden { display: none; }

        #pause-btn {
            position: fixed;
            top: 1rem;
            right: 1rem;
            z-index: 1010;
            background-color: #f6ad55;
            color: #2d3748;
            border: 2px solid #2d3748;
            width: 50px;
            height: 50px;
            border-radius: 50%;
            font-size: 1.5rem;
            font-weight: bold;
            cursor: pointer;
            display: flex;
            justify-content: center;
            align-items: center;
            box-shadow: 0 2px 8px rgba(0,0,0,0.2);
            transition: background-color 0.2s, transform 0.2s;
        }
        #pause-btn:hover {
            background-color: #f687b3;
            transform: scale(1.1);
        }
        #pause-overlay {
            position: fixed;
            top: 0;
            left: 0;
            width: 100vw;
            height: 100vh;
            background-color: rgba(226, 232, 240, 0.95);
            z-index: 1000;
            display: none;
            justify-content: center;
            align-items: center;
            text-align: center;
            flex-direction: column;
        }
        #pause-overlay .pause-content h1 {
            font-size: 5rem;
            color: #e53e3e;
            margin: 0;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.2);
        }
        #pause-overlay .pause-content .stop-sign {
            font-size: 8rem;
        }
        #pause-overlay .pause-content p {
            font-size: 1.5rem;
            color: #2d3748;
            margin-top: 1rem;
        }

        #study-guide-printable {
            display: none;
        }
        @media print {
            body * {
                visibility: hidden;
            }
            #study-guide-printable, #study-guide-printable * {
                visibility: visible;
            }
            #study-guide-printable {
                display: block;
                position: absolute;
                left: 0;
                top: 0;
                width: 100%;
                font-family: 'Times New Roman', Times, serif;
                color: #000;
                padding: 20px; /* Add padding for better print layout */
                box-sizing: border-box; /* Include padding in width */
            }
            .study-guide-item {
                page-break-inside: avoid;
                margin-bottom: 2rem;
                border-bottom: 1px solid #ccc;
                padding-bottom: 1rem;
            }
            .study-guide-item h2, .study-guide-item h3 {
                font-size: 14pt;
                margin-bottom: 1rem;
                color: #000;
            }
            .study-guide-item h1 {
                font-size: 24pt;
                text-align: center;
                margin-bottom: 2rem;
            }
            .study-guide-item p {
                font-size: 12pt;
                line-height: 1.4;
                margin: 0.5rem 0;
            }
            .study-guide-item .print-rationale {
                margin-top: 1rem;
                padding: 0.5rem;
                border-left: 3px solid #ccc;
                background-color: #f0f0f0 !important;
                font-style: italic;
            }
            .study-guide-item .print-rationale strong {
                font-style: normal;
            }
        }
    </style>
</head>
<body>
    <button id="pause-btn" class="hidden">||</button>
    <div id="pause-overlay">
        <div class="pause-content">
            <div class="stop-sign">🛑</div>
            <h1>EXAM PAUSED</h1>
            <p>Click the pause button in the corner to resume.</p>
        </div>
    </div>

    <div class="quiz-wrapper">
        <header class="quiz-header">
            <div class="logo">VSREP</div>
            <h1>Pharmacology - Glucose and Hormones - DSE</h1>
            <div id="timer-display">Time Left: 35:00</div>
        </header>

        <main class="quiz-content">
            <div id="initial-screen">
                <h2>Welcome to the Student Diagnostic Examination</h2>
                <p>This is a timed, 30-question quiz on hormones, glucose, disease pathophysiology and pharmacology. Many questions are designed to be challenging and test critical thinking. The time limit is <strong>35 minutes</strong>. You can flag questions for review. Incorrect answers <strong>AND</strong> flagged questions are displayed with the rationale upon submission of the exam. Click "Start Quiz" when you are ready to begin.</p>
                <button id="start-btn">Start Quiz</button>
            </div>

            <form id="quiz-form" class="hidden">
                <div id="question-container"></div>
                <div class="flag-container">
                    <label><input type="checkbox" id="flag-for-review"> Flag for Review</label>
                </div>
                <button type="submit" id="navigation-btn" class="hidden">Next Question</button>
            </form>

            <div id="results-area" class="hidden">
                <div id="results-summary"></div>
                <div id="results-details"></div>
                <div id="study-focus"></div>
                <button id="print-btn" class="hidden">🖨️ Print Study Guide</button>
            </div>
        </main>
    </div>

    <div id="study-guide-printable"></div>

<script>
    // --- START: QUESTION BANK ---
    const fullQuizData = [
    {
        "questionText": "What statement or statements is INCORRECT regarding the administration of levothyroxine (Synthroid)?",
        "options": {
            "A": "The medication should be taken in the morning on an empty stomach.",
            "B": "This medication is a lifelong therapy for hypothyroidism.",
            "C": "The patient should report signs of hyperthyroidism like insomnia and palpitations.",
            "D": "If the patient feels better after a month, they can take the medication every other day."
        },
        "correctAnswer": "D",
        "rationale": "Levothyroxine must be taken daily as prescribed to maintain therapeutic levels; it should not be taken intermittently or stopped without consulting the provider. The other statements are correct teaching points.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "What statement is INCORRECT regarding 'sick day' management for a patient with Type 1 diabetes?",
        "options": {
            "A": "The patient should continue taking their basal insulin even if they are not eating.",
            "B": "The patient should monitor blood glucose more frequently, such as every 2-4 hours.",
            "C": "The patient should cease all insulin if vomiting occurs to prevent hypoglycemia.",
            "D": "The patient should check urine for ketones if blood glucose is persistently >240 mg/dL."
        },
        "correctAnswer": "C",
        "rationale": "During illness, counter-regulatory stress hormones often increase blood glucose, so insulin is still required and may even need to be increased. Stopping insulin, especially in a Type 1 diabetic, would precipitate DKA. The other statements are correct sick day rules.",
        "section": "Advanced Concepts: Patient Education"
    },
    {
        "questionText": "A nurse is teaching a patient about rotating insulin injection sites. Which statement indicates the patient understands the teaching?",
        "options": {
            "A": "I should use the same exact spot for every injection to ensure consistent absorption.",
            "B": "I can give my shots in my thigh one week and my abdomen the next week.",
            "C": "I should only use my abdomen for all of my insulin injections.",
            "D": "I need to give myself the shot in a different spot every time, at least one inch away from the last one."
        },
        "correctAnswer": "D",
        "rationale": "Rotating injection sites within one anatomical area (e.g., the abdomen) prevents lipodystrophy and ensures consistent insulin absorption. Using a different spot at least an inch from the previous site is the correct technique.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "Which statement about metformin (Glucophage) is INCORRECT?",
        "options": {
            "A": "It works by decreasing glucose production in the liver.",
            "B": "It commonly causes hypoglycemia when used as monotherapy.",
            "C": "It is often the first-line medication for Type 2 Diabetes.",
            "D": "It can cause gastrointestinal side effects like diarrhea."
        },
        "correctAnswer": "B",
        "rationale": "Unlike sulfonylureas, metformin does not stimulate insulin secretion and therefore has a very low risk of causing hypoglycemia when used alone.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which of the following hormones is a glucocorticoid primarily responsible for regulating metabolism and the immune response?",
        "options": {
            "A": "Aldosterone",
            "B": "Cortisol",
            "C": "Parathyroid hormone (PTH)",
            "D": "Calcitonin"
        },
        "correctAnswer": "B",
        "rationale": "Cortisol is the body's primary glucocorticoid, produced by the adrenal cortex. It plays a key role in stress response, metabolism, and suppressing inflammation. Prednisone is a synthetic form of this hormone.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "An elderly patient with chronic kidney disease (eGFR of 25 mL/min) is prescribed glipizide for type 2 diabetes. The nurse should recognize this patient is at an exceptionally high risk for what complication?",
        "options": {
            "A": "Lactic acidosis",
            "B": "Accelerated nephropathy",
            "C": "Prolonged and severe hypoglycemia",
            "D": "Disulfiram-like reaction"
        },
        "correctAnswer": "C",
        "rationale": "Glipizide and its active metabolites are cleared by the kidneys. In a patient with significantly impaired renal function, the drug's half-life is extended, leading to accumulation and a very high risk of severe, prolonged hypoglycemia. Metformin causes lactic acidosis in renal failure; glipizide causes hypoglycemia.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "In reviewing morning labs, the nurse notes that a patient on calcitriol therapy has a serum calcium level of 11.2 mg/dL (Normal: 8.5-10.5 mg/dL). What is the nurse's priority action?",
        "options": {
            "A": "Administer the morning dose of calcitriol as ordered.",
            "B": "Encourage the patient to increase intake of dairy products.",
            "C": "Hold the morning dose of calcitriol and notify the provider.",
            "D": "Document the finding as normal."
        },
        "correctAnswer": "C",
        "rationale": "A calcium level of 11.2 mg/dL indicates hypercalcemia, which is a potential toxic effect of calcitriol. The nurse's priority is to hold the medication to prevent the level from rising further and to inform the healthcare provider.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with Type 1 diabetes is being treated for DKA with a continuous IV insulin infusion. The initial serum potassium was 5.4 mEq/L. Six hours later, the blood glucose is 250 mg/dL and the serum potassium is 3.1 mEq/L. What is the nurse's most accurate interpretation of this change?",
        "options": {
            "A": "The patient is developing renal failure, causing potassium wasting.",
            "B": "The insulin infusion has corrected the acidosis, causing an intracellular shift of potassium.",
            "C": "The initial hyperkalemia was a false reading due to lab error.",
            "D": "The IV fluids have diluted the serum potassium, requiring fluid restriction."
        },
        "correctAnswer": "B",
        "rationale": "In DKA, acidosis and insulin deficiency cause potassium to shift out of the cells, leading to normal or high serum levels despite a total body deficit. As insulin is administered and acidosis corrects, potassium shifts back into the cells, often causing severe hypokalemia. This is an expected but critical event to monitor.",
        "section": "Advanced Concepts: Antidiabetics"
    },
    {
        "questionText": "The primary nursing diagnosis for a patient with newly diagnosed Addison's disease (adrenal insufficiency) would be:",
        "options": {
            "A": "Risk for unstable blood glucose.",
            "B": "Risk for deficient fluid volume.",
            "C": "Risk for infection.",
            "D": "Disturbed body image."
        },
        "correctAnswer": "B",
        "rationale": "In Addison's disease, a deficiency of mineralocorticoids (aldosterone) leads to increased renal excretion of sodium and water, placing the patient at high risk for dehydration, hyponatremia, and hypotension. Therefore, risk for deficient fluid volume is a priority.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient is taking warfarin and is newly prescribed levothyroxine. The nurse should anticipate which change in the warfarin dose?",
        "options": {
            "A": "An increase in the warfarin dose.",
            "B": "A decrease in the warfarin dose.",
            "C": "No change to the warfarin dose.",
            "D": "Discontinuation of the warfarin."
        },
        "correctAnswer": "B",
        "rationale": "Levothyroxine can enhance the anticoagulant effect of warfarin, increasing the risk of bleeding. Therefore, the dose of warfarin often needs to be decreased when thyroid hormone therapy is initiated. The INR must be monitored closely.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "Which hormone has actions that are antagonistic to Parathyroid Hormone (PTH)?",
        "options": {
            "A": "Thyroxine (T4)",
            "B": "Calcitonin",
            "C": "Aldosterone",
            "D": "Cortisol"
        },
        "correctAnswer": "B",
        "rationale": "PTH works to increase blood calcium levels. Calcitonin works to decrease blood calcium levels by promoting calcium deposition in bone and excretion by the kidneys. Therefore, their actions are antagonistic.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "Which insulin cannot be mixed in a syringe with any other insulin?",
        "options": {
            "A": "Insulin regular",
            "B": "Insulin NPH",
            "C": "Insulin lispro",
            "D": "Insulin glargine"
        },
        "correctAnswer": "D",
        "rationale": "Long-acting insulins like glargine and detemir have a low pH and should not be mixed with any other insulin or solution in the same syringe, as this can alter their absorption profile and effectiveness.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is started on levothyroxine. Which co-administered drug would require the nurse to teach the patient to separate the administration times by at least 4 hours to ensure efficacy? Select all that apply.",
        "options": {
            "A": "Calcium carbonate (Tums)",
            "B": "Ferrous sulfate (Iron supplement)",
            "C": "Metoprolol (Beta-blocker)",
            "D": "Omeprazole (Proton Pump Inhibitor)"
        },
        "correctAnswer": ["A", "B", "D"],
        "rationale": "Calcium carbonate and ferrous sulfate directly bind to levothyroxine in the gut, impairing its absorption. Proton pump inhibitors like omeprazole reduce stomach acid, which is necessary for the proper dissolution and absorption of levothyroxine. All three require separation. Metoprolol does not have this interaction.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "A patient taking glipizide (Glucotrol) should be educated that alcohol consumption can cause which type of reaction?",
        "options": {
            "A": "A hypertensive crisis.",
            "B": "A disulfiram-like reaction (flushing, nausea).",
            "C": "Severe sedation.",
            "D": "Improved glycemic control."
        },
        "correctAnswer": "B",
        "rationale": "When combined with alcohol, sulfonylureas like glipizide can cause a disulfiram-like reaction, characterized by flushing, palpitations, and nausea. It can also potentiate the hypoglycemic effects of the drug.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "When comparing oral antidiabetic agents, which one carries the highest risk of causing hypoglycemia?",
        "options": {
            "A": "Metformin",
            "B": "Glipizide",
            "C": "Acarbose",
            "D": "Pioglitazone"
        },
        "correctAnswer": "B",
        "rationale": "Glipizide, a sulfonylurea, works by increasing insulin secretion from the pancreas. This direct stimulation of insulin release carries a significant risk of hypoglycemia compared to agents like metformin that do not directly affect insulin secretion.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which of the following is an expected side effect of long-term glucocorticoid therapy?",
        "options": {
            "A": "Weight loss",
            "B": "Hypokalemia",
            "C": "Adrenal hypertrophy",
            "D": "Fat redistribution (e.g., moon face, buffalo hump)"
        },
        "correctAnswer": "D",
        "rationale": "Long-term use of glucocorticoids like prednisone can lead to Cushing's syndrome, which is characterized by a specific pattern of fat redistribution, including a rounded 'moon' face, a fat pad on the upper back ('buffalo hump'), and central obesity.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "Which action is most appropriate for the nurse to take before administering a dose of glipizide (Glucotrol)?",
        "options": {
            "A": "Check the patient's serum potassium level.",
            "B": "Assess the patient's ability to swallow.",
            "C": "Ensure the patient's blood pressure is within normal limits.",
            "D": "Review the patient's allergy history for sulfa medications."
        },
        "correctAnswer": "D",
        "rationale": "Glipizide is a sulfonylurea. This class of drugs has a chemical similarity to sulfonamide antibiotics, and a cross-sensitivity can occur. Therefore, checking for a sulfa allergy is a critical safety measure.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "What statement is INCORRECT regarding hypoglycemia?",
        "options": {
            "A": "Symptoms include shakiness, sweating, and confusion.",
            "B": "A blood glucose level of 65 mg/dL is considered hypoglycemia.",
            "C": "Treatment involves administering 15g of a complex carbohydrate.",
            "D": "It is the most common acute complication of insulin therapy."
        },
        "correctAnswer": "C",
        "rationale": "The initial treatment for a conscious patient with hypoglycemia is 15g of a simple (fast-acting) carbohydrate, like juice or glucose tablets, not a complex carbohydrate, which would be digested too slowly.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which patient is the most likely candidate for treatment with metformin?",
        "options": {
            "A": "A patient with type 1 diabetes and a history of ketoacidosis.",
            "B": "A patient with type 2 diabetes who is overweight and has normal renal function.",
            "C": "A patient with gestational diabetes.",
            "D": "A patient with type 2 diabetes and severe chronic kidney disease."
        },
        "correctAnswer": "B",
        "rationale": "Metformin is a first-line agent for type 2 diabetes, particularly in overweight patients, as it does not cause weight gain. It is contraindicated in severe renal disease due to the risk of lactic acidosis. It is not used for type 1 diabetes.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "The nurse is about to administer a scheduled dose of NPH insulin at 4:00 PM. What is the next priority action of the nurse?",
        "options": {
            "A": "Ensure the patient has a bedtime snack available later.",
            "B": "Check the patient's most recent blood glucose reading.",
            "C": "Ask the patient if they have any allergies.",
            "D": "Draw up the medication in an oral syringe."
        },
        "correctAnswer": "B",
        "rationale": "Before administering any insulin, the nurse must check the patient's current blood glucose level to ensure it is safe to give the dose and prevent hypoglycemia. The availability of a snack is important planning but checking the glucose is the immediate priority.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient who has been taking prednisone for a month for rheumatoid arthritis suddenly stops the medication. The nurse should assess the patient for which condition first?",
        "options": {
            "A": "A Cushingoid appearance",
            "B": "Hyperglycemic hyperosmolar state (HHS)",
            "C": "An acute adrenal crisis",
            "D": "A thyroid storm"
        },
        "correctAnswer": "C",
        "rationale": "Abrupt cessation of long-term steroid therapy can precipitate an acute adrenal crisis (or Addisonian crisis), a life-threatening condition characterized by hypotension, hypoglycemia, and shock, because the adrenal glands have not had time to resume normal cortisol production.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "Parathyroid Hormone (PTH) primarily works to:",
        "options": {
            "A": "Decrease blood calcium levels.",
            "B": "Increase blood calcium levels.",
            "C": "Regulate sodium and water balance.",
            "D": "Control glucose metabolism."
        },
        "correctAnswer": "B",
        "rationale": "PTH is secreted in response to low serum calcium and works to increase calcium levels by stimulating bone resorption, increasing intestinal absorption, and increasing renal reabsorption of calcium.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient has a serum calcium level of 7.9 mg/dL. The nurse would expect to see which hormone level elevated in response?",
        "options": {
            "A": "Calcitonin",
            "B": "Parathyroid hormone (PTH)",
            "C": "Thyroid-stimulating hormone (TSH)",
            "D": "Adrenocorticotropic hormone (ACTH)"
        },
        "correctAnswer": "B",
        "rationale": "A normal serum calcium level is approximately 8.5 to 10.5 mg/dL. A level of 7.9 mg/dL is low (hypocalcemia). In response, the parathyroid glands release PTH to raise calcium levels by stimulating bone resorption and kidney reabsorption of calcium.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "The nurse is caring for a patient on long-term glucocorticoid therapy. The nurse should prioritize monitoring for which of the following complications?",
        "options": {
            "A": "Hypoglycemia",
            "B": "Weight loss",
            "C": "Osteoporosis",
            "D": "Bradycardia"
        },
        "correctAnswer": "C",
        "rationale": "Long-term glucocorticoid use can decrease bone formation and increase bone resorption, leading to osteoporosis and an increased risk of fractures. This is a major complication that requires monitoring (e.g., via bone density scans).",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient with Type 2 diabetes on metformin and an SGLT2 inhibitor (e.g., canagliflozin) is admitted with a blood glucose of 230 mg/dL, positive serum ketones, and an anion gap of 18. The nurse recognizes this presentation as:",
        "options": {
            "A": "Hyperglycemic Hyperosmolar State (HHS)",
            "B": "Starvation ketosis",
            "C": "Alcoholic ketoacidosis",
            "D": "Euglycemic Diabetic Ketoacidosis (eDKA)"
        },
        "correctAnswer": "D",
        "rationale": "SGLT2 inhibitors can cause DKA with only mild to moderate glucose elevation (euglycemic DKA) by increasing urinary glucose excretion and promoting ketogenesis. The presence of significant ketosis and an anion gap acidosis with a blood glucose <250 mg/dL is the hallmark of eDKA.",
        "section": "Advanced Concepts: Antidiabetics"
    },
    {
        "questionText": "Which patient is the most likely candidate for treatment with calcitriol?",
        "options": {
            "A": "A patient with osteoporosis and high serum calcium.",
            "B": "A patient with hyperparathyroidism.",
            "C": "A patient with hypocalcemia secondary to chronic kidney disease.",
            "D": "A patient with a vitamin D overdose."
        },
        "correctAnswer": "C",
        "rationale": "Chronic kidney disease impairs the kidney's ability to convert vitamin D to its active form (calcitriol), leading to hypocalcemia. Therefore, supplementing with calcitriol is a common treatment for these patients.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient's morning blood glucose is 350 mg/dL. Which type of insulin would be most appropriate to administer at this time to provide the quickest correction?",
        "options": {
            "A": "NPH",
            "B": "Glargine",
            "C": "Regular",
            "D": "Aspart"
        },
        "correctAnswer": "D",
        "rationale": "Aspart is a rapid-acting insulin with the fastest onset (15 min). It is ideal for correcting acute hyperglycemia, such as a high pre-meal blood sugar reading. Regular insulin is also short-acting but has a slower onset than aspart.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which statement best describes the mechanism of action for Glipizide and Metformin?",
        "options": {
            "A": "Both medications primarily work by reducing glucose absorption in the intestines.",
            "B": "Glipizide stimulates insulin release, while Metformin reduces liver glucose production.",
            "C": "Both medications primarily increase insulin sensitivity in peripheral tissues.",
            "D": "Glipizide reduces liver glucose production, while Metformin stimulates insulin release."
        },
        "correctAnswer": "B",
        "rationale": "Glipizide (a sulfonylurea) works by stimulating the pancreas to release insulin. Metformin (a biguanide) works by reducing liver glucose production and increasing peripheral insulin sensitivity. Their mechanisms are different.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with hypothyroidism is prescribed levothyroxine. What is the primary therapeutic goal for this patient?",
        "options": {
            "A": "To increase the serum TSH level.",
            "B": "To decrease the heart rate and lower metabolism.",
            "C": "To achieve a euthyroid state with normal TSH and T4 levels.",
            "D": "To cure the hypothyroidism."
        },
        "correctAnswer": "C",
        "rationale": "The goal of thyroid hormone replacement therapy is to restore normal thyroid function (euthyroid state), which is evidenced by clinical improvement and normalization of serum TSH and free T4 levels. Hypothyroidism is typically not cured but managed.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "How does glucagon work to treat severe hypoglycemia?",
        "options": {
            "A": "It converts glucose into glycogen in the liver.",
            "B": "It stimulates the liver to convert glycogen to glucose.",
            "C": "It increases insulin sensitivity in the muscle cells.",
            "D": "It provides a direct source of intravenous glucose."
        },
        "correctAnswer": "B",
        "rationale": "Glucagon is a hormone that has the opposite effect of insulin. It stimulates the liver to break down its glycogen stores into glucose (glycogenolysis), which is then released into the bloodstream to raise blood sugar levels.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "What statement by a patient taking metformin indicates a need for further teaching?",
        "options": {
            "A": "I will take this pill with my meals to avoid an upset stomach.",
            "B": "I need to tell my doctor I take this medication before I get any CT scans with contrast.",
            "C": "This medication will help my pancreas secrete more insulin.",
            "D": "I should not drink alcohol while taking this medication."
        },
        "correctAnswer": "C",
        "rationale": "Metformin does not stimulate the pancreas to secrete insulin. It works by reducing hepatic glucose output and increasing insulin sensitivity. This misunderstanding requires clarification by the nurse.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient is prescribed both insulin glargine and insulin lispro. Which is an appropriate nursing action?",
        "options": {
            "A": "Draw up the two insulins in the same syringe to reduce the number of injections.",
            "B": "Administer the glargine at bedtime and the lispro 15 minutes before meals.",
            "C": "Administer the lispro 30-60 minutes before the meal arrives.",
            "D": "Hold the glargine if the pre-meal Accu-check is less than 150 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "Glargine (long-acting) provides basal coverage and is often given once daily. Lispro (rapid-acting) is used as a bolus to cover meals and should be given shortly before eating. They should never be mixed in the same syringe.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which insulin has no peak action and provides consistent, basal coverage over 24 hours?",
        "options": {
            "A": "Insulin regular (Humulin R)",
            "B": "Insulin NPH (Humulin N)",
            "C": "Insulin glargine (Lantus)",
            "D": "Insulin aspart (NovoLog)"
        },
        "correctAnswer": "C",
        "rationale": "Insulin glargine is a long-acting insulin designed to provide a steady, basal level of insulin over 24 hours with no pronounced peak. This helps to control blood glucose levels between meals and overnight.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "The nurse is caring for a patient who has been on prednisone 40 mg daily for 2 years. Which laboratory finding would be an expected consequence of this therapy?",
        "options": {
            "A": "Hyperkalemia",
            "B": "Neutropenia",
            "C": "Leukocytosis",
            "D": "Anemia"
        },
        "correctAnswer": "C",
        "rationale": "Glucocorticoids cause demargination of neutrophils from blood vessel walls, leading to an artificially elevated white blood cell count (leukocytosis) in the absence of infection. This is a common and expected lab finding. They cause hypokalemia and do not typically cause neutropenia or anemia.",
        "section": "Advanced Concepts: Adrenal Hormones"
    },
    {
        "questionText": "A patient with Type 1 diabetes is found unconscious. The patient's skin is cool and clammy. Which medication should the nurse anticipate administering?",
        "options": {
            "A": "Intravenous regular insulin",
            "B": "Subcutaneous NPH insulin",
            "C": "Intramuscular glucagon",
            "D": "Oral glucose tablet"
        },
        "correctAnswer": "C",
        "rationale": "The patient's signs and symptoms (unconscious, cool, clammy skin) are classic for severe hypoglycemia. Since the patient is unconscious and cannot take anything orally, intramuscular glucagon or intravenous dextrose is the appropriate emergency treatment.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with type 2 diabetes managed with metformin is now prescribed prednisone for a severe inflammatory condition. What does the nurse anticipate will be necessary for this patient's care?",
        "options": {
            "A": "A decreased dose of metformin.",
            "B": "Frequent monitoring of blood glucose and potential need for insulin.",
            "C": "Holding the metformin while the patient is on prednisone.",
            "D": "A low carbohydrate diet only."
        },
        "correctAnswer": "B",
        "rationale": "Prednisone can cause significant hyperglycemia. A patient with diabetes will likely experience elevated blood glucose levels that may not be controlled by their oral antidiabetic agent alone, often requiring temporary insulin therapy and close monitoring.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "For a patient with hyperparathyroidism, maintaining high fluid intake is primarily encouraged to:",
        "options": {
            "A": "Improve hydration status.",
            "B": "Prevent the formation of calcium-based renal calculi.",
            "C": "Enhance the absorption of calcium supplements.",
            "D": "Dilute elevated sodium levels in the blood."
        },
        "correctAnswer": "B",
        "rationale": "Hyperparathyroidism leads to hypercalciuria (high levels of calcium in the urine). High fluid intake helps to dilute the urine and prevent the supersaturation of calcium oxalate or calcium phosphate, which reduces the risk of kidney stone formation, a major complication of the disease.",
        "section": "Advanced Concepts: Parathyroid Disorders"
    },
    {
        "questionText": "A patient taking prednisone asks why they need to be concerned about getting sick. What is the nurse's best response?",
        "options": {
            "A": "Prednisone can make you feel tired, which makes it harder to fight off illness.",
            "B": "Prednisone suppresses your immune system, which lowers your ability to fight infection.",
            "C": "Prednisone causes a low white blood cell count, which is permanent.",
            "D": "Prednisone can mask the signs of a fever, so you won't know when you're sick."
        },
        "correctAnswer": "B",
        "rationale": "Glucocorticoids like prednisone have immunosuppressive effects. This is a primary reason they are used, but it also puts the patient at an increased risk for developing infections because their natural defense mechanisms are weakened.",
        "section": "Patient Education"
    },
    {
        "questionText": "A patient with type 1 diabetes receives a dose of NPH insulin at 7:00 AM. The nurse should be most alert for a hypoglycemic reaction at what time?",
        "options": {
            "A": "8:00 AM",
            "B": "11:00 AM",
            "C": "3:00 PM",
            "D": "11:00 PM"
        },
        "correctAnswer": "C",
        "rationale": "NPH is an intermediate-acting insulin. Its peak effect occurs approximately 6-14 hours after administration. A hypoglycemic reaction is most likely to occur during this peak time. 3:00 PM is 8 hours after the 7:00 AM dose and falls within this peak window.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which insulin combinations are incompatible for mixing in the same syringe? Select all that apply.",
        "options": {
            "A": "Insulin NPH and Insulin Regular",
            "B": "Insulin Glargine and Insulin Lispro",
            "C": "Insulin Detemir and Insulin Aspart",
            "D": "Insulin Regular and Insulin Lispro"
        },
        "correctAnswer": ["B", "C"],
        "rationale": "Long-acting insulins (glargine, detemir) have a specific pH and must never be mixed with any other insulin. Insulin Regular and Insulin Lispro can be used as basal or bolus in separate syringes, but not generally mixed.",
        "section": "Advanced Concepts: Insulin Therapy"
    },
    {
        "questionText": "Which of the following actions demonstrates the correct technique for administering insulin? Select all that apply.",
        "options": {
            "A": "Injecting the insulin into the deltoid muscle.",
            "B": "Gently rolling a vial of NPH insulin to mix it.",
            "C": "Administering the injection at a 90-degree angle.",
            "D": "Massaging the site after the injection to increase absorption."
        },
        "correctAnswer": ["B", "C"],
        "rationale": "NPH (cloudy) insulin should be gently rolled, not shaken, to mix. Insulin is a subcutaneous injection, typically administered at a 90-degree angle (or 45 for very thin individuals). It is injected into fatty tissue, not muscle, and the site should not be massaged.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is administering insulin lispro to a patient with type 1 diabetes. When should the nurse ensure the patient's meal tray is available?",
        "options": {
            "A": "Within 15 minutes of administration.",
            "B": "30 to 60 minutes after administration.",
            "C": "1 to 2 hours after administration.",
            "D": "At any time, as onset is delayed."
        },
        "correctAnswer": "A",
        "rationale": "Insulin lispro is a rapid-acting insulin with an onset of 15-30 minutes. To prevent hypoglycemia, the patient should eat within this timeframe.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is receiving insulin via a continuous subcutaneous insulin pump. The nurse knows that which type of insulin is used in the pump?",
        "options": {
            "A": "Long-acting insulin (glargine)",
            "B": "Intermediate-acting insulin (NPH)",
            "C": "Rapid-acting insulin (lispro or aspart)",
            "D": "A mixture of regular and NPH insulin"
        },
        "correctAnswer": "C",
        "rationale": "Insulin pumps use rapid-acting insulin. The pump delivers a continuous small (basal) dose throughout the day and the patient can program a larger (bolus) dose at mealtimes to cover the carbohydrate intake.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with Type 1 diabetes on an insulin pump reports a 3 AM blood glucose of 60 mg/dL and a 7 AM blood glucose of 220 mg/dL. What is the most likely cause and the appropriate intervention?",
        "options": {
            "A": "Dawn phenomenon; increase the overnight basal rate.",
            "B": "Somogyi effect; decrease the overnight basal rate or give a bedtime snack.",
            "C": "Insulin stacking; counsel the patient on timing of correction boluses.",
            "D": "Waning insulin; switch to a more concentrated insulin."
        },
        "correctAnswer": "B",
        "rationale": "The pattern of nocturnal hypoglycemia followed by rebound hyperglycemia (due to counter-regulatory hormone release) is characteristic of the Somogyi effect. The appropriate intervention is to prevent the initial hypoglycemia by reducing the overnight insulin dose or providing a snack.",
        "section": "Advanced Concepts: Insulin Therapy"
    },
    {
        "questionText": "Which instructions are essential for a patient newly diagnosed with type 1 diabetes? (Select All That Apply)",
        "options": {
            "A": "How to monitor blood glucose levels.",
            "B": "How to administer insulin injections.",
            "C": "The signs and symptoms of both hypo- and hyperglycemia.",
            "D": "How to adjust metformin dosage based on meals."
        },
        "correctAnswer": ["A", "B", "C"],
        "rationale": "A patient with type 1 diabetes requires insulin for survival. Essential 'survival skills' teaching includes blood glucose monitoring, insulin administration, and recognizing/managing high and low blood sugar. Metformin is an oral agent used for type 2 diabetes.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient receiving long-term prednisone therapy is at risk for which of the following conditions? (Select All That Apply)",
        "options": {
            "A": "Hyperglycemia",
            "B": "Increased risk of infection",
            "C": "Hypotension",
            "D": "Osteoporosis"
        },
        "correctAnswer": ["A", "B", "D"],
        "rationale": "Glucocorticoids like prednisone can increase blood glucose levels, suppress the immune system (increasing infection risk), and lead to bone demineralization (osteoporosis) with long-term use. They typically cause fluid retention and hypertension, not hypotension.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "The nurse is providing discharge instructions to a patient going home on glipizide. Which instruction is the priority?",
        "options": {
            "A": "Weigh yourself daily at the same time.",
            "B": "Follow the prescribed diet and exercise plan.",
            "C": "Report any signs of hypoglycemia like dizziness or sweating.",
            "D": "Maintain a log of your medication times."
        },
        "correctAnswer": "C",
        "rationale": "Glipizide is a sulfonylurea that can cause hypoglycemia. Recognizing and managing hypoglycemia is a critical safety issue and is the priority teaching point to prevent acute complications.",
        "section": "Patient Education"
    },
    {
        "questionText": "The nurse is applying the nursing process to a patient taking oral antidiabetic agents. Which component is a critical part of the evaluation phase?",
        "options": {
            "A": "Assessing the patient's knowledge of the disease.",
            "B": "Administering the medication as prescribed.",
            "C": "Reviewing the patient's Hemoglobin A1c levels.",
            "D": "Planning a diet in collaboration with the patient."
        },
        "correctAnswer": "C",
        "rationale": "The evaluation phase of the nursing process involves determining the effectiveness of the interventions. For a patient on antidiabetic agents, reviewing the Hemoglobin A1c is the best long-term indicator of glycemic control and treatment effectiveness.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with Addison's disease will exhibit hyperpigmentation of the skin (bronze skin) due to:",
        "options": {
            "A": "Excessive secretion of parathyroid hormone (PTH).",
            "B": "Increased production of melanocyte-stimulating hormone (MSH) by the pituitary.",
            "C": "Iron deposits in the skin from chronic anemia.",
            "D": "A side effect of mineralocorticoid replacement therapy."
        },
        "correctAnswer": "B",
        "rationale": "In primary adrenal insufficiency (Addison's), the pituitary gland secretes high levels of ACTH to try and stimulate the failing adrenal glands. Pro-opiomelanocortin (POMC), the precursor to ACTH, is also cleaved into melanocyte-stimulating hormone (MSH), causing hyperpigmentation. It is unrelated to PTH.",
        "section": "Advanced Concepts: Adrenal Disorders"
    },
    {
        "questionText": "A patient is ordered to receive 10 units of NPH insulin and 5 units of Regular insulin. What is the priority nursing action?",
        "options": {
            "A": "Verify the dose with another licensed nurse.",
            "B": "Draw up the Regular (clear) insulin into the syringe first.",
            "C": "Administer the two insulins in separate injections.",
            "D": "Ask the patient where they would like the injection."
        },
        "correctAnswer": "B",
        "rationale": "When mixing insulins, the correct procedure is to draw up the short-acting (clear) insulin before the intermediate-acting (cloudy) insulin to prevent contamination of the short-acting vial. While dose verification is important, the immediate action related to preparing the dose is drawing it up correctly.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which type of insulin is the only one that can be administered intravenously?",
        "options": {
            "A": "Insulin NPH (Humulin N)",
            "B": "Insulin glargine (Lantus)",
            "C": "Insulin regular (Humulin R)",
            "D": "Insulin detemir (Levemir)"
        },
        "correctAnswer": "C",
        "rationale": "Regular insulin is a short-acting insulin and is the standard insulin used for IV administration, such as for the treatment of DKA or in critical care settings for tight glycemic control.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient's Hemoglobin A1C level is 9.2%. The nurse interprets this as:",
        "options": {
            "A": "Excellent long-term glycemic control.",
            "B": "Normal glycemic control.",
            "C": "Poor long-term glycemic control.",
            "D": "An indication of recent hypoglycemia."
        },
        "correctAnswer": "C",
        "rationale": "An HgbA1c level reflects average blood glucose over the past 2-3 months. A level of 9.2% is significantly elevated (target is typically <7% for most diabetics), indicating poor long-term glycemic control and a need for intervention.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "The nurse is caring for a patient receiving IV insulin for DKA. The patient's blood glucose has decreased to 240 mg/dL. The nurse will notify the provider and anticipate which order?",
        "options": {
            "A": "Discontinuing the insulin infusion immediately.",
            "B": "Adding dextrose to the intravenous fluids.",
            "C": "Administering a dose of subcutaneous NPH insulin.",
            "D": "Switching the patient to an oral diet."
        },
        "correctAnswer": "B",
        "rationale": "When treating DKA, as the blood glucose approaches 250 mg/dL, dextrose is typically added to the IV fluids. This allows the insulin infusion to continue to resolve the ketoacidosis without causing the patient to become hypoglycemic.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with adrenal insufficiency is treated with hormone replacement. Which statement indicates the patient understands the therapy?",
        "options": {
            "A": "I only need to take this medication when I feel stressed.",
            "B": "This medication will cure my condition after a few months.",
            "C": "I may need to increase my dose of glucocorticoid during times of illness or stress.",
            "D": "I should take my hydrocortisone with a full glass of milk."
        },
        "correctAnswer": "C",
        "rationale": "During times of physical stress (e.g., illness, surgery), the body naturally produces more cortisol. Patients on replacement therapy must mimic this by taking a higher dose (stress dosing) of their glucocorticoid to prevent an adrenal crisis.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A nurse is preparing to administer NPH insulin and regular insulin in the same syringe. What is the correct procedure?",
        "options": {
            "A": "Draw up the NPH insulin first, then the regular insulin.",
            "B": "Draw up the regular insulin first, then the NPH insulin.",
            "C": "Inject air into the NPH vial, then inject air into the regular vial, and draw up the NPH first.",
            "D": "It does not matter which insulin is drawn up first."
        },
        "correctAnswer": "B",
        "rationale": "To prevent contaminating the short-acting insulin with the longer-acting insulin, the mnemonic 'clear before cloudy' is used. Regular insulin (clear) should be drawn into the syringe before NPH insulin (cloudy).",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with Cushing's syndrome caused by an adrenal adenoma undergoes lab testing. Which set of results would the nurse expect?",
        "options": {
            "A": "High ACTH, High Cortisol",
            "B": "Low ACTH, High Cortisol",
            "C": "High ACTH, Low Cortisol",
            "D": "Low ACTH, Low Cortisol"
        },
        "correctAnswer": "B",
        "rationale": "An adrenal adenoma independently secretes excess cortisol. This high level of cortisol exerts negative feedback on the pituitary gland, suppressing its production of ACTH. This pattern distinguishes it from pituitary-dependent Cushing's (Cushing's disease), which would have high ACTH.",
        "section": "Advanced Concepts: Adrenal Disorders"
    },
    {
        "questionText": "Which statement is INCORRECT regarding insulin glargine (Lantus)?",
        "options": {
            "A": "It is considered a long-acting, basal insulin.",
            "B": "It has a pronounced peak action at 4-6 hours.",
            "C": "It cannot be mixed in the same syringe with other insulins.",
            "D": "It is often administered once a day, at the same time each day."
        },
        "correctAnswer": "B",
        "rationale": "Insulin glargine is designed to have no significant peak, providing a relatively steady level of insulin over 24 hours to act as a basal insulin.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient taking glipizide for type 2 diabetes presents with shakiness, confusion, and palpitations. The nurse checks the patient's fingerstick blood glucose and finds it to be 58 mg/dL. What is the nurse's priority action?",
        "options": {
            "A": "Administer the patient's prescribed dose of glipizide.",
            "B": "Provide the patient with 15 grams of a simple carbohydrate, such as orange juice.",
            "C": "Notify the healthcare provider immediately.",
            "D": "Recheck the blood glucose in one hour."
        },
        "correctAnswer": "B",
        "rationale": "The patient is experiencing hypoglycemia, likely caused by the glipizide (a sulfonylurea). The priority is to rapidly increase the blood glucose level by administering a fast-acting carbohydrate. The other actions would be inappropriate or delayed.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "Which hormone is responsible for lowering blood calcium levels by promoting calcium deposition in the bone?",
        "options": {
            "A": "Parathyroid hormone (PTH)",
            "B": "Thyroxine (T4)",
            "C": "Aldosterone",
            "D": "Calcitonin"
        },
        "correctAnswer": "D",
        "rationale": "Calcitonin, produced by the thyroid gland, opposes the action of parathyroid hormone. It lowers blood calcium by inhibiting osteoclast activity (which breaks down bone) and promoting calcium deposition in bones.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "Rapid correction of severe hyponatremia in a patient with HHS or DKA can lead to which devastating neurological complication?",
        "options": {
            "A": "Cerebral edema",
            "B": "Osmotic demyelination syndrome",
            "C": "Bacterial meningitis",
            "D": "Guillain-Barré syndrome"
        },
        "correctAnswer": "B",
        "rationale": "While rapid reduction of glucose can cause cerebral edema, the rapid correction of chronic hyponatremia with hypertonic fluids can cause osmotic demyelination syndrome (formerly central pontine myelinolysis), a severe, often irreversible neurological disorder. This is a key principle in fluid resuscitation for these patients.",
        "section": "Advanced Concepts: Antidiabetics"
    },
    {
        "questionText": "What is the primary difference in the action of insulin versus oral antidiabetic agents?",
        "options": {
            "A": "Insulin directly facilitates glucose entry into cells, while most oral agents work by other mechanisms.",
            "B": "Oral agents are more potent at lowering blood sugar than insulin.",
            "C": "Insulin can only be used for type 1 diabetes, and oral agents only for type 2.",
            "D": "Oral agents work by stimulating glucagon release."
        },
        "correctAnswer": "A",
        "rationale": "Insulin is a hormone that acts like a key to allow glucose to move from the bloodstream into cells for energy. Oral antidiabetic agents work through various other means, such as increasing insulin secretion (sulfonylureas), reducing liver glucose output (metformin), or improving insulin sensitivity.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "Which of the following is a primary mineralocorticoid, and what is its function?",
        "options": {
            "A": "Cortisol; regulates the immune response.",
            "B": "Prednisone; reduces inflammation.",
            "C": "Aldosterone; regulates sodium and water balance.",
            "D": "Levothyroxine; regulates metabolism."
        },
        "correctAnswer": "C",
        "rationale": "Aldosterone is the principal mineralocorticoid produced by the adrenal cortex. Its primary role is to regulate blood pressure by managing sodium and water reabsorption and potassium excretion in the kidneys.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient is prescribed calcitriol for hypocalcemia. The nurse should instruct the patient to avoid excessive intake of which foods?",
        "options": {
            "A": "Foods high in potassium, like bananas.",
            "B": "Foods high in vitamin C, like citrus fruits.",
            "C": "Foods high in calcium, like dairy products.",
            "D": "Foods high in iron, like red meat."
        },
        "correctAnswer": "C",
        "rationale": "Since calcitriol promotes calcium absorption, a high intake of dietary calcium can increase the risk of developing hypercalcemia. The patient should be taught to maintain a consistent calcium intake as advised by their provider.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "Which are appropriate teaching points for a patient taking prednisone? Select all that apply.",
        "options": {
            "A": "Take this medication with food or milk.",
            "B": "You may need to monitor your blood glucose levels.",
            "C": "Stop taking the drug as soon as your symptoms resolve.",
            "D": "Report any signs of infection, such as a sore throat or fever."
        },
        "correctAnswer": ["A", "B", "D"],
        "rationale": "Prednisone should be taken with food to reduce GI upset. It can cause hyperglycemia, so glucose monitoring may be necessary. It also suppresses the immune system, so reporting signs of infection is critical. Prednisone must be tapered and not stopped abruptly.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "The nurse should question a new order for metformin (Glucophage) for which patient?",
        "options": {
            "A": "A 55-year-old with type 2 diabetes and an HgbA1c of 7.8%.",
            "B": "A 62-year-old with type 2 diabetes and a history of hypertension.",
            "C": "A 48-year-old with type 2 diabetes who is overweight.",
            "D": "A 70-year-old with type 2 diabetes and severe renal impairment."
        },
        "correctAnswer": "D",
        "rationale": "Metformin is contraindicated in patients with significant renal impairment due to the increased risk of lactic acidosis, a serious metabolic complication. The other patients are appropriate candidates for metformin therapy.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "Which statement regarding the pharmacology of metformin is INCORRECT?",
        "options": {
            "A": "Its primary mechanism involves inhibition of mitochondrial glycerophosphate dehydrogenase.",
            "B": "It undergoes significant hepatic metabolism via the CYP2C9 enzyme pathway.",
            "C": "It can interfere with the absorption of Vitamin B12 with long-term use.",
            "D": "It does not cause weight gain and has a low risk of hypoglycemia as monotherapy."
        },
        "correctAnswer": "B",
        "rationale": "A key pharmacokinetic feature of metformin is that it is not metabolized by the liver. It is excreted unchanged by the kidneys, which is why it is contraindicated in severe renal impairment. The other statements are correct.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "Which antidiabetic agent's mechanism of action involves stimulating insulin release from the beta cells of the pancreas, making it effective only for patients with some remaining pancreatic function?",
        "options": {
            "A": "Metformin",
            "B": "Acarbose",
            "C": "Glipizide",
            "D": "Pioglitazone"
        },
        "correctAnswer": "C",
        "rationale": "Glipizide is a sulfonylurea. This class of drugs works by stimulating the pancreatic beta cells to secrete insulin. Therefore, they are not effective for patients with type 1 diabetes, who lack functioning beta cells.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A diabetic patient who is on NPH insulin is most likely to experience a hypoglycemic reaction during which phase of the insulin's action?",
        "options": {
            "A": "Onset",
            "B": "Peak",
            "C": "Duration",
            "D": "After its therapeutic effect has worn off"
        },
        "correctAnswer": "B",
        "rationale": "The risk of hypoglycemia is greatest when the insulin is exerting its maximum effect, which is known as its peak time. For NPH, this is approximately 6-14 hours after administration.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient taking digoxin for heart failure and furosemide for edema is started on calcitriol for hypoparathyroidism. Which assessment finding is the highest priority for the nurse to report?",
        "options": {
            "A": "Serum calcium of 11.5 mg/dL.",
            "B": "Serum potassium of 3.6 mEq/L.",
            "C": "Presence of 1+ pedal edema.",
            "D": "Blood pressure of 130/84 mmHg."
        },
        "correctAnswer": "A",
        "rationale": "Hypercalcemia, a potential effect of calcitriol, potentiates the effects of digoxin and can lead to severe digoxin toxicity, even with a therapeutic digoxin level. This is a life-threatening drug-lab interaction that takes priority over the other findings.",
        "section": "Advanced Concepts: Parathyroid Hormones"
    },
    {
        "questionText": "In the nursing process for a patient newly started on prednisone, which intervention is critical?",
        "options": {
            "A": "Monitoring blood glucose levels.",
            "B": "Administering the medication with an antacid.",
            "C": "Encouraging a low-protein diet.",
            "D": "Checking for peripheral neuropathy."
        },
        "correctAnswer": "A",
        "rationale": "Prednisone, a glucocorticoid, can cause hyperglycemia as a significant side effect by promoting gluconeogenesis and causing insulin resistance. Therefore, regular monitoring of blood glucose levels is a critical nursing intervention.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "Which of these are signs of Diabetic Ketoacidosis (DKA)? Select all that apply.",
        "options": {
            "A": "Fruity-scented breath",
            "B": "Kussmaul respirations (deep, rapid breathing)",
            "C": "Bradycardia",
            "D": "Blood glucose of 100 mg/dL"
        },
        "correctAnswer": ["A", "B"],
        "rationale": "DKA is characterized by hyperglycemia, ketosis, and acidosis. The ketones cause a fruity odor on the breath, and the metabolic acidosis leads to a compensatory respiratory pattern called Kussmaul respirations. Tachycardia (not bradycardia) and hyperglycemia (>250 mg/dL) are also present.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with a history of hypertension controlled with a beta-blocker is diagnosed with Type 2 diabetes and started on glipizide. Which teaching point is most critical for this specific patient?",
        "options": {
            "A": "Beta-blockers can mask the adrenergic symptoms of hypoglycemia, such as shakiness and palpitations.",
            "B": "Glipizide can worsen hypertension, requiring an increased dose of the beta-blocker.",
            "C": "The patient must take their beta-blocker at a different time than the glipizide.",
            "D": "This combination of drugs significantly increases the risk for lactic acidosis."
        },
        "correctAnswer": "A",
        "rationale": "Beta-blockers block the sympathetic response that causes tachycardia, tremors, and anxiety during a hypoglycemic episode. The patient will not experience these early warning signs, making it critical for them to rely on other cues (like sweating) and frequent glucose monitoring.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "When a patient is NPO for a procedure, what is the typical approach to their long-acting insulin (glargine)?",
        "options": {
            "A": "It should be held immediately to prevent hypoglycemia.",
            "B": "The dose should be significantly reduced or held based on direct provider order.",
            "C": "It should generally not be held, or only slightly reduced, with close monitoring.",
            "D": "It should be switched to a rapid-acting insulin given every 4 hours."
        },
        "correctAnswer": "C",
        "rationale": "Long-acting insulin provides basal coverage to prevent DKA and should typically not be held, or the dose only slightly reduced, even when a patient is NPO. The provider should always be consulted for specific orders, but complete discontinuation is generally incorrect as it puts the patient at risk for hyperglycemia and DKA.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is prescribed prednisone for an acute exacerbation of an autoimmune disease. What is the most important instruction for the nurse to provide regarding this medication?",
        "options": {
            "A": "Take the medication on an empty stomach to increase absorption.",
            "B": "Stop the medication immediately if you feel better.",
            "C": "Do not stop taking this medication abruptly; the dose must be tapered.",
            "D": "Avoid dairy products while on this medication."
        },
        "correctAnswer": "C",
        "rationale": "Abrupt cessation of long-term prednisone can cause acute adrenal insufficiency, which is a life-threatening condition. The dose must be tapered slowly to allow the adrenal glands to resume their natural cortisol production.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A nurse is administering glipizide to a patient. The nurse understands that this medication works by:",
        "options": {
            "A": "Improving insulin sensitivity in muscle and fat tissue.",
            "B": "Stimulating the pancreatic beta cells to release insulin.",
            "C": "Slowing carbohydrate digestion in the small intestine.",
            "D": "Decreasing the production of glucose by the liver."
        },
        "correctAnswer": "B",
        "rationale": "Glipizide is a sulfonylurea, a class of drugs that directly stimulates the pancreas to secrete more insulin. This is its primary mechanism of action for lowering blood glucose.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient asks why they need to rotate their insulin injection sites. What is the nurse's best response?",
        "options": {
            "A": "To prevent the skin from becoming too calloused to inject.",
            "B": "To prevent tissue damage and ensure consistent insulin absorption.",
            "C": "To decrease the amount of pain associated with the injections.",
            "D": "To make sure all parts of your body get used to the insulin."
        },
        "correctAnswer": "B",
        "rationale": "Rotating sites prevents lipodystrophy (changes in subcutaneous fat) which can be either atrophy or hypertrophy. This tissue damage can interfere with the absorption of insulin, leading to erratic blood glucose levels.",
        "section": "Patient Education"
    },
    {
        "questionText": "A patient with Type 2 diabetes has a history of alcohol use disorder and is admitted with decompensated heart failure. A new order for metformin is written. What is the nurse's priority action?",
        "options": {
            "A": "Administer the metformin as ordered with a meal.",
            "B": "Hold the metformin and question the order with the provider.",
            "C": "Obtain an order for Vitamin B12 supplementation.",
            "D": "Educate the patient on the disulfiram-like reaction with alcohol."
        },
        "correctAnswer": "B",
        "rationale": "Conditions that predispose to tissue hypoxia, such as decompensated heart failure and acute alcohol intoxication, are contraindications for metformin due to a significantly increased risk of developing life-threatening lactic acidosis. The order should be questioned for patient safety.",
        "section": "Advanced Concepts: Safety/Nursing Judgment"
    },
    {
        "questionText": "A patient has been taking levothyroxine for 6 months. Which finding would indicate that the treatment has been effective?",
        "options": {
            "A": "A decreased heart rate from 88 to 62 bpm.",
            "B": "A decreased TSH level.",
            "C": "An increased T3 level.",
            "D": "A weight gain of 5 pounds."
        },
        "correctAnswer": "B",
        "rationale": "In primary hypothyroidism, the TSH level is high as the pituitary tries to stimulate the thyroid. Effective levothyroxine therapy replaces the thyroid hormone, which in turn reduces the TSH level back to a normal range through a negative feedback loop.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "What statement is INCORRECT regarding the hormone vasopressin (ADH)?",
        "options": {
            "A": "It is synthesized in the hypothalamus and released from the posterior pituitary.",
            "B": "Its primary action is to increase the permeability of the collecting ducts to water.",
            "C": "In high doses, it causes vasodilation, leading to hypotension.",
            "D": "A deficiency of vasopressin results in diabetes insipidus."
        },
        "correctAnswer": "C",
        "rationale": "In addition to its antidiuretic effect on the kidneys (V2 receptors), vasopressin in high (pharmacologic) doses is a potent vasoconstrictor (acting on V1 receptors), which increases blood pressure. It is sometimes used as a pressor in shock states.",
        "section": "Advanced Concepts: Pituitary Hormones"
    },
    {
        "questionText": "A patient is admitted with a blood glucose of 650 mg/dL, a negative urine ketone test, and profound dehydration. The nurse recognizes these findings are most consistent with which condition?",
        "options": {
            "A": "Diabetic Ketoacidosis (DKA)",
            "B": "Hyperglycemic Hyperosmolar State (HHS)",
            "C": "Severe hypoglycemia",
            "D": "Thyroid storm"
        },
        "correctAnswer": "B",
        "rationale": "HHS is characterized by extremely high blood glucose (>600 mg/dL), severe dehydration, and minimal or no ketones. DKA presents with ketones and typically lower, though still elevated, glucose levels.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A nurse is teaching a patient about the signs and symptoms of hypoglycemia. Which of the following should be included? (Select All That Apply)",
        "options": {
            "A": "Diaphoresis (sweating)",
            "B": "Tachycardia",
            "C": "Polyuria (frequent urination)",
            "D": "Shakiness and irritability"
        },
        "correctAnswer": ["A", "B", "D"],
        "rationale": "Hypoglycemia triggers a sympathetic nervous system response, causing diaphoresis, tachycardia, and shakiness. Irritability is a neuroglycopenic symptom. Polyuria is a classic sign of hyperglycemia, not hypoglycemia.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "The nurse is caring for several patients. Which patient should be assessed first?",
        "options": {
            "A": "A patient taking metformin who reports mild nausea.",
            "B": "A patient on levothyroxine with a heart rate of 78 bpm.",
            "C": "A patient on insulin who is reporting shakiness and is diaphoretic.",
            "D": "A patient taking prednisone who has a blood glucose of 145 mg/dL."
        },
        "correctAnswer": "C",
        "rationale": "The patient reporting shakiness and diaphoresis is exhibiting classic signs of hypoglycemia, an acute, life-threatening condition that requires immediate intervention. The other patients' conditions are either expected side effects or less urgent.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient on levothyroxine is also prescribed cholestyramine for high cholesterol. What is the most important instruction for the nurse to provide?",
        "options": {
            "A": "Take both medications together in the morning for convenience.",
            "B": "Take the levothyroxine, wait 4 hours, then take the cholestyramine.",
            "C": "Discontinue the levothyroxine while taking cholestyramine.",
            "D": "Take the cholestyramine with a full glass of grapefruit juice."
        },
        "correctAnswer": "B",
        "rationale": "Bile acid sequestrants like cholestyramine can bind to levothyroxine in the gut and prevent its absorption. To avoid this interaction, the medications should be separated by at least 4 hours.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient is taking levothyroxine 125 mcg daily. A lab report shows a TSH level of 0.2 mU/L (normal 0.5-5.0 mU/L). How should the nurse interpret this result?",
        "options": {
            "A": "The TSH is low, suggesting the levothyroxine dose may be too high.",
            "B": "The TSH is low, suggesting the levothyroxine dose may be too low.",
            "C": "The TSH level is within the normal range.",
            "D": "The TSH level is irrelevant when a patient is on hormone replacement."
        },
        "correctAnswer": "A",
        "rationale": "A low TSH level indicates that the pituitary gland has reduced its stimulation of the thyroid, which occurs when circulating thyroid hormone levels are high or excessive. This suggests the patient's dose of levothyroxine is too high, causing iatrogenic hyperthyroidism.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "The nurse is caring for four patients. Which patient should the nurse assess first?",
        "options": {
            "A": "A patient on prednisone complaining of increased appetite.",
            "B": "A patient with a new order for metformin.",
            "C": "A patient with a morning blood glucose of 115 mg/dL.",
            "D": "A patient who received regular insulin 2 hours ago and is now uncharacteristically irritable and confused."
        },
        "correctAnswer": "D",
        "rationale": "Irritability and confusion are neuroglycopenic signs of hypoglycemia. The timing (2 hours after regular insulin) corresponds with the peak action of the insulin, making hypoglycemia highly likely. This is an acute, dangerous condition requiring immediate assessment and intervention.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient is scheduled for a CT scan with intravenous contrast dye. The nurse notes the patient is taking metformin. What action should the nurse anticipate?",
        "options": {
            "A": "Increase the metformin dose before the procedure.",
            "B": "Withhold the metformin on the day of the procedure and for 48 hours after.",
            "C": "Administer the metformin with a full glass of water before the scan.",
            "D": "Switch the patient to insulin for the day."
        },
        "correctAnswer": "B",
        "rationale": "IV contrast dye can cause temporary kidney injury. If this occurs in a patient taking metformin, the drug can accumulate and lead to lactic acidosis, a rare but serious complication. Standard protocol is to hold metformin before the procedure and until renal function is confirmed to be normal.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "Which are appropriate teaching points for a newly diagnosed Type 1 diabetic? Select all that apply.",
        "options": {
            "A": "Rotate insulin injection sites to prevent lipodystrophy.",
            "B": "Monitor your blood glucose as directed by your provider.",
            "C": "You will likely be able to switch to oral medications like metformin later on.",
            "D": "Recognize the signs of hypoglycemia, such as sweating and irritability."
        },
        "correctAnswer": ["A", "B", "D"],
        "rationale": "Site rotation, glucose monitoring, and recognizing hypoglycemia are essential survival skills for a Type 1 diabetic. Type 1 diabetes requires lifelong insulin therapy; oral agents are not effective.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient taking levothyroxine reports a heart rate of 110 bpm, anxiety, and weight loss. The nurse anticipates which change to the patient's medication regimen?",
        "options": {
            "A": "An increase in the dose of levothyroxine.",
            "B": "A decrease in the dose of levothyroxine.",
            "C": "The addition of a beta-blocker.",
            "D": "No change is needed."
        },
        "correctAnswer": "B",
        "rationale": "The patient is exhibiting signs of hyperthyroidism, which indicates the dose of levothyroxine is too high. The provider will likely decrease the dose to alleviate these symptoms and bring the patient to a euthyroid state.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A nurse is assessing a patient taking levothyroxine for hypothyroidism. Which finding would suggest the dose is too high?",
        "options": {
            "A": "Bradycardia",
            "B": "Weight gain",
            "C": "Intolerance to cold",
            "D": "Nervousness and tremors"
        },
        "correctAnswer": "D",
        "rationale": "An excessive dose of levothyroxine can induce iatrogenic hyperthyroidism, leading to symptoms like nervousness, tremors, tachycardia, and heat intolerance. The other options are signs of hypothyroidism, suggesting the dose may be too low.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient with type 2 diabetes is prescribed metformin. Which of the following is the primary action of this drug?",
        "options": {
            "A": "It stimulates the pancreas to produce and secrete more insulin.",
            "B": "It increases the renal excretion of glucose.",
            "C": "It reduces hepatic glucose production and increases insulin sensitivity in tissues.",
            "D": "It slows the absorption of carbohydrates from the intestine."
        },
        "correctAnswer": "C",
        "rationale": "Metformin, a biguanide, works primarily by decreasing glucose production in the liver and improving the body's sensitivity to insulin. It does not directly stimulate insulin secretion.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is newly prescribed levothyroxine for hypothyroidism. Which statement by the patient indicates a need for further education?",
        "options": {
            "A": "I will take this medication on an empty stomach first thing in the morning.",
            "B": "I should report any chest pain or heart palpitations to my doctor.",
            "C": "I can stop taking this medication once my symptoms have resolved.",
            "D": "I will need periodic blood tests to monitor my thyroid levels."
        },
        "correctAnswer": "C",
        "rationale": "Levothyroxine is a lifelong therapy for most patients with hypothyroidism. Stopping the medication will cause symptoms to return. The other statements demonstrate correct understanding of the medication's administration and monitoring.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "Which of the following are potential side effects of prednisone therapy? Select all that apply.",
        "options": {
            "A": "Hypotension",
            "B": "Fluid retention",
            "C": "Hypoglycemia",
            "D": "Increased appetite"
        },
        "correctAnswer": ["B", "D"],
        "rationale": "Glucocorticoids like prednisone can cause fluid and sodium retention (leading to hypertension) and commonly increase appetite and cause weight gain. They cause hyperglycemia, not hypoglycemia.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient on long-term, high-dose prednisone therapy for an autoimmune condition is scheduled for major abdominal surgery. Which perioperative medication adjustment should the nurse anticipate?",
        "options": {
            "A": "Abruptly stopping the prednisone 48 hours before surgery to reduce infection risk.",
            "B": "Administering a supplemental 'stress dose' of an IV glucocorticoid.",
            "C": "Switching the patient to an equivalent dose of metformin.",
            "D": "Continuing the usual oral dose of prednisone without change."
        },
        "correctAnswer": "B",
        "rationale": "Long-term steroid use causes HPA axis suppression, meaning the patient cannot mount a normal cortisol response to a major stressor like surgery. This can lead to cardiovascular collapse. A 'stress dose' of IV glucocorticoids (e.g., hydrocortisone) is required to prevent an acute adrenal crisis.",
        "section": "Advanced Concepts: Adrenal Hormones"
    },
    {
        "questionText": "Which statement regarding the treatment of an Addisonian crisis is accurate?",
        "options": {
            "A": "Primary treatment involves rapid infusion of hypertonic saline.",
            "B": "Patients are typically administered a low-dose oral glucocorticoid.",
            "C": "Rapid infusion of isotonic saline and IV hydrocortisone are key interventions.",
            "D": "The focus is on managing hypertension with antihypertensive medications."
        },
        "correctAnswer": "C",
        "rationale": "Patients in Addisonian crisis have hyponatremia and profound fluid volume deficit, along with severe cortisol deficiency. The primary treatment is rapid infusion of ISOTONIC saline (0.9% NaCl) to restore fluid volume and correct hyponatremia, and immediate administration of IV hydrocortisone to replace the deficient hormone. Hypertonic saline could correct sodium too quickly and worsen dehydration. Hypertension is not a primary concern; hypotension is.",
        "section": "Advanced Concepts: Adrenal Disorders"
    },
    {
        "questionText": "What is the onset of action for regular insulin (Humulin R)?",
        "options": {
            "A": "15-30 minutes",
            "B": "30-60 minutes",
            "C": "60-120 minutes",
            "D": "2-4 hours"
        },
        "correctAnswer": "B",
        "rationale": "Regular insulin is a short-acting insulin with an onset of 30 to 60 minutes, a peak of 2 to 4 hours, and a duration of 5 to 8 hours.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient receives insulin lispro at 12:00 PM. The nurse should ensure the patient eats their lunch by what time?",
        "options": {
            "A": "12:15 PM",
            "B": "12:30 PM",
            "C": "1:00 PM",
            "D": "2:00 PM"
        },
        "correctAnswer": "A",
        "rationale": "Insulin lispro is a rapid-acting insulin with an onset of 15-30 minutes. To prevent hypoglycemia, the patient should eat within 15 minutes of the injection.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is being treated for hypoparathyroidism with calcitriol. The nurse should monitor for which sign of an adverse effect related to this therapy?",
        "options": {
            "A": "Hypotension",
            "B": "Tetany",
            "C": "Hypercalcemia",
            "D": "Hypoglycemia"
        },
        "correctAnswer": "C",
        "rationale": "Calcitriol increases serum calcium levels. The primary risk of therapy is developing hypercalcemia, which can manifest as lethargy, bone pain, and constipation. Tetany is a sign of hypocalcemia, the condition being treated.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "What is the primary function of calcitriol as a medication?",
        "options": {
            "A": "To lower serum calcium levels.",
            "B": "To promote the intestinal absorption of calcium.",
            "C": "To inhibit the action of the thyroid gland.",
            "D": "To increase the excretion of phosphate."
        },
        "correctAnswer": "B",
        "rationale": "Calcitriol is the active form of vitamin D. Its primary function is to increase calcium levels in the body by promoting the absorption of calcium from the intestines and reabsorption from the kidneys.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient presents with a TSH of 8.5 mU/L (high), a free T4 of 0.6 ng/dL (low), and positive anti-thyroid peroxidase (TPO) antibodies. The nurse correctly identifies this condition as:",
        "options": {
            "A": "Secondary hypothyroidism",
            "B": "Graves' disease",
            "C": "Subclinical hypothyroidism",
            "D": "Hashimoto's thyroiditis"
        },
        "correctAnswer": "D",
        "rationale": "The combination of high TSH and low T4 indicates primary hypothyroidism. The presence of TPO antibodies confirms the autoimmune etiology, which is Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient areas.",
        "section": "Advanced Concepts: Thyroid Disorders"
    },
{
        "questionText": "A 58-year-old patient with a history of Type 2 Diabetes Mellitus and hypertension presents to the clinic for a routine follow-up. He is currently prescribed metformin 1000 mg twice daily, lisinopril 20 mg daily, and atorvastatin 40 mg daily. His recent labs show an eGFR of 45 mL/min/1.73m2. Which adjustment to his current medication regimen is the most appropriate next step for the nurse to anticipate?",
        "options": {
            "A": "Increase the metformin dose to 1500 mg twice daily due to the eGFR indicating worsening diabetes control.",
            "B": "Discontinue metformin immediately and initiate insulin therapy due to renal impairment.",
            "C": "Continue metformin but reduce the dose and monitor renal function closely.",
            "D": "Add a sulfonylurea to his regimen as the metformin is no longer effective at this eGFR."
        },
        "correctAnswer": "C",
        "rationale": "Metformin's dose typically needs to be reduced when eGFR falls below 60 mL/min/1.73m2 and is generally contraindicated below 30 mL/min/1.73m2 due to the increased risk of lactic acidosis. An eGFR of 45 mL/min/1.73m2 indicates moderate renal impairment, necessitating a dose reduction rather than complete discontinuation or increase. Adding a sulfonylurea carries a higher risk of hypoglycemia, especially with renal impairment.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A nurse is preparing to administer NPH insulin 15 units and Regular insulin 8 units to a patient. The patient has a new order for insulin glargine 20 units at bedtime. Which action by the nurse is correct?",
        "options": {
            "A": "Mix the NPH and Regular insulin in one syringe, then draw up the glargine into a separate syringe.",
            "B": "Draw up the Regular insulin first, then the NPH insulin into the same syringe, and administer the glargine in a separate injection.",
            "C": "Mix all three insulins (NPH, Regular, and Glargine) in one syringe to minimize injections.",
            "D": "Administer each insulin (NPH, Regular, and Glargine) as separate injections because they are all incompatible."
        },
        "correctAnswer": "B",
        "rationale": "Regular and NPH insulin can be mixed, with Regular (clear) drawn up first to prevent contamination of the Regular vial with NPH. Insulin glargine is a long-acting insulin that cannot be mixed with any other insulin due to its acidic pH, which would alter its absorption profile. Therefore, glargine must always be administered as a separate injection.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A 72-year-old patient with long-standing Type 2 Diabetes is admitted with a severe urinary tract infection. Her blood glucose levels have been consistently elevated (ranging from 300-450 mg/dL) despite her usual oral antidiabetic medications (metformin and glipizide). The nurse anticipates a temporary change in the patient's diabetes management strategy. Which intervention is most likely to be initiated?",
        "options": {
            "A": "Increasing the doses of her current oral antidiabetic medications.",
            "B": "Starting a continuous intravenous insulin infusion.",
            "C": "Administering oral glucagon to help lower blood glucose.",
            "D": "Switching her to a diet exclusively of simple carbohydrates."
        },
        "correctAnswer": "B",
        "rationale": "During acute illness, infection, or severe stress, oral antidiabetic medications may not be sufficient to control hyperglycemia due to increased counter-regulatory hormones and insulin resistance. Continuous intravenous insulin infusion provides precise and flexible glucose control, making it the most appropriate intervention for acute, severe hyperglycemia in a hospitalized patient with an infection. Oral glucagon raises blood glucose. A simple carbohydrate diet would worsen hyperglycemia.",
        "section": "Advanced Concepts: Antidiabetics"
    },
    {
        "questionText": "A patient with newly diagnosed Addison's disease is receiving hydrocortisone and fludrocortisone. The nurse teaches the patient about 'stress dosing' of hydrocortisone. Which statement by the patient indicates a need for further teaching?",
        "options": {
            "A": "“I should take a double dose of my hydrocortisone if I have a fever or the flu.”",
            "B": "“If I am having surgery, I will need an increased dose of hydrocortisone.”",
            "C": "“I should carry an emergency injection of hydrocortisone with me at all times.”",
            "D": "“I only need to increase my hydrocortisone if I experience significant weight gain.”"
        },
        "correctAnswer": "D",
        "rationale": "Stress dosing of hydrocortisone is crucial during periods of physical stress (e.g., fever, illness, surgery, trauma) to mimic the body's natural response and prevent an adrenal crisis. Significant weight gain is usually a sign of over-replacement (Cushing's syndrome), not a reason to increase the dose. Carrying an emergency injection is also appropriate.",
        "section": "Patient Education"
    },
    {
        "questionText": "A 45-year-old female patient presents with symptoms of weight loss, nervousness, increased appetite, and heat intolerance. Her lab results show a suppressed TSH and elevated free T4. She is diagnosed with Graves' disease and prescribed propylthiouracil (PTU). The nurse should prioritize teaching the patient to report which serious adverse effect of PTU?",
        "options": {
            "A": "Skin rash and itching.",
            "B": "Joint pain and swelling.",
            "C": "Sore throat, fever, or signs of infection.",
            "D": "Temporary hair loss."
        },
        "correctAnswer": "C",
        "rationale": "Agranulocytosis (a severe reduction in white blood cells) is a rare but life-threatening adverse effect of antithyroid medications like PTU. A sore throat, fever, or other signs of infection can indicate agranulocytosis and require immediate medical attention. While skin rash and joint pain can occur, agranulocytosis is the most critical to report.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is admitted with Diabetic Ketoacidosis (DKA). The nurse is reviewing the physician's orders. Which order should the nurse question?",
        "options": {
            "A": "Start regular insulin IV infusion at 0.1 unit/kg/hr.",
            "B": "Administer 0.9% Normal Saline IV bolus of 1 liter over 30 minutes.",
            "C": "Switch intravenous fluids to D5W when blood glucose reaches 250 mg/dL.",
            "D": "Administer intravenous potassium chloride (KCl) when serum potassium is 5.5 mEq/L."
        },
        "correctAnswer": "D",
        "rationale": "Although patients in DKA often have a total body potassium deficit, their initial serum potassium can be normal or even elevated due to the extracellular shift caused by acidosis. Administering potassium with a serum level of 5.5 mEq/L (which is high-normal to slightly elevated) could lead to hyperkalemia, which is dangerous. Potassium replacement is typically initiated once serum potassium levels fall to the normal range or lower, and urine output is adequate.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A 35-year-old patient with chronic hypoparathyroidism is taking calcitriol and calcium supplements. During a routine visit, the patient reports increasing fatigue, constipation, and muscle weakness. The nurse suspects hypercalcemia. Which intervention should the nurse anticipate first?",
        "options": {
            "A": "Increasing the patient's fluid intake and administering a loop diuretic.",
            "B": "Administering a dose of calcitonin to lower calcium levels.",
            "C": "Discontinuing calcitriol and calcium supplements.",
            "D": "Ordering a parathyroid hormone (PTH) level to assess primary hyperparathyroidism."
        },
        "correctAnswer": "C",
        "rationale": "The reported symptoms are classic for hypercalcemia, which is a significant risk with calcitriol and calcium supplementation. The immediate priority is to discontinue the medications causing the hypercalcemia to prevent further elevation and severe complications. While fluid and loop diuretics can help, and calcitonin might be used in severe cases, removing the causative agent is primary. Ordering a PTH level is not the first step in managing acute symptomatic hypercalcemia caused by medication.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient is prescribed a new oral antidiabetic medication that belongs to the SGLT2 inhibitor class (e.g., empagliflozin). Which teaching point is most important for the nurse to emphasize to this patient?",
        "options": {
            "A": "This medication may cause significant weight gain, so dietary changes are essential.",
            "B": "You should check your blood glucose frequently, as this drug has a high risk of hypoglycemia.",
            "C": "It is important to maintain good hydration and perineal hygiene due to potential side effects.",
            "D": "You will need to take this medication exactly 30 minutes before your largest meal."
        },
        "correctAnswer": "C",
        "rationale": "SGLT2 inhibitors work by causing glucose excretion in the urine. This can lead to increased risk of genitourinary infections (e.g., yeast infections, UTIs) and dehydration. Therefore, emphasis on hydration and perineal hygiene is crucial. These drugs generally have a low risk of hypoglycemia as monotherapy and typically promote weight loss.",
        "section": "Patient Education"
    },
    {
        "questionText": "A 60-year-old patient with type 2 diabetes has been prescribed empagliflozin. Two weeks later, she develops severe generalized itching and a blistering rash. The nurse recognizes these findings as a rare but serious adverse effect. What is the nurse's priority action?",
        "options": {
            "A": "Advise the patient to take an antihistamine and continue the medication.",
            "B": "Instruct the patient to stop the medication immediately and seek urgent medical attention.",
            "C": "Document the findings and monitor the patient for improvement.",
            "D": "Recommend applying a topical corticosteroid cream to the rash."
        },
        "correctAnswer": "B",
        "rationale": "Severe itching and blistering rash, particularly a bullous eruption, can indicate a serious hypersensitivity reaction (e.g., bullous pemphigoid) associated with SGLT2 inhibitors. This requires immediate discontinuation of the drug and urgent medical evaluation to prevent further progression and potential systemic involvement. Antihistamines or topical creams are insufficient for this severity of reaction.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient is admitted to the emergency department with symptoms of an 'adrenal crisis,' including profound hypotension, severe weakness, and hypoglycemia. The nurse anticipates administering which medication as a priority?",
        "options": {
            "A": "Oral prednisone 60 mg daily.",
            "B": "Intravenous regular insulin to correct hyperglycemia.",
            "C": "Intravenous hydrocortisone (Solu-Cortef).",
            "D": "Fludrocortisone oral tablet."
        },
        "correctAnswer": "C",
        "rationale": "An adrenal (Addisonian) crisis is a life-threatening emergency caused by acute adrenal insufficiency, requiring immediate intravenous glucocorticoid replacement. Hydrocortisone (Solu-Cortef) is the drug of choice for rapid action. Oral prednisone or fludrocortisone would be too slow or insufficient. Insulin is inappropriate as the patient is hypoglycemic.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "Which assessment finding in a patient receiving long-term prednisone therapy would require immediate follow-up by the nurse?",
        "options": {
            "A": "Blood glucose of 180 mg/dL.",
            "B": "Moon face and buffalo hump.",
            "C": "Complaint of new onset blurry vision and eye pain.",
            "D": "Increased appetite and mild weight gain."
        },
        "correctAnswer": "C",
        "rationale": "Long-term prednisone use can lead to serious ocular complications, including cataracts and glaucoma. New onset blurry vision and eye pain could indicate increased intraocular pressure (glaucoma) or the development of cataracts, requiring urgent ophthalmologic evaluation. While other options are expected side effects or common complications, ocular changes can lead to irreversible vision loss if not addressed promptly.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 1 diabetes reports recurrent episodes of hypoglycemia, especially overnight, despite adjusting evening insulin doses. She also reports high morning blood sugars. The nurse identifies this as a potential Somogyi effect. What is the most appropriate next step for the nurse to advise the patient or anticipate the provider might order?",
        "options": {
            "A": "Increase the evening dose of long-acting insulin.",
            "B": "Decrease the evening dose of intermediate or long-acting insulin.",
            "C": "Add a rapid-acting insulin dose before breakfast.",
            "D": "Perform a 3 AM blood glucose check to confirm."
        },
        "correctAnswer": "D",
        "rationale": "The Somogyi effect is characterized by nocturnal hypoglycemia followed by rebound hyperglycemia. To differentiate it from the Dawn Phenomenon (which also causes morning hyperglycemia but without nocturnal hypoglycemia), a 3 AM blood glucose check is crucial. If the 3 AM glucose is low, it supports the Somogyi effect, and the evening insulin dose would then need to be *decreased* or a bedtime snack added. Without confirmation, increasing insulin (A) would worsen the hypoglycemia.",
        "section": "Advanced Concepts: Insulin Therapy"
    },
    {
        "questionText": "A 28-year-old patient with Graves' disease is prescribed methimazole. The nurse plans to include which critical instruction in the patient's teaching plan?",
        "options": {
            "A": "Take this medication at bedtime to maximize its effect.",
            "B": "It is safe to become pregnant while taking this medication as it is very mild.",
            "C": "Report any signs of yellowing of the skin or eyes immediately.",
            "D": "This medication will likely be lifelong therapy."
        },
        "correctAnswer": "C",
        "rationale": "Hepatotoxicity (liver damage) is a serious but rare adverse effect of methimazole. Jaundice (yellowing of skin/eyes) is a key sign of liver impairment and must be reported immediately. Methimazole is generally contraindicated in pregnancy (especially first trimester) due to teratogenic effects, and therapy is often not lifelong but may be for 1-2 years.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A nurse is teaching a patient about the proper use of an insulin pen. Which statement by the patient indicates a need for further instruction?",
        "options": {
            "A": "“I will always dial up and waste 2 units of insulin (prime the pen) before each injection.”",
            "B": "“I should insert the needle at a 90-degree angle and hold it in place for at least 5-10 seconds after injecting.”",
            "C": "“I can store my opened insulin pen at room temperature for up to 28 days.”",
            "D": "“I will replace the needle on my pen once a week to save money.”"
        },
        "correctAnswer": "D",
        "rationale": "Insulin pen needles are single-use devices and should be replaced with each injection. Reusing needles can cause needle dulling, increased pain, lipohypertrophy, and increase the risk of infection. Priming the pen, injection angle, and storage are generally correct practices.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed liraglutide (Victoza), a GLP-1 receptor agonist. The nurse explains how this medication works. Which mechanism of action should the nurse include in her teaching?",
        "options": {
            "A": "It directly stimulates insulin secretion from pancreatic alpha cells.",
            "B": "It increases glucose uptake by muscle and fat cells directly.",
            "C": "It slows gastric emptying, increases glucose-dependent insulin secretion, and suppresses glucagon secretion.",
            "D": "It primarily inhibits glucose production in the liver and increases insulin sensitivity."
        },
        "correctAnswer": "C",
        "rationale": "GLP-1 receptor agonists like liraglutide mimic the action of incretin hormones. Their key mechanisms include slowing gastric emptying (leading to satiety and less post-prandial glucose spike), increasing glucose-dependent insulin secretion (reducing hypoglycemia risk), and suppressing post-prandial glucagon secretion (reducing hepatic glucose output). Option D describes metformin.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A patient with a history of Addison's disease reports severe fatigue, dizziness upon standing, and recent nausea/vomiting after developing a viral illness. Her blood pressure is 80/50 mmHg. The nurse suspects an adrenal crisis. In addition to administering intravenous fluids and glucocorticoids, which electrolyte imbalance is the nurse most likely to find and need to manage?",
        "options": {
            "A": "Hyperkalemia and hyponatremia.",
            "B": "Hypokalemia and hypernatremia.",
            "C": "Hypercalcemia and hypophosphatemia.",
            "D": "Hypomagnesemia and hyperchloremia."
        },
        "correctAnswer": "A",
        "rationale": "In adrenal crisis (severe Addison's disease), there is a deficiency of both glucocorticoids (cortisol) and mineralocorticoids (aldosterone). Aldosterone deficiency leads to impaired sodium and water reabsorption and impaired potassium excretion by the kidneys. This results in hyponatremia and hyperkalemia. The profound fluid volume deficit causes hypotension.",
        "section": "Advanced Concepts: Adrenal Disorders"
    },
    {
        "questionText": "A 50-year-old patient diagnosed with hypothyroidism due to Hashimoto's thyroiditis has been on levothyroxine for several months. She complains of persistent fatigue, constipation, and cold intolerance. Her recent lab results show a TSH of 6.2 mU/L (normal 0.5-5.0 mU/L) and free T4 in the lower end of the normal range. What is the most appropriate interpretation of these findings and anticipated intervention?",
        "options": {
            "A": "The patient is experiencing hyperthyroidism; the levothyroxine dose should be decreased.",
            "B": "The patient is still hypothyroid; the levothyroxine dose may need to be increased.",
            "C": "The patient is euthyroid, and her symptoms are unrelated to thyroid function.",
            "D": "The patient is likely developing thyroid resistance; add liothyronine."
        },
        "correctAnswer": "B",
        "rationale": "A TSH level of 6.2 mU/L is elevated, indicating that the pituitary gland is still over-stimulating the thyroid (or trying to compensate for inadequate thyroid hormone replacement). Coupled with persistent hypothyroid symptoms and a low-normal free T4, this suggests the current levothyroxine dose is insufficient, and an increase is likely needed to achieve a euthyroid state.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with a history of Type 2 Diabetes is prescribed oral prednisone for an acute allergic reaction. The nurse should advise the patient that this new medication is likely to:",
        "options": {
            "A": "Decrease their insulin requirements.",
            "B": "Cause hypoglycemia, requiring frequent glucose monitoring.",
            "C": "Increase their blood glucose levels and may necessitate temporary insulin or increased oral antidiabetic medication.",
            "D": "Have no significant effect on their blood glucose levels."
        },
        "correctAnswer": "C",
        "rationale": "Glucocorticoids like prednisone are known to cause hyperglycemia by increasing hepatic glucose production and promoting insulin resistance in peripheral tissues. Patients with diabetes, even Type 2, will almost certainly experience elevated blood glucose and may require temporary insulin therapy or an adjustment to their existing oral antidiabetic regimen.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "Which of the following is a common early symptom of hypoglycemia that might be masked in a diabetic patient also taking a beta-blocker (e.g., metoprolol)?",
        "options": {
            "A": "Sweating",
            "B": "Hunger",
            "C": "Tachycardia",
            "D": "Confusion"
        },
        "correctAnswer": "C",
        "rationale": "Beta-blockers can mask the adrenergic symptoms of hypoglycemia, particularly tachycardia and shakiness, by blocking the sympathetic nervous system response. Sweating and hunger are cholinergic symptoms and are generally not masked. Confusion is a neuroglycopenic symptom and indicates more severe hypoglycemia.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "A nurse is reviewing medication orders for a patient with hypocalcemia. The patient has been prescribed calcium carbonate and calcitriol. Which order would lead the nurse to seek clarification from the provider?",
        "options": {
            "A": "Administer calcium carbonate with meals.",
            "B": "Administer calcitriol once daily in the morning.",
            "C": "Administer calcium carbonate and calcitriol simultaneously to enhance absorption.",
            "D": "Monitor serum calcium levels weekly."
        },
        "correctAnswer": "C",
        "rationale": "While calcium carbonate and calcitriol are often prescribed together for hypocalcemia, they should not be administered simultaneously. Calcium-containing products can interfere with the absorption of other medications, including calcitriol. Although not as strong an interaction as with levothyroxine, it's best practice to separate administration times to ensure optimal absorption of both medications. Calcium carbonate is often given with meals to enhance absorption.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient is prescribed desmopressin (DDAVP) for diabetes insipidus. The nurse should prioritize monitoring for which adverse effect?",
        "options": {
            "A": "Hypernatremia and dehydration.",
            "B": "Polyuria and polydipsia.",
            "C": "Hyponatremia and water intoxication.",
            "D": "Hyperkalemia and metabolic acidosis."
        },
        "correctAnswer": "C",
        "rationale": "Desmopressin is a synthetic analog of ADH, which promotes water reabsorption in the kidneys. Over-treatment or excessive fluid intake can lead to excessive water retention, resulting in dilutional hyponatremia and water intoxication (signs include headache, confusion, seizures). Diabetes insipidus is characterized by polyuria and polydipsia, and desmopressin treats it.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A 68-year-old male with type 2 diabetes and a history of heart failure is admitted with pneumonia. His current medications include insulin glargine, metformin, and furosemide. His blood glucose levels are now consistently elevated (250-300 mg/dL). Which nursing intervention related to his diabetes management is most appropriate?",
        "options": {
            "A": "Increase the dose of metformin.",
            "B": "Add a sulfonylurea to his current regimen.",
            "C": "Initiate a sliding scale regular insulin regimen.",
            "D": "Discontinue all diabetic medications until the pneumonia resolves."
        },
        "correctAnswer": "C",
        "rationale": "Infections like pneumonia increase metabolic stress, leading to insulin resistance and elevated blood glucose. A sliding scale regular insulin regimen provides effective short-term glucose control during acute illness without relying solely on oral agents (which may be less effective or contraindicated, like metformin in acute illness/renal impairment). Increasing metformin is generally not recommended in acute illness with potential renal strain. Sulfonylureas increase hypoglycemia risk. Discontinuing all medications risks DKA/HHS.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with newly diagnosed Type 1 diabetes is learning to administer insulin. The nurse correctly teaches the patient to inject insulin into which tissue type?",
        "options": {
            "A": "Intramuscular tissue for rapid absorption.",
            "B": "Intradermal tissue for slowest absorption.",
            "C": "Subcutaneous tissue for consistent and predictable absorption.",
            "D": "Intravenous tissue for immediate effect."
        },
        "correctAnswer": "C",
        "rationale": "Insulin is administered via subcutaneous injection. This route allows for consistent and predictable absorption into the bloodstream, which is essential for glucose control. Intramuscular injection can lead to faster but more erratic absorption and potential hypoglycemia. Intradermal and intravenous routes are incorrect for routine insulin administration.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient has been initiated on oral thyroid hormone replacement. The nurse teaches the patient that full therapeutic effects may not be seen for:",
        "options": {
            "A": "24-48 hours.",
            "B": "3-5 days.",
            "C": "Several weeks to months.",
            "D": "Immediately after the first dose."
        },
        "correctAnswer": "C",
        "rationale": "Levothyroxine has a long half-life, and it takes time for circulating thyroid hormone levels to reach a steady state. Therefore, full therapeutic effects and stabilization of TSH levels may not be seen for several weeks to months after initiating therapy or adjusting the dose. Patients should be advised not to expect immediate symptomatic relief.",
        "section": "Patient Education"
    },
    {
        "questionText": "A patient with diabetes is taking pioglitazone (Actos). The nurse understands that this medication works by:",
        "options": {
            "A": "Increasing insulin secretion from the pancreas.",
            "B": "Reducing glucose absorption from the gastrointestinal tract.",
            "C": "Decreasing insulin resistance in peripheral tissues.",
            "D": "Promoting glucose excretion via the kidneys."
        },
        "correctAnswer": "C",
        "rationale": "Pioglitazone is a thiazolidinedione (TZD). This class of drugs works by improving insulin sensitivity in muscle, fat, and liver tissues. They do not primarily increase insulin secretion, slow GI absorption, or promote renal excretion of glucose.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is taking propylthiouracil (PTU) for hyperthyroidism. Which lab result would be a priority for the nurse to monitor due to a potential serious adverse effect of this medication?",
        "options": {
            "A": "Serum potassium levels.",
            "B": "White blood cell (WBC) count with differential.",
            "C": "Hemoglobin and hematocrit.",
            "D": "Blood urea nitrogen (BUN) and creatinine."
        },
        "correctAnswer": "B",
        "rationale": "PTU can cause agranulocytosis, a severe and life-threatening reduction in neutrophil count. Therefore, monitoring the WBC count with differential is crucial to detect this adverse effect early. Patients should be taught to report any signs of infection immediately.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A 40-year-old patient with Type 2 Diabetes is considering starting an intensive exercise program. She takes insulin detemir once daily at bedtime and metformin twice daily. What is the most important teaching point regarding her insulin regimen and exercise?",
        "options": {
            "A": "She should always skip her insulin detemir dose on days she exercises to prevent hypoglycemia.",
            "B": "She may need to reduce her insulin detemir dose or increase carbohydrate intake before exercise to prevent hypoglycemia.",
            "C": "She should only exercise in the morning to avoid impacting her bedtime insulin.",
            "D": "Her insulin detemir dose will need to be significantly increased due to increased glucose demand from exercise."
        },
        "correctAnswer": "B",
        "rationale": "Exercise increases glucose uptake by muscles and improves insulin sensitivity, which can lower blood glucose levels and increase the risk of hypoglycemia, especially for patients taking insulin. Patients on basal insulin (like detemir) need to learn how to adjust their insulin or carbohydrate intake to match their increased energy expenditure during exercise. Skipping the dose (A) could lead to hyperglycemia and ketoacidosis. Exercise can be done at any time, and increased glucose demand from exercise actually *lowers* blood glucose, not increases it.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is experiencing a 'honeymoon phase' shortly after diagnosis and initiation of insulin therapy. Which statement accurately describes this phase?",
        "options": {
            "A": "It is a period where the patient no longer requires insulin due to pancreatic recovery.",
            "B": "It is a temporary phase of partial pancreatic recovery, requiring lower insulin doses.",
            "C": "It indicates the diabetes has resolved and the patient is cured.",
            "D": "It is a period of increased insulin resistance, requiring higher doses."
        },
        "correctAnswer": "B",
        "rationale": "The 'honeymoon phase' in Type 1 Diabetes is a temporary period after diagnosis and initiation of insulin therapy when the remaining pancreatic beta cells may partially recover function, leading to a temporary reduction in insulin requirements. It does not mean the patient is cured or will no longer require insulin, and it is not a period of increased resistance.",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A 25-year-old female with Type 1 Diabetes is planning pregnancy. She asks the nurse about her insulin regimen during pregnancy. Which is the most appropriate initial response by the nurse?",
        "options": {
            "A": "You will need to switch from insulin injections to oral antidiabetic medications.",
            "B": "Insulin requirements typically decrease during pregnancy, especially in the first trimester.",
            "C": "Strict glycemic control is crucial throughout pregnancy, and insulin needs often fluctuate and increase as pregnancy progresses.",
            "D": "You should aim for an A1C of 9% or higher to prevent hypoglycemia for the baby."
        },
        "correctAnswer": "C",
        "rationale": "Strict glycemic control is paramount throughout pregnancy for patients with pre-existing diabetes to prevent maternal and fetal complications. Insulin requirements often decrease in the first trimester (due to increased insulin sensitivity and nausea/vomiting) but generally increase significantly in the second and third trimesters as placental hormones cause insulin resistance. Oral antidiabetics are generally not used in Type 1 diabetes, and A1C targets during pregnancy are much lower (typically <6-6.5%).",
        "section": "Advanced Concepts: Patient Education"
    },
    {
        "questionText": "A patient is admitted with syndrome of inappropriate antidiuretic hormone (SIADH). Which medication would the nurse anticipate administering to help manage this condition?",
        "options": {
            "A": "Desmopressin (DDAVP)",
            "B": "Furosemide (Lasix)",
            "C": "Tolvaptan (Samsca)",
            "D": "Levothyroxine (Synthroid)"
        },
        "correctAnswer": "C",
        "rationale": "SIADH involves excessive secretion of ADH, leading to water retention and hyponatremia. Tolvaptan is an ADH receptor antagonist (a 'vaptan') that specifically blocks the action of ADH in the kidneys, leading to increased free water excretion and correction of hyponatremia. Desmopressin would worsen SIADH. Furosemide is a diuretic but doesn't directly address the ADH excess. Levothyroxine is for thyroid disorders.",
        "section": "Advanced Concepts: Pituitary Hormones"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed a new medication, exenatide (Byetta), an injectable GLP-1 receptor agonist. The nurse instructs the patient on its administration. Which is the most important teaching point?",
        "options": {
            "A": "Inject the medication immediately after meals to reduce post-prandial glucose.",
            "B": "This medication should be injected subcutaneously twice daily, before the morning and evening meals.",
            "C": "It is essential to massage the injection site to ensure proper absorption.",
            "D": "This medication is a type of insulin, so adjust carbohydrate intake accordingly."
        },
        "correctAnswer": "B",
        "rationale": "Exenatide (Byetta) is an injectable GLP-1 receptor agonist that is typically administered subcutaneously twice daily, within 60 minutes before the morning and evening meals. It is not an insulin and should not be massaged. Administering immediately after meals would miss its optimal timing for post-prandial glucose control.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient is taking prednisone for Crohn's disease. The patient reports having difficulty sleeping. The nurse should advise the patient to:",
        "options": {
            "A": "Take the prednisone at bedtime to promote sleep.",
            "B": "Take the prednisone in the morning to minimize sleep disturbance.",
            "C": "Discontinue the prednisone and report the insomnia to the provider.",
            "D": "Increase the dose of prednisone, as insomnia is a sign of under-treatment."
        },
        "correctAnswer": "B",
        "rationale": "Prednisone (a glucocorticoid) can cause insomnia and nervousness as side effects. To minimize these effects, it is generally recommended to take the medication in the morning, mimicking the body's natural diurnal cortisol rhythm. Stopping abruptly is dangerous, and increasing the dose would likely worsen insomnia.",
        "section": "Patient Education"
    },
    {
        "questionText": "A nurse is preparing to educate a patient with Type 2 Diabetes about a new prescription for canagliflozin (Invokana). The nurse should specifically warn the patient about the increased risk of which serious complication?",
        "options": {
            "A": "Hypoglycemia, especially when combined with insulin.",
            "B": "Myocardial infarction.",
            "C": "Lower limb amputation.",
            "D": "Pancreatitis."
        },
        "correctAnswer": "C",
        "rationale": "Canagliflozin, an SGLT2 inhibitor, has been associated with an increased risk of lower limb amputations, particularly in patients with pre-existing risk factors like neuropathy, peripheral artery disease, or previous amputation. This is a black box warning. While SGLT2s have a low risk of hypoglycemia as monotherapy, the other options are generally not primary concerns or are associated with other drug classes.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with newly diagnosed Type 1 diabetes expresses concern about hypoglycemia. The nurse teaches the patient to carry a fast-acting source of glucose. Which item would be the best choice for treating mild to moderate hypoglycemia (conscious patient)?",
        "options": {
            "A": "A candy bar (chocolate with nuts).",
            "B": "A glass of milk.",
            "C": "Glucose tablets or 4 oz of fruit juice.",
            "D": "A packet of granulated sugar dissolved in water."
        },
        "correctAnswer": "C",
        "rationale": "For conscious patients with mild to moderate hypoglycemia, 15 grams of a simple, fast-acting carbohydrate is recommended (e.g., glucose tablets, 4 oz of juice, or regular soda). Candy bars (especially with fat) or milk contain fat/protein that slows glucose absorption. Granulated sugar can be used, but glucose tablets or juice are more convenient and standardized.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with diabetes is considering taking an over-the-counter herbal supplement to help manage blood sugar. Which action by the nurse is most appropriate?",
        "options": {
            "A": "Advise the patient that herbal supplements are generally safe and effective for diabetes.",
            "B": "Instruct the patient to discontinue all prescribed medications and rely solely on the supplement.",
            "C": "Educate the patient about potential interactions with prescribed medications and advise discussing with their provider.",
            "D": "Recommend specific herbal supplements that are proven to lower blood glucose."
        },
        "correctAnswer": "C",
        "rationale": "Many herbal supplements can interact with prescribed medications, including antidiabetic agents, potentially causing hypoglycemia, hyperglycemia, or other adverse effects. It is crucial for the nurse to educate the patient about these risks and emphasize the importance of discussing all supplements with their healthcare provider to ensure safety and prevent adverse interactions.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A nurse is administering insulin glargine to a patient with Type 2 Diabetes. Which principle guides the nurse's administration technique for this specific insulin?",
        "options": {
            "A": "It must be given intravenously for immediate effect.",
            "B": "It should be shaken vigorously before administration to ensure proper mixing.",
            "C": "It provides a peak action within 2-4 hours, so administer before meals.",
            "D": "It should be administered subcutaneously once daily, at the same time each day, without mixing."
        },
        "correctAnswer": "D",
        "rationale": "Insulin glargine is a long-acting basal insulin designed to provide a relatively flat, peakless profile over 24 hours. It is administered subcutaneously once daily, at the same time each day, and it should never be mixed with other insulins or solutions due to its acidic pH, which can alter its pharmacodynamics.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with Type 1 Diabetes on insulin therapy is recovering from a viral illness. The nurse notes her blood glucose has been elevated (300-400 mg/dL) for the past 24 hours, and she reports abdominal pain and nausea. The nurse should immediately assess for which sign of a worsening complication?",
        "options": {
            "A": "Weight gain.",
            "B": "Kussmaul respirations.",
            "C": "Bradycardia.",
            "D": "Decreased urine output."
        },
        "correctAnswer": "B",
        "rationale": "The patient's symptoms (elevated glucose, abdominal pain, nausea in Type 1 diabetic during illness) are classic for Diabetic Ketoacidosis (DKA). Kussmaul respirations (deep, rapid breathing) are a compensatory mechanism for metabolic acidosis, a hallmark of DKA. Weight gain, bradycardia, and decreased urine output are not characteristic of DKA in this context.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "Which medication is an appropriate treatment for a patient with hyperthyroidism?",
        "options": {
            "A": "Levothyroxine (Synthroid)",
            "B": "Radioactive iodine (I-131)",
            "C": "Calcitonin",
            "D": "Desmopressin (DDAVP)"
        },
        "correctAnswer": "B",
        "rationale": "Radioactive iodine (I-131) is a common treatment for hyperthyroidism. It is absorbed by the thyroid gland, leading to the destruction of thyroid cells and reduction in hormone production. Levothyroxine treats hypothyroidism. Calcitonin lowers calcium. Desmopressin treats diabetes insipidus.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A patient with Type 2 Diabetes on metformin is scheduled for an elective cardiac catheterization with contrast dye in 2 days. What is the most appropriate nursing action regarding the metformin?",
        "options": {
            "A": "Inform the patient to take the metformin as usual.",
            "B": "Instruct the patient to hold the metformin on the day of the procedure only.",
            "C": "Advise the patient to stop metformin 24-48 hours prior to the procedure and resume 48-72 hours after, once renal function is assessed.",
            "D": "Tell the patient to switch to insulin for the days around the procedure."
        },
        "correctAnswer": "C",
        "rationale": "Metformin should be held 24-48 hours before and 48-72 hours after procedures involving intravenous contrast dye, especially in patients with compromised renal function or those at risk of acute kidney injury. This is to prevent the accumulation of metformin and subsequent lactic acidosis, a severe complication. Renal function should be re-evaluated before resuming the medication.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A nurse is teaching a patient about meal planning while taking insulin lispro. The nurse emphasizes that the patient should consume food by which time after administering the injection?",
        "options": {
            "A": "Within 5 minutes.",
            "B": "Within 15 minutes.",
            "C": "Within 30 minutes.",
            "D": "Within 60 minutes."
        },
        "correctAnswer": "B",
        "rationale": "Insulin lispro is a rapid-acting insulin with an onset of action typically within 15 minutes. To prevent hypoglycemia, patients should be instructed to eat a meal shortly after (within 15 minutes) administering this insulin.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient on long-term prednisone therapy develops new onset edema, weight gain, and elevated blood pressure. The nurse recognizes these symptoms are primarily related to prednisone's effect on which hormone pathway?",
        "options": {
            "A": "Thyroid hormone regulation.",
            "B": "Androgen production.",
            "C": "Mineralocorticoid activity.",
            "D": "Parathyroid hormone regulation."
        },
        "correctAnswer": "C",
        "rationale": "Prednisone, a glucocorticoid, also possesses some mineralocorticoid activity (similar to aldosterone). This mineralocorticoid effect leads to increased sodium and water reabsorption in the kidneys, resulting in fluid retention, edema, and hypertension. The other options are incorrect hormone pathways related to these side effects.",
        "section": "Advanced Concepts: Adrenal Hormones"
    },
    {
        "questionText": "A patient with diabetes is started on an alpha-glucosidase inhibitor (e.g., acarbose). The nurse explains that this medication works by:",
        "options": {
            "A": "Increasing insulin secretion from the pancreas.",
            "B": "Slowing the digestion and absorption of carbohydrates in the small intestine.",
            "C": "Improving insulin sensitivity in peripheral tissues.",
            "D": "Decreasing glucose production by the liver."
        },
        "correctAnswer": "B",
        "rationale": "Alpha-glucosidase inhibitors like acarbose work by inhibiting the enzyme alpha-glucosidase in the small intestine, which is responsible for breaking down complex carbohydrates into absorbable glucose. By slowing this process, they reduce the rise in post-prandial blood glucose.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A 70-year-old patient with Type 2 Diabetes, who is frail and has a history of multiple hypoglycemic episodes, is on glipizide. The nurse discusses with the provider the potential need to switch to a different oral antidiabetic medication. Which class of medication would be a safer alternative given this patient's profile?",
        "options": {
            "A": "Another sulfonylurea (e.g., glyburide).",
            "B": "A meglitinide (e.g., repaglinide).",
            "C": "An SGLT2 inhibitor (e.g., empagliflozin).",
            "D": "A GLP-1 receptor agonist (e.g., dulaglutide)."
        },
        "correctAnswer": "D",
        "rationale": "Glipizide (a sulfonylurea) carries a high risk of hypoglycemia, especially in elderly and frail patients. Both SGLT2 inhibitors and GLP-1 receptor agonists have a significantly lower risk of hypoglycemia when used as monotherapy because their insulin-stimulating effect is glucose-dependent or they work by other mechanisms. GLP-1 agonists (e.g., dulaglutide, liraglutide) also offer cardiovascular and weight benefits. Meglitinides also stimulate insulin and have hypoglycemia risk, and another sulfonylurea would have the same issue.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A patient with adrenal insufficiency is taking fludrocortisone. The nurse knows that this medication primarily replaces which hormone, and what is its main therapeutic effect?",
        "options": {
            "A": "Cortisol; reduces inflammation.",
            "B": "Aldosterone; regulates fluid and electrolyte balance.",
            "C": "Adrenocorticotropic hormone (ACTH); stimulates cortisol production.",
            "D": "Thyroxine; increases metabolic rate."
        },
        "correctAnswer": "B",
        "rationale": "Fludrocortisone is a synthetic mineralocorticoid. Its primary role is to replace aldosterone, helping to regulate sodium and water balance and potassium excretion in the kidneys. It is used to treat the mineralocorticoid deficiency seen in Addison's disease.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A nurse is preparing to administer lispro insulin to a patient with Type 1 Diabetes. The patient's meal tray is currently unavailable, but the nurse is told it will arrive in 30 minutes. What is the most appropriate action by the nurse?",
        "options": {
            "A": "Administer the lispro insulin now, as its onset is immediate.",
            "B": "Hold the lispro insulin and administer it only after the meal arrives.",
            "C": "Administer the lispro insulin and provide the patient with a snack immediately.",
            "D": "Notify the charge nurse and delay the insulin administration until the meal is at the bedside."
        },
        "correctAnswer": "D",
        "rationale": "Lispro insulin has a rapid onset (15-30 minutes). Administering it 30 minutes before a meal could lead to hypoglycemia before the food's glucose is absorbed. It is safest to administer rapid-acting insulin within 5-15 minutes *before* a meal or immediately with the first bite of food. The most appropriate action is to delay administration until the meal is present, or nearly so, to synchronize insulin action with food intake and prevent a hypoglycemic event.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with a history of hypothyroidism is scheduled for a thyroidectomy due to a large goiter. The patient has been taking levothyroxine for many years. The nurse understands that stopping levothyroxine abruptly pre-operatively could lead to which life-threatening condition?",
        "options": {
            "A": "Thyroid storm.",
            "B": "Myxedema coma.",
            "C": "Adrenal crisis.",
            "D": "Diabetic ketoacidosis."
        },
        "correctAnswer": "B",
        "rationale": "Myxedema coma is a severe, life-threatening manifestation of uncorrected hypothyroidism, characterized by severe hypothermia, hypotension, hypoventilation, and altered mental status. Abruptly stopping lifelong thyroid hormone replacement would precipitate profound hypothyroidism, increasing the risk of myxedema coma. Thyroid storm is hyperthyroidism; adrenal crisis is related to adrenal glands; DKA is related to insulin deficiency.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "Which of the following is the most important teaching point for a patient newly prescribed metformin?",
        "options": {
            "A": "You should take this medication with plenty of water on an empty stomach.",
            "B": "It is normal to experience significant weight gain on this medication.",
            "C": "Report any unusual muscle pain, weakness, or fatigue, especially if accompanied by difficulty breathing.",
            "D": "You will likely experience frequent episodes of hypoglycemia, so carry a glucose source."
        },
        "correctAnswer": "C",
        "rationale": "Metformin's most serious (though rare) adverse effect is lactic acidosis. Symptoms include unusual muscle pain, weakness, fatigue, and difficulty breathing. Patients should be taught to report these immediately. Metformin should be taken with meals to minimize GI upset, typically causes weight loss or neutrality, and has a low risk of hypoglycemia as monotherapy.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is caring for a patient on continuous intravenous insulin infusion for DKA. The patient's blood glucose is 200 mg/dL, and they are still acidotic. What is the next most appropriate action by the nurse, according to DKA management protocols?",
        "options": {
            "A": "Decrease the insulin infusion rate by half and switch IV fluids to D5W.",
            "B": "Discontinue the insulin infusion and transition to subcutaneous insulin.",
            "C": "Add dextrose to the intravenous fluids while continuing the insulin infusion.",
            "D": "Administer a bolus of 50% dextrose to rapidly raise blood glucose."
        },
        "correctAnswer": "C",
        "rationale": "In DKA treatment, once blood glucose approaches 200-250 mg/dL, dextrose is typically added to the intravenous fluids (e.g., D5NS) while continuing the insulin infusion. This is done to prevent hypoglycemia and ensure continued insulin delivery to resolve the underlying ketoacidosis, which takes longer than glucose correction. Discontinuing insulin (B) or giving a large D50 bolus (D) are inappropriate while acidosis persists.",
        "section": "Advanced Concepts: Antidiabetics"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed dulaglutide (Trulicity). The nurse is educating the patient about this medication. Which statement by the patient indicates a need for further teaching?",
        "options": {
            "A": "“I will inject this medication once a week, on the same day each week.”",
            "B": "“This medication will help me lose some weight and lower my blood sugar.”",
            "C": "“I should report any severe, persistent abdominal pain that radiates to my back.”",
            "D": "“I need to inject this medication in my upper arm, abdomen, or thigh exactly 30 minutes before my first meal.”"
        },
        "correctAnswer": "D",
        "rationale": "Dulaglutide is a once-weekly GLP-1 receptor agonist and can be given at any time of day, with or without meals. It does not need to be timed before a specific meal. The other statements reflect correct understanding: it's once-weekly (A), can aid weight loss and lower blood sugar (B), and severe abdominal pain could indicate pancreatitis, a serious side effect to report (C).",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is assessing a patient with hyperthyroidism. Which clinical manifestation would indicate that the patient is experiencing a thyroid storm?",
        "options": {
            "A": "Bradycardia, hypothermia, and lethargy.",
            "B": "Extreme tachycardia, fever, and altered mental status.",
            "C": "Weight gain, constipation, and dry skin.",
            "D": "Profound hypotension and severe hypoglycemia."
        },
        "correctAnswer": "B",
        "rationale": "Thyroid storm (thyrotoxic crisis) is a life-threatening exaggeration of hyperthyroidism. It is characterized by severe hypermetabolism, manifesting as extreme tachycardia, hyperthermia (fever), severe agitation, delirium, and potentially coma. Options A and C describe myxedema (severe hypothyroidism). Option D describes adrenal crisis.",
        "section": "Advanced Concepts: Thyroid Disorders"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed exenatide. The nurse should explain that this medication is classified as a(n):",
        "options": {
            "A": "Biguanide",
            "B": "Sulfonylurea",
            "C": "GLP-1 receptor agonist",
            "D": "Thiazolidinedione"
        },
        "correctAnswer": "C",
        "rationale": "Exenatide (Byetta) is an incretin mimetic, specifically a GLP-1 receptor agonist. This class of drugs enhances glucose-dependent insulin secretion, suppresses glucagon, and slows gastric emptying.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A nurse is caring for a patient with diabetes insipidus who is receiving desmopressin. The nurse observes the patient drinking large amounts of water and complaining of a headache. The most appropriate initial nursing action is to:",
        "options": {
            "A": "Encourage more fluid intake to prevent dehydration.",
            "B": "Administer an additional dose of desmopressin.",
            "C": "Assess serum sodium levels and consider fluid restriction.",
            "D": "Administer a PRN analgesic for the headache."
        },
        "correctAnswer": "C",
        "rationale": "The symptoms (large fluid intake, headache) in a patient on desmopressin suggest potential water intoxication and dilutional hyponatremia, a serious adverse effect of desmopressin therapy. Assessing serum sodium is critical, and restricting fluid intake is a primary intervention to prevent further water retention and worsening hyponatremia. The headache is a symptom of the hyponatremia and requires addressing the underlying cause.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient on long-term levothyroxine therapy for hypothyroidism asks the nurse, 'How often will I need blood tests to check my thyroid levels?' The nurse's best response is:",
        "options": {
            "A": "Every 6 months to a year, or if your symptoms change.",
            "B": "Only if you experience symptoms of hyperthyroidism.",
            "C": "Once a year, regardless of symptoms.",
            "D": "You will no longer need blood tests once your symptoms are resolved."
        },
        "correctAnswer": "A",
        "rationale": "Once a stable dose of levothyroxine is achieved, TSH levels are typically monitored annually or every 6-12 months. However, if symptoms of hypo- or hyperthyroidism reappear, or if there are changes in other medications that could affect levothyroxine absorption, more frequent monitoring is necessary. Options B and D are incorrect as symptoms can be subtle, and ongoing monitoring is usually required.",
        "section": "Patient Education"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed an oral medication that works by delaying the breakdown of incretin hormones, thereby increasing insulin synthesis and release. The nurse identifies this medication as belonging to which class?",
        "options": {
            "A": "Dipeptidyl Peptidase-4 (DPP-4) inhibitors.",
            "B": "Sulfonylureas.",
            "C": "Biguanides.",
            "D": "Alpha-glucosidase inhibitors."
        },
        "correctAnswer": "A",
        "rationale": "Dipeptidyl Peptidase-4 (DPP-4) inhibitors (e.g., sitagliptin, saxagliptin) work by preventing the breakdown of natural incretin hormones (GLP-1 and GIP). This prolongs the action of incretins, leading to glucose-dependent increases in insulin synthesis and release and decreases in glucagon secretion. Sulfonylureas directly stimulate insulin release, biguanides reduce hepatic glucose production, and alpha-glucosidase inhibitors delay carbohydrate absorption.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "Which of the following is a potential serious adverse effect of thiazolidinediones (TZDs) like pioglitazone that the nurse should monitor for?",
        "options": {
            "A": "Significant hypoglycemia.",
            "B": "Lactic acidosis.",
            "C": "Fluid retention leading to heart failure exacerbation.",
            "D": "Severe gastrointestinal distress and diarrhea."
        },
        "correctAnswer": "C",
        "rationale": "Thiazolidinediones (TZDs) like pioglitazone are known to cause fluid retention, which can lead to or worsen congestive heart failure. They are contraindicated in patients with symptomatic heart failure. Lactic acidosis is associated with metformin, and significant hypoglycemia is less common with TZDs as monotherapy. GI distress is more common with metformin.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 1 Diabetes uses an insulin pump. The patient wakes up with a blood glucose of 280 mg/dL. The nurse explains that this might be due to a 'Dawn phenomenon'. What is the physiological basis of the Dawn phenomenon?",
        "options": {
            "A": "Nocturnal hypoglycemia followed by rebound hyperglycemia due to counter-regulatory hormones.",
            "B": "Progressive decrease in insulin sensitivity due to prolonged insulin use.",
            "C": "A normal physiological increase in blood glucose in the early morning due to hormonal release.",
            "D": "Insulin resistance caused by obesity."
        },
        "correctAnswer": "C",
        "rationale": "The Dawn phenomenon is a normal physiological process characterized by an early morning (usually between 2 AM and 8 AM) increase in blood glucose due to the release of growth hormone, cortisol, glucagon, and catecholamines, which stimulate glucose production by the liver. It's distinguished from the Somogyi effect by the absence of nocturnal hypoglycemia.",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A patient with primary hypothyroidism has been receiving levothyroxine. Which lab value would be the primary indicator of the effectiveness of the treatment?",
        "options": {
            "A": "Serum T3 level.",
            "B": "Free T4 level.",
            "C": "Thyroid-stimulating hormone (TSH) level.",
            "D": "Thyroid peroxidase antibodies (TPOAb)."
        },
        "correctAnswer": "C",
        "rationale": "For patients with primary hypothyroidism on levothyroxine, the TSH level is the most sensitive and reliable indicator of treatment effectiveness. A normalized TSH indicates that the pituitary gland is no longer over-stimulating the thyroid, meaning adequate hormone replacement is being provided. T3 and free T4 are monitored but TSH is the primary target.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient is taking propylthiouracil (PTU) for hyperthyroidism. The nurse teaches the patient about dietary considerations. Which foods should the patient be advised to limit or avoid?",
        "options": {
            "A": "Foods high in iron.",
            "B": "Foods high in calcium.",
            "C": "Foods high in iodine.",
            "D": "Foods high in potassium."
        },
        "correctAnswer": "C",
        "rationale": "Excessive iodine intake can interfere with the effectiveness of antithyroid medications like PTU and methimazole. Foods high in iodine (e.g., seafood, kelp, some iodized salts, some dairy products) should be limited or avoided to optimize treatment. The other food groups are not directly contraindicated.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is explaining the difference between Type 1 and Type 2 Diabetes to a newly diagnosed patient. Which statement accurately describes a key pathophysiological difference?",
        "options": {
            "A": "Type 1 diabetes involves insulin resistance, while Type 2 involves absolute insulin deficiency.",
            "B": "Type 1 diabetes is an autoimmune destruction of pancreatic beta cells, while Type 2 involves insulin resistance and impaired insulin secretion.",
            "C": "Type 1 diabetes is always managed with oral medications, while Type 2 requires insulin injections.",
            "D": "Type 1 diabetes typically develops in adulthood, while Type 2 is usually diagnosed in childhood."
        },
        "correctAnswer": "B",
        "rationale": "Type 1 diabetes is an autoimmune disorder leading to the destruction of pancreatic beta cells, resulting in absolute insulin deficiency. Type 2 diabetes is characterized by both insulin resistance (cells don't respond effectively to insulin) and a progressive decline in pancreatic beta cell function, leading to impaired insulin secretion. Options A, C, and D describe the opposite or incorrect characteristics.",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed an SGLT2 inhibitor (e.g., dapagliflozin). The nurse educates the patient about potential side effects. Which side effect would require the nurse to advise the patient to seek immediate medical attention?",
        "options": {
            "A": "Increased urination.",
            "B": "Thirst.",
            "C": "Genital itching or burning.",
            "D": "Severe abdominal pain with nausea/vomiting and back pain."
        },
        "correctAnswer": "D",
        "rationale": "While increased urination, thirst, and genital itching/burning are common side effects of SGLT2 inhibitors (due to glucose excretion in urine), severe abdominal pain radiating to the back, with nausea/vomiting, is a classic sign of pancreatitis, a rare but serious adverse effect associated with several antidiabetic agents, including SGLT2 inhibitors. This symptom requires immediate medical attention.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A nurse is educating a patient with Type 1 Diabetes on 'sick day rules'. The patient asks, 'If I have the flu and am vomiting, should I stop taking my insulin?' What is the nurse's best response?",
        "options": {
            "A": "Yes, you should stop your insulin to prevent hypoglycemia since you're not eating.",
            "B": "No, you must continue your insulin, but monitor blood glucose more frequently and take small amounts of carbohydrates.",
            "C": "You should only take your long-acting insulin, and skip your rapid-acting doses.",
            "D": "Only take your insulin if your blood glucose is above 300 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "During illness, stress hormones can increase blood glucose levels, making insulin still essential, especially for Type 1 diabetics. Stopping insulin can lead to Diabetic Ketoacidosis (DKA). Patients should continue insulin, monitor blood glucose and ketones frequently, and try to consume small amounts of carbohydrate-containing fluids to prevent dehydration and hypoglycemia.",
        "section": "Patient Education"
    },
    {
        "questionText": "A patient with Addison's disease is taking daily hydrocortisone and fludrocortisone. The patient calls the clinic complaining of severe muscle cramps and weakness. The nurse suspects an electrolyte imbalance. Which lab finding would the nurse anticipate and be most concerned about?",
        "options": {
            "A": "Serum sodium of 145 mEq/L.",
            "B": "Serum potassium of 2.8 mEq/L.",
            "C": "Serum calcium of 9.0 mg/dL.",
            "D": "Blood glucose of 120 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "Both hydrocortisone (due to its mineralocorticoid activity at higher doses) and fludrocortisone (a pure mineralocorticoid) promote potassium excretion. Excessive dosing can lead to hypokalemia, which manifests as muscle weakness and cramps. A serum potassium of 2.8 mEq/L is significantly low and would be a priority concern. The other values are within or near normal limits or less concerning in this context.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient is prescribed a new medication that is a synthetic analogue of somatostatin (e.g., octreotide). The nurse understands this medication is primarily used to treat disorders involving which endocrine gland?",
        "options": {
            "A": "Thyroid gland.",
            "B": "Adrenal gland.",
            "C": "Pituitary gland.",
            "D": "Pancreas."
        },
        "correctAnswer": "C",
        "rationale": "Somatostatin is a hormone that inhibits the secretion of various hormones, including growth hormone. Octreotide, a somatostatin analogue, is primarily used to treat disorders caused by excessive hormone secretion from the pituitary gland, such as acromegaly (excess growth hormone) or neuroendocrine tumors (e.g., carcinoid syndrome, VIPomas, glucagonomas) that secrete excessive hormones.",
        "section": "Advanced Concepts: Pituitary Hormones"
    },
    {
        "questionText": "A 60-year-old patient with long-standing Type 2 Diabetes is admitted with Hyperglycemic Hyperosmolar State (HHS). The nurse reviews the orders. Which order should the nurse question as potentially harmful in the initial management of HHS?",
        "options": {
            "A": "Administer normal saline 1 L/hour for the first 2 hours.",
            "B": "Start IV regular insulin infusion at 0.1 unit/kg/hr.",
            "C": "Administer a bolus of IV potassium chloride 20 mEq.",
            "D": "Closely monitor neurological status and signs of cerebral edema."
        },
        "correctAnswer": "C",
        "rationale": "While fluid and insulin therapy will cause a shift of potassium into cells, leading to eventual hypokalemia, initial serum potassium levels in HHS (and DKA) can be normal or elevated due to severe dehydration and acid-base disturbances. Administering a potassium bolus with an unknown or potentially elevated initial potassium level could cause life-threatening hyperkalemia. Potassium replacement is typically initiated only after confirming hypokalemia and adequate urine output. Options A, B, and D are standard initial management for HHS.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient is taking levothyroxine. The nurse advises the patient to avoid taking the medication with which of the following beverages or supplements?",
        "options": {
            "A": "Water only.",
            "B": "Coffee.",
            "C": "Orange juice.",
            "D": "Milk."
        },
        "correctAnswer": "B",
        "rationale": "Coffee, like some other beverages and supplements (calcium, iron, antacids), can significantly impair the absorption of levothyroxine. It is recommended to take levothyroxine with water only, on an empty stomach, at least 30-60 minutes before breakfast or other medications/supplements. Milk contains calcium, which also interferes with absorption.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A 45-year-old patient with Cushing's syndrome due to prolonged exogenous corticosteroid use is being tapered off prednisone. The nurse emphasizes the importance of a slow taper. What is the primary reason for this gradual reduction?",
        "options": {
            "A": "To prevent an allergic reaction to the cessation of the drug.",
            "B": "To allow the adrenal glands to gradually resume endogenous cortisol production.",
            "C": "To avoid rebound inflammation and pain from the underlying condition.",
            "D": "To prevent sudden hypoglycemia and electrolyte imbalances."
        },
        "correctAnswer": "B",
        "rationale": "Long-term exogenous corticosteroid use suppresses the hypothalamic-pituitary-adrenal (HPA) axis, leading to adrenal atrophy and impaired endogenous cortisol production. A slow taper is crucial to allow the adrenal glands to gradually recover their ability to produce sufficient cortisol. Abrupt cessation can precipitate a life-threatening adrenal crisis.",
        "section": "Patient Education"
    },
    {
        "questionText": "A patient with diabetes is considering switching from multiple daily insulin injections to an insulin pump. The nurse explains the advantages of pump therapy. Which advantage should the nurse highlight?",
        "options": {
            "A": "Eliminates the need for blood glucose monitoring.",
            "B": "Provides continuous basal insulin and boluses for meals, potentially offering tighter glycemic control.",
            "C": "Allows for the use of long-acting insulin, which is safer.",
            "D": "Requires less patient education and management."
        },
        "correctAnswer": "B",
        "rationale": "Insulin pumps deliver continuous subcutaneous rapid-acting insulin (basal rate) and allow for precise bolus dosing at meal times and for corrections. This can lead to more flexible lifestyles and potentially tighter glycemic control compared to multiple daily injections. It does not eliminate glucose monitoring (in fact, requires more frequent), uses rapid-acting insulin, and requires *significant* patient education and active management.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is teaching a patient about glargine (Lantus) insulin. The patient asks, 'When should I expect this insulin to start working?' The nurse's best response is:",
        "options": {
            "A": "Within 15-30 minutes, so take it just before your meal.",
            "B": "Within 30-60 minutes, and it will peak in about 2-4 hours.",
            "C": "It begins working in 1-2 hours and has no pronounced peak, providing a steady effect.",
            "D": "It works very slowly, over 24-48 hours, so its onset is delayed."
        },
        "correctAnswer": "C",
        "rationale": "Insulin glargine (Lantus) is a long-acting insulin designed to provide a steady, basal level of insulin over 24 hours with a relatively slow onset (1-2 hours) and no pronounced peak. This helps to control blood glucose levels between meals and overnight.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed sitagliptin (Januvia). The nurse educates the patient that this medication works by:",
        "options": {
            "A": "Decreasing hepatic glucose production and increasing insulin sensitivity.",
            "B": "Stimulating the pancreas to release more insulin independently of glucose levels.",
            "C": "Enhancing the body's natural incretin hormones to increase glucose-dependent insulin release.",
            "D": "Increasing glucose excretion in the urine."
        },
        "correctAnswer": "C",
        "rationale": "Sitagliptin is a DPP-4 inhibitor. It works by preventing the breakdown of incretin hormones (GLP-1 and GIP), which are naturally released after a meal. This enhancement leads to increased glucose-dependent insulin secretion and suppressed glucagon secretion, thereby lowering blood glucose. Option A describes metformin, B describes sulfonylureas, and D describes SGLT2 inhibitors.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A nurse is assessing a patient on thyroid hormone replacement who has developed fine tremors, unexplained weight loss, and intolerance to heat. The nurse suspects that the patient's levothyroxine dose may be too high. Which lab test would confirm this suspicion?",
        "options": {
            "A": "An elevated TSH level.",
            "B": "A suppressed TSH level.",
            "C": "A low Free T4 level.",
            "D": "An elevated calcitonin level."
        },
        "correctAnswer": "B",
        "rationale": "Symptoms of fine tremors, weight loss, and heat intolerance are indicative of hyperthyroidism. If a patient on levothyroxine develops these, it suggests an excessive dose. This would be confirmed by a suppressed (low) TSH level, indicating negative feedback from excess thyroid hormone, and often an elevated free T4. An elevated TSH would indicate hypothyroidism.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed canagliflozin (Invokana). The nurse teaches the patient about common side effects. Which side effect should the nurse specifically mention as frequent due to the drug's mechanism of action?",
        "options": {
            "A": "Diarrhea and abdominal cramping.",
            "B": "Hypoglycemia (when used alone).",
            "C": "Genital yeast infections and urinary tract infections.",
            "D": "Peripheral edema and weight gain."
        },
        "correctAnswer": "C",
        "rationale": "Canagliflozin is an SGLT2 inhibitor, which works by causing glucose to be excreted in the urine. This increased glucose in the urine creates a favorable environment for bacterial and fungal growth, leading to an increased incidence of genitourinary infections, such as yeast infections and UTIs. Diarrhea is more common with metformin, hypoglycemia is less common with SGLT2s as monotherapy, and peripheral edema/weight gain are more associated with TZDs.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient is taking propylthiouracil (PTU) for hyperthyroidism. The nurse instructs the patient that this medication should be taken:",
        "options": {
            "A": "On an empty stomach, once daily.",
            "B": "With meals, to reduce gastrointestinal upset.",
            "C": "At bedtime to minimize side effects.",
            "D": "Only when symptoms of hyperthyroidism are present."
        },
        "correctAnswer": "B",
        "rationale": "PTU should be taken with food (or milk) to minimize gastrointestinal upset, which is a common side effect. It is typically administered in multiple doses throughout the day due to its shorter half-life. It is a daily medication, not just PRN for symptoms.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is providing discharge instructions to a patient with Type 1 Diabetes newly prescribed an insulin regimen involving insulin glargine and insulin aspart. Which statement indicates proper understanding of the insulin regimen?",
        "options": {
            "A": "“I will mix my glargine and aspart in the same syringe to save injections.”",
            "B": "“I will take my glargine at bedtime and my aspart before each meal.”",
            "C": "“I can skip my glargine dose if I don’t plan to eat much that day.”",
            "D": "“My aspart insulin will control my blood sugar for a full 24 hours.”"
        },
        "correctAnswer": "B",
        "rationale": "Insulin glargine is a long-acting basal insulin, typically taken once daily (often at bedtime) to provide continuous glucose control. Insulin aspart is a rapid-acting bolus insulin, taken before meals to cover carbohydrate intake. Glargine and aspart should never be mixed. Glargine should not be skipped, even if eating less, as it provides basal coverage. Aspart only works for a few hours, not 24.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient is admitted with a diagnosis of pheochromocytoma. The nurse understands that this condition involves excessive secretion of hormones from which part of the adrenal gland?",
        "options": {
            "A": "Adrenal cortex (glucocorticoids).",
            "B": "Adrenal medulla (catecholamines).",
            "C": "Adrenal cortex (mineralocorticoids).",
            "D": "Adrenal cortex (sex hormones)."
        },
        "correctAnswer": "B",
        "rationale": "A pheochromocytoma is a tumor of the adrenal medulla that secretes excessive amounts of catecholamines (epinephrine and norepinephrine). This leads to symptoms like severe hypertension, palpitations, and headaches. The adrenal cortex produces glucocorticoids, mineralocorticoids, and sex hormones.",
        "section": "Advanced Concepts: Adrenal Disorders"
    },
    {
        "questionText": "A nurse is performing an assessment on a patient with newly diagnosed primary hyperparathyroidism. Which abnormal laboratory finding would the nurse most likely expect to find?",
        "options": {
            "A": "Hypocalcemia and hyperphosphatemia.",
            "B": "Hypercalcemia and hypophosphatemia.",
            "C": "Normal calcium and elevated PTH.",
            "D": "Low PTH and high calcium."
        },
        "correctAnswer": "B",
        "rationale": "Primary hyperparathyroidism involves excessive secretion of parathyroid hormone (PTH) from the parathyroid glands. PTH's primary role is to raise serum calcium and lower serum phosphate. Therefore, the nurse would expect to find hypercalcemia (high calcium) and hypophosphatemia (low phosphate). Option C would indicate secondary hyperparathyroidism or early stage. Option D describes conditions like hypercalcemia of malignancy or vitamin D toxicity, not primary hyperparathyroidism.",
        "section": "Advanced Concepts: Parathyroid Disorders"
    },
    {
        "questionText": "A patient is prescribed a new oral antidiabetic drug, repaglinide (Prandin). The nurse should teach the patient to take this medication:",
        "options": {
            "A": "Once daily in the morning.",
            "B": "With the first bite of each meal.",
            "C": "At bedtime only.",
            "D": "Every other day to prevent hypoglycemia."
        },
        "correctAnswer": "B",
        "rationale": "Repaglinide is a meglitinide, a class of drugs that stimulates rapid, short-acting insulin release from the pancreas in a glucose-dependent manner. To match insulin release with carbohydrate intake and minimize the risk of hypoglycemia, it should be taken shortly before or with the first bite of each main meal.",
        "section": "Patient Teaching"
    },
 {
        "questionText": "A 68-year-old patient with a history of Type 2 Diabetes, chronic kidney disease (eGFR 28 mL/min), and heart failure with reduced ejection fraction (HFrEF) is admitted with pneumonia. His current medications include metformin 500 mg daily, insulin glargine 20 units nightly, and furosemide. On admission, his blood glucose is 380 mg/dL. The nurse receives an order for 'continue home medications'. Which action by the nurse is the most appropriate?",
        "options": {
            "A": "Administer metformin as ordered and monitor blood glucose closely.",
            "B": "Hold the metformin and notify the provider regarding the patient's eGFR and acute illness.",
            "C": "Administer all home medications as ordered, anticipating increased insulin needs.",
            "D": "Administer the insulin glargine and furosemide, but hold the metformin until the pneumonia resolves."
        },
        "correctAnswer": "B",
        "rationale": "Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min) and during acute illness (like pneumonia) due to the significantly increased risk of lactic acidosis. While insulin glargine provides basal coverage and should likely be continued (with potential adjustments), metformin poses an immediate safety risk in this context. Notifying the provider to discuss holding or discontinuing metformin is the priority. Holding it independently without questioning or clarifying the order is not ideal practice.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A 55-year-old patient with Type 1 Diabetes and gastroparesis is transitioning from multiple daily insulin injections to an insulin pump. The patient expresses concern about post-meal hyperglycemia and asks how the pump helps. The nurse should explain that a key advantage of pump therapy in gastroparesis is:",
        "options": {
            "A": "The pump can deliver rapid-acting insulin as a square wave or dual wave bolus to match delayed gastric emptying.",
            "B": "The pump uses long-acting insulin, which is less affected by delayed absorption.",
            "C": "The pump eliminates the need for mealtime insulin adjustments.",
            "D": "The pump actively monitors glucose levels and automatically adjusts insulin delivery based on gastroparesis severity."
        },
        "correctAnswer": "A",
        "rationale": "Gastroparesis causes unpredictable and delayed absorption of carbohydrates. Standard boluses might lead to early hypoglycemia followed by delayed hyperglycemia. Insulin pumps allow for advanced bolus options like square wave (extended over time) or dual wave (initial bolus followed by extended delivery), which can be tailored to match the prolonged absorption of food in gastroparesis, offering better post-meal glucose control. Pumps use rapid-acting insulin, not long-acting, and do not eliminate mealtime adjustments or automatically adjust based on gastroparesis severity.",
        "section": "Advanced Concepts: Insulin Therapy"
    },
    {
        "questionText": "A 30-year-old patient with Graves' disease is prescribed methimazole. Six weeks into therapy, she calls the clinic reporting a sudden onset of a sore throat, fever of 101.5°F (38.6°C), and chills. The nurse should instruct the patient to:",
        "options": {
            "A": "Take acetaminophen for the fever and continue her methimazole as prescribed.",
            "B": "Come to the clinic immediately for a complete blood count (CBC) with differential.",
            "C": "Temporarily stop the methimazole and schedule a routine follow-up appointment.",
            "D": "Increase her fluid intake and rest, as these are common viral symptoms."
        },
        "correctAnswer": "B",
        "rationale": "Agranulocytosis is a rare but life-threatening adverse effect of antithyroid medications like methimazole and PTU. Symptoms of infection (sore throat, fever, chills) in a patient on these drugs should be considered a medical emergency until agranulocytosis is ruled out. An immediate CBC with differential is needed to assess neutrophil count. Delaying evaluation or continuing the drug could be fatal.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with primary adrenal insufficiency (Addison's disease) is being educated on the importance of lifelong hormone replacement. The nurse is explaining how stress affects their medication needs. Which example correctly demonstrates the concept of 'stress dosing'?",
        "options": {
            "A": "Taking their usual hydrocortisone dose every day regardless of physical activity.",
            "B": "Doubling the hydrocortisone dose before going to bed on a normal day.",
            "C": "Increasing the daily dose of hydrocortisone if experiencing a moderate fever or undergoing a minor dental procedure.",
            "D": "Discontinuing fludrocortisone if they have increased sodium intake."
        },
        "correctAnswer": "C",
        "rationale": "Stress dosing refers to increasing the glucocorticoid dose during periods of physical stress (e.g., illness, surgery, trauma) to mimic the body's natural increased cortisol production. A moderate fever or minor dental procedure represents a moderate stressor that would typically warrant a temporary increase in hydrocortisone. Options A and B are incorrect applications of stress dosing. Fludrocortisone management is separate and not dictated by sodium intake in this manner for stress dosing.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A 75-year-old patient with Type 2 Diabetes and a history of chronic pancreatitis is prescribed dulaglutide. The nurse understands that this medication has a black box warning for a specific adverse effect. Which symptom should the nurse instruct the patient to report immediately?",
        "options": {
            "A": "Severe, persistent abdominal pain radiating to the back, with or without vomiting.",
            "B": "Increased urination and thirst.",
            "C": "Pain, swelling, or redness at the injection site.",
            "D": "Dizziness and confusion upon standing."
        },
        "correctAnswer": "A",
        "rationale": "GLP-1 receptor agonists, including dulaglutide, carry a black box warning for the risk of thyroid C-cell tumors (medullary thyroid carcinoma) and a general warning for acute pancreatitis. Given the patient's history of chronic pancreatitis, severe, persistent abdominal pain radiating to the back, with or without vomiting, is a critical symptom of acute pancreatitis and must be reported immediately. Increased urination/thirst are symptoms of hyperglycemia or SGLT2 inhibitors. Injection site reactions are common but not severe. Dizziness/confusion upon standing could be orthostatic hypotension but not a black box warning for this drug.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with newly diagnosed Type 1 Diabetes is discharged on a basal-bolus insulin regimen (glargine once daily, aspart before meals). The patient calls the clinic stating, 'My blood sugar is 280 mg/dL before dinner, but I took my aspart before breakfast. Should I take another dose of aspart now?' What is the nurse's most appropriate response?",
        "options": {
            "A": "Yes, take another dose of aspart now to bring your blood sugar down.",
            "B": "No, you should only take aspart before breakfast and dinner, not at other times.",
            "C": "You may need a correction dose of aspart; let's calculate it based on your insulin sensitivity factor.",
            "D": "You should check your blood sugar again in 30 minutes, as it might come down on its own."
        },
        "correctAnswer": "C",
        "rationale": "In a basal-bolus regimen, rapid-acting insulin (like aspart) is used for meal coverage and for 'correction doses' to bring down high blood sugars outside of meal times. Patients are often provided with an insulin sensitivity factor (ISF) or correction factor to calculate how much additional rapid-acting insulin is needed to correct hyperglycemia. Simply taking 'another dose' without calculation or waiting for it to come down is inappropriate. Options A, B, and D are potentially dangerous or insufficient.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with long-standing Type 2 Diabetes is starting empagliflozin. The nurse teaches the patient about the potential for 'euglycemic DKA'. Which finding would specifically prompt the nurse to instruct the patient to seek immediate medical attention, even if their blood glucose is not extremely high?",
        "options": {
            "A": "Blood glucose of 200 mg/dL.",
            "B": "Excessive urination and thirst.",
            "C": "Persistent nausea, vomiting, and abdominal pain.",
            "D": "Muscle cramps and weakness."
        },
        "correctAnswer": "C",
        "rationale": "Euglycemic DKA (eDKA) is a severe complication of SGLT2 inhibitors where ketoacidosis occurs with blood glucose levels that are not severely elevated (often <250 mg/dL). Key symptoms of eDKA include persistent nausea, vomiting, and abdominal pain, along with fatigue, and shortness of breath. Excessive urination/thirst are expected drug effects. Muscle cramps can occur with electrolyte imbalances but are not indicative of DKA. A blood glucose of 200 mg/dL itself is not alarming, but in combination with GI symptoms, it is highly concerning for eDKA.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient is admitted with syndrome of inappropriate antidiuretic hormone (SIADH) and has a serum sodium of 118 mEq/L. The nurse anticipates administration of a hypertonic saline solution. During the infusion, which complication is the nurse most concerned about and should monitor for closely?",
        "options": {
            "A": "Hypoglycemia due to fluid overload.",
            "B": "Osmotic demyelination syndrome (formerly central pontine myelinolysis).",
            "C": "Thyroid storm from rapid sodium correction.",
            "D": "Hyperkalemia due to intracellular fluid shifts."
        },
        "correctAnswer": "B",
        "rationale": "Rapid correction of chronic hyponatremia (like 118 mEq/L in SIADH) with hypertonic saline can lead to osmotic demyelination syndrome. This severe neurological complication results from rapid osmotic shifts in brain cells. Sodium correction must be done slowly and cautiously to avoid this devastating outcome. While fluid overload is a concern with hypertonic solutions, the specific neurological complication is the priority when correcting hyponatremia too quickly.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A nurse is preparing to administer insulin aspart 10 units subcutaneously to a patient with Type 1 Diabetes. The patient's breakfast tray has just arrived. What is the most appropriate nursing action?",
        "options": {
            "A": "Administer the insulin now and ensure the patient starts eating immediately.",
            "B": "Wait 30 minutes for the insulin to take effect before the patient begins eating.",
            "C": "Administer the insulin after the patient has finished their meal.",
            "D": "Check the patient's blood glucose, then administer the insulin only if the glucose is above 150 mg/dL."
        },
        "correctAnswer": "A",
        "rationale": "Insulin aspart is a rapid-acting insulin with an onset of 5-15 minutes. It should be administered just before (within 5-15 minutes) or with the first bite of a meal to prevent post-injection hypoglycemia. Waiting 30 minutes would risk hypoglycemia. Administering after the meal would not cover the post-prandial glucose rise effectively. Checking glucose is always necessary, but the question is about timing of administration *with* the meal.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is newly prescribed pioglitazone. The nurse assesses the patient's medical history. Which finding would lead the nurse to question this order?",
        "options": {
            "A": "History of mild hypertension controlled with diet.",
            "B": "Currently on metformin for glucose control.",
            "C": "Diagnosis of New York Heart Association (NYHA) Class III heart failure.",
            "D": "Previous history of gestational diabetes."
        },
        "correctAnswer": "C",
        "rationale": "Pioglitazone (a TZD) is contraindicated in patients with New York Heart Association (NYHA) Class III or IV heart failure due to its propensity to cause fluid retention and exacerbate heart failure symptoms. This is a black box warning for the drug. The other conditions do not contraindicate pioglitazone.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient is taking levothyroxine for hypothyroidism. The nurse reviews the patient's medication list and notes the patient also takes calcium carbonate and a proton pump inhibitor (omeprazole). The nurse should advise the patient to:",
        "options": {
            "A": "Take all three medications together in the morning for convenience.",
            "B": "Take levothyroxine first thing in the morning, then separate calcium and omeprazole by at least 4 hours.",
            "C": "Take calcium carbonate and omeprazole with the levothyroxine to enhance absorption.",
            "D": "Take levothyroxine at night and calcium/omeprazole in the morning."
        },
        "correctAnswer": "D",
        "rationale": "Levothyroxine absorption is significantly impaired by calcium-containing products (like calcium carbonate) and by medications that reduce gastric acid (like omeprazole). To ensure optimal absorption, levothyroxine should be taken alone, on an empty stomach, at least 30-60 minutes before breakfast. To further minimize interactions, taking levothyroxine at night (e.g., 3-4 hours after the last meal) and then taking calcium/omeprazole in the morning is a common strategy to maximize the separation of these interacting medications.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "A 48-year-old patient with no prior history of diabetes is admitted with a severe septic infection. His blood glucose levels are consistently in the range of 250-350 mg/dL. The nurse anticipates a temporary insulin regimen. What is the primary reason for initiating insulin therapy in this non-diabetic patient during severe illness?",
        "options": {
            "A": "To prevent the development of Type 1 Diabetes.",
            "B": "To reduce the catabolic effects of hyperglycemia and improve clinical outcomes.",
            "C": "To stimulate his pancreas to produce more insulin on its own.",
            "D": "To prepare him for long-term insulin therapy after discharge."
        },
        "correctAnswer": "B",
        "rationale": "Hyperglycemia during severe illness (stress-induced hyperglycemia) is associated with worse clinical outcomes, including increased mortality, infection rates, and length of hospital stay, even in non-diabetic patients. Insulin therapy is used to manage this hyperglycemia to reduce its harmful catabolic effects and improve patient recovery, not to prevent diabetes or stimulate pancreatic function. It's often a temporary measure.",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is prescribed pramlintide (Symlin), an amylin analog. The nurse instructs the patient to administer this medication immediately prior to major meals. The nurse must also emphasize which crucial administration detail to prevent severe hypoglycemia?",
        "options": {
            "A": "Always take pramlintide at the same time as rapid-acting insulin in the same syringe.",
            "B": "Reduce the dose of rapid-acting or short-acting insulin by 50% before meals when taking pramlintide.",
            "C": "Administer pramlintide intravenously for faster action.",
            "D": "Only take pramlintide if planning to eat a meal with less than 250 calories."
        },
        "correctAnswer": "B",
        "rationale": "Pramlintide significantly slows gastric emptying and suppresses post-prandial glucagon, which can lead to severe hypoglycemia when used with insulin, especially rapid-acting insulin. To mitigate this risk, the dose of rapid-acting or short-acting insulin given with the meal should be reduced by 50% (or as specifically prescribed by the provider) when starting pramlintide. It cannot be mixed with insulin and is given subcutaneously. The calorie restriction applies to 'major meals', not less than 250 calories.",
        "section": "Advanced Concepts: Antidiabetics"
    },
    {
        "questionText": "A 65-year-old patient on long-term prednisone for rheumatoid arthritis has developed bilateral lower extremity edema, a moon face, and hypertension. The nurse anticipates an order for a new medication to address the fluid retention. Which medication would be most appropriate?",
        "options": {
            "A": "Potassium-sparing diuretic (e.g., spironolactone).",
            "B": "Thiazide diuretic (e.g., hydrochlorothiazide).",
            "C": "Loop diuretic (e.g., furosemide).",
            "D": "Beta-blocker (e.g., metoprolol)."
        },
        "correctAnswer": "C",
        "rationale": "Prednisone's mineralocorticoid effects cause significant sodium and water retention. Loop diuretics (like furosemide) are the most potent diuretics and are typically used to manage significant edema and fluid overload. While thiazide diuretics can help with hypertension, a loop diuretic is more effective for the degree of fluid retention suggested. Spironolactone is potassium-sparing, and beta-blockers primarily manage heart rate and blood pressure, not fluid retention directly.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed a new oral antidiabetic medication, sitagliptin. The nurse is explaining its mechanism of action. Which statement accurately describes how sitagliptin works?",
        "options": {
            "A": "It directly stimulates the pancreas to release more insulin.",
            "B": "It decreases glucose production in the liver and increases insulin sensitivity.",
            "C": "It enhances the body's natural incretin hormones, which increase glucose-dependent insulin release and decrease glucagon.",
            "D": "It promotes the excretion of glucose in the urine by inhibiting its reabsorption in the kidneys."
        },
        "correctAnswer": "C",
        "rationale": "Sitagliptin is a DPP-4 inhibitor. It works by inhibiting the enzyme DPP-4, which normally breaks down incretin hormones (GLP-1 and GIP). By preserving incretins, sitaglipt enhances glucose-dependent insulin secretion from the pancreas and suppresses glucagon secretion from alpha cells, thereby lowering blood glucose. Option A describes sulfonylureas, B describes metformin, and D describes SGLT2 inhibitors.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is taking levothyroxine 100 mcg daily. Her recent lab results show a TSH of 0.1 mU/L (normal 0.5-5.0 mU/L) and a free T4 of 2.1 ng/dL (normal 0.8-1.8 ng/dL). She reports feeling more energetic but also has some palpitations and difficulty sleeping. What is the nurse's priority action?",
        "options": {
            "A": "Encourage the patient to continue the medication as it is improving her energy.",
            "B": "Advise the patient to take the medication at night to help with sleep.",
            "C": "Notify the healthcare provider immediately as the patient is likely hyperthyroid due to overtreatment.",
            "D": "Suggest adding a beta-blocker to manage the palpitations."
        },
        "correctAnswer": "C",
        "rationale": "The patient's symptoms (palpitations, insomnia, increased energy) combined with suppressed TSH and elevated free T4 strongly indicate iatrogenic hyperthyroidism due to an excessive dose of levothyroxine. This puts the patient at risk for cardiac complications (e.g., atrial fibrillation, heart failure, angina). Notifying the provider for a dose reduction is the priority. Managing symptoms with a beta-blocker is a secondary measure; the underlying cause (overdosing) needs to be addressed.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 2 Diabetes has been on metformin for several years. He is now complaining of numbness and tingling in his feet. The nurse reviews his chart and sees he has been consistently adherent to his medication and diet. Which additional lab test might the nurse anticipate the provider ordering to investigate this new symptom?",
        "options": {
            "A": "Serum creatinine to check for nephropathy.",
            "B": "Hemoglobin A1c to assess glycemic control.",
            "C": "Vitamin B12 level.",
            "D": "Liver function tests (LFTs)."
        },
        "correctAnswer": "C",
        "rationale": "Long-term metformin use, particularly at higher doses, can interfere with vitamin B12 absorption, leading to B12 deficiency. Symptoms of B12 deficiency include peripheral neuropathy (numbness and tingling), fatigue, and cognitive changes. While neuropathy can also be a diabetic complication, B12 deficiency is a specific consideration with metformin that requires assessment.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A 35-year-old patient with Addison's disease is admitted for an elective appendectomy. Pre-operatively, the nurse anticipates which medication adjustment as a priority?",
        "options": {
            "A": "Discontinuing hydrocortisone to prevent surgical site infection.",
            "B": "Increasing the daily dose of fludrocortisone.",
            "C": "Administering an intravenous stress dose of hydrocortisone.",
            "D": "Initiating a long-acting insulin regimen to manage surgical stress-induced hyperglycemia."
        },
        "correctAnswer": "C",
        "rationale": "Patients with Addison's disease lack the ability to produce adequate cortisol in response to stress. Major stressors like surgery require a significant increase in glucocorticoid (hydrocortisone) dose to prevent an acute adrenal crisis (hypotension, shock). This is known as 'stress dosing' and is a critical perioperative intervention. Discontinuing hydrocortisone would be life-threatening. Fludrocortisone replacement is for mineralocorticoid deficiency, not the acute stress response. Hyperglycemia management is secondary to preventing adrenal crisis.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "Which mechanism of action is characteristic of SGLT2 inhibitors (e.g., canagliflozin, empagliflozin)?",
        "options": {
            "A": "Increased insulin secretion from pancreatic beta cells.",
            "B": "Reduction of hepatic glucose production.",
            "C": "Inhibition of glucose reabsorption in the renal tubules, leading to glucosuria.",
            "D": "Enhancement of insulin sensitivity in peripheral tissues."
        },
        "correctAnswer": "C",
        "rationale": "SGLT2 inhibitors work by blocking the sodium-glucose co-transporter 2 in the kidneys, which is responsible for reabsorbing most of the filtered glucose back into the bloodstream. By inhibiting this transporter, they cause glucose to be excreted in the urine (glucosuria), thereby lowering blood glucose levels. Option A describes sulfonylureas/meglitinides, B describes metformin, and D describes TZDs/metformin.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient taking insulin glargine daily is scheduled for a morning surgical procedure and is NPO after midnight. The nurse receives an order to 'hold all oral medications'. What is the most appropriate nursing action regarding the patient's scheduled insulin glargine dose?",
        "options": {
            "A": "Hold the insulin glargine entirely to prevent hypoglycemia.",
            "B": "Administer the full dose of insulin glargine as scheduled.",
            "C": "Administer half the usual dose of insulin glargine.",
            "D": "Clarify the order with the provider regarding the insulin glargine."
        },
        "correctAnswer": "D",
        "rationale": "Long-acting basal insulins like glargine provide continuous glucose control and are essential for preventing DKA in Type 1 diabetes and significant hyperglycemia in Type 2. They should generally NOT be held entirely, even when NPO, as the patient still needs basal insulin. However, the exact dose may need adjustment (e.g., a reduced dose) depending on the patient's baseline control, the type and duration of the procedure, and the overall clinical picture. The safest and most appropriate action is to clarify the specific order for the insulin glargine with the provider rather than making an independent decision.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 2 Diabetes on a stable regimen of metformin and insulin glargine has an A1C of 7.2%. The provider is considering adding a new medication to further improve glycemic control and also wants to address potential cardiovascular risk. Which medication class would be the most appropriate addition based on current evidence-based guidelines?",
        "options": {
            "A": "Sulfonylurea (e.g., glipizide).",
            "B": "Thiazolidinedione (e.g., pioglitazone).",
            "C": "SGLT2 inhibitor (e.g., empagliflozin) or GLP-1 receptor agonist (e.g., liraglutide).",
            "D": "Alpha-glucosidase inhibitor (e.g., acarbose)."
        },
        "correctAnswer": "C",
        "rationale": "Current guidelines for managing Type 2 Diabetes, especially in patients with established cardiovascular disease (or high risk) or kidney disease, recommend SGLT2 inhibitors or GLP-1 receptor agonists as preferred add-on therapies due to their demonstrated cardiovascular and renal benefits, independent of their glucose-lowering effects. Sulfonylureas and TZDs do not offer these benefits and may even have specific risks (hypoglycemia with sulfonylureas, heart failure with TZDs).",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A 50-year-old male with new onset Type 2 Diabetes is prescribed metformin. Which of the following adverse effects should the nurse primarily educate the patient about to ensure adherence and proper management?",
        "options": {
            "A": "Significant risk of hypoglycemia requiring consistent carbohydrate intake.",
            "B": "Gastrointestinal side effects such as nausea, diarrhea, and abdominal discomfort.",
            "C": "Need for frequent blood tests to monitor for liver toxicity.",
            "D": "Weight gain and fluid retention."
        },
        "correctAnswer": "B",
        "rationale": "Gastrointestinal side effects (nausea, diarrhea, abdominal discomfort) are very common with metformin, especially when therapy is initiated or the dose is increased. These side effects are often transient but can impact adherence significantly. Taking metformin with meals and starting with a low dose and titrating slowly helps to mitigate them. Metformin has a low risk of hypoglycemia as monotherapy, does not typically cause liver toxicity (except lactic acidosis in specific circumstances), and usually causes weight loss or neutrality, not gain.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is teaching a patient with diabetes about the Somogyi effect. Which symptom pattern should the nurse describe as characteristic of this phenomenon?",
        "options": {
            "A": "Consistently high blood glucose levels throughout the night and morning.",
            "B": "High blood glucose levels in the early morning (2-3 AM) with no prior dip.",
            "C": "Nocturnal hypoglycemia (low blood glucose in the early morning) followed by rebound hyperglycemia.",
            "D": "Gradual increase in blood glucose throughout the day due to insulin resistance."
        },
        "correctAnswer": "C",
        "rationale": "The Somogyi effect (also known as rebound hyperglycemia) is characterized by undetected hypoglycemia, typically occurring during the night (e.g., 2-3 AM), which then triggers a release of counter-regulatory hormones (glucagon, epinephrine, cortisol, growth hormone) that cause a rebound hyperglycemia in the morning. Option A describes poor control generally. Option B describes the Dawn phenomenon. Option D describes general insulin resistance.",
        "section": "Advanced Concepts: Insulin Therapy"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is admitted with Diabetic Ketoacidosis (DKA). The nurse initiates IV fluid resuscitation. What is the rationale for using 0.9% Normal Saline (isotonic solution) initially in DKA?",
        "options": {
            "A": "To rapidly correct the severe hypernatremia often seen in DKA.",
            "B": "To prevent cerebral edema by keeping the serum osmolality high.",
            "C": "To re-establish circulating volume and perfusion due to profound dehydration.",
            "D": "To provide a vehicle for rapid administration of dextrose."
        },
        "correctAnswer": "C",
        "rationale": "Patients in DKA are profoundly dehydrated due to osmotic diuresis caused by hyperglycemia. The initial priority in DKA management is aggressive fluid resuscitation with isotonic saline (0.9% NaCl) to re-establish circulating volume, restore renal perfusion, and reduce serum osmolality. While hyponatremia is often seen (or normonatremia masked by hyperglycemia), the primary goal is fluid volume replacement, not direct sodium correction. Dextrose is added later, and hypotonic solutions are used cautiously to prevent cerebral edema, not isotonic initially.",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A patient is prescribed both insulin glargine and insulin lispro. The nurse is observing the patient's self-administration technique. Which action by the patient indicates a need for immediate correction by the nurse?",
        "options": {
            "A": "Drawing up the glargine and lispro into separate syringes for two injections.",
            "B": "Injecting the insulin into their abdomen, two inches from their umbilicus.",
            "C": "Shaking the vial of glargine vigorously before drawing up the dose.",
            "D": "Holding the insulin pen at the injection site for 10 seconds after pushing the plunger."
        },
        "correctAnswer": "C",
        "rationale": "Insulin glargine (Lantus) is a clear, long-acting insulin that should not be shaken. Shaking can cause foaming and alter the integrity and absorption of the insulin, potentially affecting its duration of action. Options A, B, and D are correct administration techniques (glargine cannot be mixed, abdomen is a good site, holding after injection ensures full dose delivery).",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A 70-year-old patient is prescribed calcitriol for chronic hypocalcemia due to renal failure. The nurse teaches the patient about potential signs of hypercalcemia. Which of the following would be included?",
        "options": {
            "A": "Muscle spasms and positive Chvostek's sign.",
            "B": "Increased appetite and weight gain.",
            "C": "Bone pain, constipation, and lethargy.",
            "D": "Increased urine output and thirst, with diluted urine."
        },
        "correctAnswer": "C",
        "rationale": "Hypercalcemia (too much calcium) symptoms include 'stones, bones, groans, and psychiatric overtones'. Specifically, bone pain (from calcium leaving bones), constipation (slowed GI motility), and lethargy/fatigue are common. Muscle spasms and Chvostek's sign are symptoms of hypocalcemia. Increased appetite/weight gain are non-specific. Increased urine output and thirst with diluted urine could indicate diabetes insipidus, not typically associated with calcitriol overdose.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed liraglutide (Victoza), a GLP-1 receptor agonist. The nurse teaches the patient about possible side effects. Which side effect, if severe and persistent, would warrant contacting the provider immediately?",
        "options": {
            "A": "Nausea, especially when starting the medication.",
            "B": "Mild diarrhea.",
            "C": "Severe abdominal pain radiating to the back.",
            "D": "Injection site redness and itching."
        },
        "correctAnswer": "C",
        "rationale": "Severe abdominal pain radiating to the back is a hallmark symptom of acute pancreatitis, a rare but serious adverse effect associated with GLP-1 receptor agonists like liraglutide. While nausea, mild diarrhea, and injection site reactions are common and often transient side effects, severe abdominal pain requires immediate medical evaluation.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with hyperthyroidism is prescribed radioactive iodine (I-131) therapy. The nurse provides detailed discharge instructions. Which statement from the patient indicates a need for further teaching?",
        "options": {
            "A": "“I should avoid close contact with pregnant women and young children for several days after treatment.”",
            "B": "“I need to use a separate toilet and flush it twice after use for a few days.”",
            "C": "“I can resume sharing utensils and towels with my family immediately after I leave the clinic.”",
            "D": "“I will need to wash my laundry separately for a short period.”"
        },
        "correctAnswer": "C",
        "rationale": "Radioactive iodine therapy involves the patient emitting radiation for a period. To minimize exposure to others, especially vulnerable populations, patients need to follow strict precautions including avoiding close contact, using separate bathrooms and flushing twice, washing laundry separately, and not sharing utensils or towels for several days to weeks post-treatment. The statement that sharing utensils and towels can be resumed immediately is incorrect and indicates a need for further teaching.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is administering a dose of insulin regular via intravenous infusion to a patient in Diabetic Ketoacidosis. The patient's initial serum potassium was 5.8 mEq/L. After 2 hours, the blood glucose has decreased from 550 mg/dL to 300 mg/dL, and the new serum potassium is 3.2 mEq/L. The nurse anticipates which action regarding potassium management?",
        "options": {
            "A": "Continue the insulin infusion, but do not administer any potassium.",
            "B": "Discontinue the insulin infusion immediately.",
            "C": "Add potassium to the intravenous fluids, as ordered, while continuing the insulin infusion.",
            "D": "Administer a bolus of 50% dextrose to prevent further potassium drops."
        },
        "correctAnswer": "C",
        "rationale": "Insulin administration, particularly for DKA, drives potassium from the extracellular space back into cells. Even if initial potassium is normal or high, it can rapidly fall to dangerously low levels (hypokalemia) as DKA resolves. A drop from 5.8 to 3.2 mEq/L is significant, placing the patient at risk for dysrhythmias. Potassium replacement is crucial once levels normalize or drop, and insulin must be continued to resolve the acidosis. Dextrose is added to fluids, but the primary concern with a dropping potassium is direct replacement.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "Which medication, commonly used for Type 2 Diabetes, is known to have a specific cardiovascular benefit, reducing the risk of major adverse cardiovascular events (MACE) in patients with established cardiovascular disease?",
        "options": {
            "A": "Glipizide",
            "B": "Pioglitazone",
            "C": "Metformin",
            "D": "Empagliflozin"
        },
        "correctAnswer": "D",
        "rationale": "Among the options, Empagliflozin (an SGLT2 inhibitor) has demonstrated significant cardiovascular benefits, including reduction in MACE, cardiovascular death, and hospitalization for heart failure, particularly in patients with established cardiovascular disease. While metformin is often first-line, its primary benefit is glucose lowering. Glipizide and pioglitazone do not have the same level of evidence for cardiovascular benefit and may even have risks (hypoglycemia, heart failure exacerbation, respectively).",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A 50-year-old patient with hypothyroidism reports that she takes her levothyroxine with her morning coffee and iron supplement. She also complains that she is still very tired and constipated despite increasing her dose of levothyroxine twice in the past 6 months. What is the most likely explanation for her persistent symptoms?",
        "options": {
            "A": "She is developing resistance to levothyroxine and needs a different thyroid medication.",
            "B": "The coffee and iron supplement are interfering with the absorption of her levothyroxine.",
            "C": "Her symptoms are not related to her thyroid function and need to be investigated separately.",
            "D": "She needs to take her levothyroxine with food to enhance absorption."
        },
        "correctAnswer": "B",
        "rationale": "Both coffee and iron supplements are well-known to significantly impair the absorption of levothyroxine. Taking her medication with these substances means she is not receiving the full prescribed dose, leading to persistent hypothyroid symptoms despite dose increases. Levothyroxine should be taken with water only, on an empty stomach, and separated from interacting substances by at least 4 hours. Taking it with food would further impair absorption.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "A nurse is teaching a patient with diabetes about the safe disposal of insulin syringes and pen needles. Which statement indicates proper understanding?",
        "options": {
            "A": "“I can throw my used needles directly into the kitchen trash can.”",
            "B": "“I should recap the needle before placing it in the trash to prevent needlesticks.”",
            "C": "“I will place all used needles and syringes in a hard plastic container, like a laundry detergent bottle, and seal it when full.”",
            "D": "“I can break the needle off my syringe and dispose of the syringe in regular trash.”"
        },
        "correctAnswer": "C",
        "rationale": "Safe disposal of sharps (needles and syringes) is crucial to prevent accidental needlestick injuries. A rigid, puncture-resistant container (like a hard plastic laundry detergent bottle) is an acceptable alternative to a formal sharps container for home use, provided it is securely sealed when full and disposed of according to local regulations. Recapping, throwing directly in trash, or breaking needles increases the risk of injury.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient is admitted with a severe exacerbation of ulcerative colitis and is prescribed high-dose intravenous methylprednisolone. The nurse notes the patient also has Type 2 Diabetes managed with oral metformin. Which of the following effects of the methylprednisolone should the nurse anticipate and actively manage?",
        "options": {
            "A": "Significant hypoglycemia requiring reduced metformin dose.",
            "B": "Fluid loss and hypovolemia requiring increased intravenous fluids.",
            "C": "Increased risk of infection and hyperglycemia.",
            "D": "Hypokalemia and metabolic acidosis."
        },
        "correctAnswer": "C",
        "rationale": "High-dose glucocorticoids like methylprednisolone are potent immunosuppressants, significantly increasing the risk of infection. They also cause hyperglycemia by promoting gluconeogenesis and insulin resistance. The nurse should anticipate managing these two major side effects. Glucocorticoids cause fluid retention (not loss) and often hyperkalemia (not hypokalemia). They cause hyperglycemia, not hypoglycemia.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "Which hormone is directly responsible for increasing the reabsorption of water in the renal collecting ducts, thus concentrating urine and decreasing urine output?",
        "options": {
            "A": "Aldosterone",
            "B": "Parathyroid hormone (PTH)",
            "C": "Antidiuretic hormone (ADH) / Vasopressin",
            "D": "Calcitonin"
        },
        "correctAnswer": "C",
        "rationale": "Antidiuretic hormone (ADH), also known as vasopressin, is released from the posterior pituitary and acts on the renal collecting ducts to increase their permeability to water, leading to increased water reabsorption and more concentrated urine. Aldosterone regulates sodium and potassium, PTH regulates calcium and phosphate, and calcitonin lowers calcium.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A 28-year-old female patient with Type 1 Diabetes is admitted with Diabetic Ketoacidosis (DKA). Her initial labs show a blood glucose of 600 mg/dL, pH 7.18, and positive urine ketones. Her serum sodium is 130 mEq/L. The nurse initiates IV insulin and fluids. Given these labs, what is the most accurate interpretation of her serum sodium level?",
        "options": {
            "A": "The patient is truly hyponatremic and requires hypertonic saline.",
            "B": "The low sodium is a pseudohyponatremia due to severe hyperglycemia.",
            "C": "The sodium level is normal for a patient in DKA.",
            "D": "The patient is hypernatremic but fluid overload has diluted it."
        },
        "correctAnswer": "B",
        "rationale": "In severe hyperglycemia, glucose acts as an osmotically active solute, drawing water from the intracellular to the extracellular space. This dilutes the serum sodium, leading to 'pseudohyponatremia' or dilutional hyponatremia. The true sodium level is higher once the glucose is corrected. Therefore, the low serum sodium (130 mEq/L) is a result of the hyperglycemia, not true hyponatremia requiring hypertonic saline (which would be dangerous).",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A patient with Type 2 Diabetes who is overweight is prescribed liraglutide (Victoza). In addition to glucose lowering, the nurse should inform the patient about which other potential benefit of this medication?",
        "options": {
            "A": "Significant reduction in risk of hypoglycemia as monotherapy.",
            "B": "Weight gain due to improved glycemic control.",
            "C": "Cardiovascular risk reduction and potential for weight loss.",
            "D": "Improvement in kidney function leading to complete resolution of nephropathy."
        },
        "correctAnswer": "C",
        "rationale": "GLP-1 receptor agonists like liraglutide are known for their glucose-lowering effects, but they also promote satiety, leading to weight loss, and have demonstrated cardiovascular benefits in clinical trials, reducing the risk of major adverse cardiovascular events. While they have a low risk of hypoglycemia as monotherapy, this is not the most unique or primary additional benefit compared to others. They do not cause weight gain or fully resolve nephropathy.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A nurse is preparing to administer NPH insulin 10 units and Regular insulin 5 units to a patient. The nurse should correctly perform which action when mixing these insulins?",
        "options": {
            "A": "Inject air into the Regular insulin vial, then into the NPH insulin vial, and then draw up the NPH first.",
            "B": "Inject air into the NPH insulin vial, then into the Regular insulin vial, and then draw up the Regular first.",
            "C": "Draw up the NPH insulin first, then the Regular insulin, without injecting air.",
            "D": "Draw up the Regular insulin first, then the NPH insulin, without injecting air."
        },
        "correctAnswer": "B",
        "rationale": "The correct procedure for mixing NPH and Regular insulin is 'RN' (Regular then NPH) or 'clear before cloudy'. Also, air should be injected into both vials before drawing up. So, inject air into cloudy (NPH), then inject air into clear (Regular), then draw up clear (Regular), then draw up cloudy (NPH). This prevents contamination of the clear vial with the cloudy insulin.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with diabetes is taking an oral antidiabetic medication that delays carbohydrate absorption. The nurse teaches the patient that a common side effect of this medication is flatulence and abdominal discomfort. Which class of medication is the patient likely taking?",
        "options": {
            "A": "Biguanide (e.g., metformin).",
            "B": "Sulfonylurea (e.g., glipizide).",
            "C": "Alpha-glucosidase inhibitor (e.g., acarbose).",
            "D": "Dipeptidyl Peptidase-4 (DPP-4) inhibitor (e.g., sitagliptin)."
        },
        "correctAnswer": "C",
        "rationale": "Alpha-glucosidase inhibitors (like acarbose and miglitol) work by inhibiting enzymes in the small intestine that break down complex carbohydrates. This leads to undigested carbohydrates reaching the colon, where they are fermented by bacteria, causing common side effects like flatulence, bloating, and abdominal discomfort. While metformin can cause GI upset, these specific symptoms are more characteristic of alpha-glucosidase inhibitors.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is admitted with a 'thyroid storm'. In addition to antithyroid medications (e.g., PTU) and iodine, the nurse anticipates the administration of which medication to manage the severe sympathetic symptoms (tachycardia, tremors)?",
        "options": {
            "A": "Insulin regular.",
            "B": "Prednisone.",
            "C": "Propranolol.",
            "D": "Levothyroxine."
        },
        "correctAnswer": "C",
        "rationale": "Thyroid storm is a hypermetabolic state with exaggerated sympathetic activity. Beta-blockers, particularly non-selective ones like propranolol, are crucial in managing the cardiovascular symptoms (tachycardia, arrhythmias) and other adrenergic manifestations (tremors, anxiety). Insulin is for glucose, prednisone for inflammation/adrenal crisis, and levothyroxine would worsen hyperthyroidism.",
        "section": "Advanced Concepts: Thyroid Disorders"
    },
    {
        "questionText": "A 60-year-old patient with Type 2 Diabetes has been prescribed a new oral antidiabetic medication. Upon follow-up, the nurse reviews the patient's labs and notes an unexplained elevation in serum amylase and lipase. The nurse should immediately assess the patient for symptoms of:",
        "options": {
            "A": "Lactic acidosis.",
            "B": "Hypoglycemia.",
            "C": "Pancreatitis.",
            "D": "Hypothyroidism."
        },
        "correctAnswer": "C",
        "rationale": "Elevated amylase and lipase are indicators of pancreatitis. Several newer oral antidiabetic medications, particularly GLP-1 receptor agonists (e.g., liraglutide, dulaglutide) and DPP-4 inhibitors (e.g., sitagliptin), have been associated with a rare but serious risk of acute pancreatitis. The nurse should assess for severe abdominal pain, nausea, and vomiting. Lactic acidosis involves lactate. Hypoglycemia involves low glucose. Hypothyroidism involves thyroid hormones.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A nurse is teaching a patient about potential drug interactions with insulin. The nurse explains that which class of medications can increase the risk of hypoglycemia and mask its adrenergic symptoms?",
        "options": {
            "A": "Thiazide diuretics.",
            "B": "Glucocorticoids.",
            "C": "Beta-blockers.",
            "D": "Statins."
        },
        "correctAnswer": "C",
        "rationale": "Beta-blockers (e.g., metoprolol, propranolol) can both potentiate the hypoglycemic effect of insulin and, more importantly, mask the adrenergic (sympathetic) symptoms of hypoglycemia, such as tachycardia, tremors, and anxiety. This makes it harder for the patient to recognize and treat low blood sugar. Sweating is usually not masked. Thiazide diuretics and glucocorticoids tend to increase blood glucose. Statins affect cholesterol.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "A patient with diabetes insipidus is taking desmopressin. The nurse observes the patient's intake and output records. The nurse should be most concerned about which finding?",
        "options": {
            "A": "Decreased urine output with increased urine specific gravity.",
            "B": "Increased urine output with decreased urine specific gravity.",
            "C": "Daily weight gain of 2 kg and a headache.",
            "D": "Blood pressure of 140/90 mmHg."
        },
        "correctAnswer": "C",
        "rationale": "Desmopressin treats diabetes insipidus by causing water reabsorption. A daily weight gain of 2 kg (equivalent to 2 liters of fluid retention) along with a headache (a sign of cerebral edema due to hyponatremia) suggests fluid overload and potential water intoxication due to over-treatment or excessive fluid intake. This is a critical and potentially life-threatening adverse effect of desmopressin. Options A and B relate to effective treatment or untreated DI. Elevated BP is less concerning than fluid overload in this context.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is receiving a new prescription for canagliflozin. The nurse instructs the patient to report which symptom immediately, as it could indicate a rare but serious Fournier's gangrene?",
        "options": {
            "A": "Increased frequency of urination.",
            "B": "Pain, tenderness, redness, or swelling in the genital or perineal area, with or without fever.",
            "C": "Mild rash on the legs.",
            "D": "Muscle weakness or cramps."
        },
        "correctAnswer": "B",
        "rationale": "Fournier's gangrene (necrotizing fasciitis of the perineum) is a rare but severe and potentially fatal bacterial infection that has been associated with SGLT2 inhibitors like canagliflozin. Patients must be educated to seek immediate medical attention for any pain, tenderness, redness, or swelling in the genital or perineal area, especially if accompanied by fever or malaise. The other options are more common or less severe side effects.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A 55-year-old patient is on long-term corticosteroid therapy (prednisone 20 mg daily) for an autoimmune disorder. The nurse assesses the patient and observes thinning skin, easy bruising, and a rounded face. Which of the following is the most appropriate long-term complication prevention strategy for this patient?",
        "options": {
            "A": "Encourage a high-sodium diet to prevent hypotension.",
            "B": "Teach techniques for meticulous skin care and reinforce fall prevention.",
            "C": "Administer insulin daily to manage hyperglycemia.",
            "D": "Suggest a low-protein diet to prevent kidney damage."
        },
        "correctAnswer": "B",
        "rationale": "Thinning skin, easy bruising, and a rounded face are characteristic signs of Cushingoid appearance from long-term corticosteroid use. These patients are at high risk for skin tears, poor wound healing, and fractures due to osteoporosis. Meticulous skin care and fall prevention strategies are crucial to prevent injuries. High-sodium diet is contraindicated (causes fluid retention/hypertension). Insulin is for hyperglycemia, not a general prevention strategy for skin/bone issues. A low-protein diet is inappropriate as protein is needed for healing.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed a GLP-1 receptor agonist that is administered once weekly. Which medication is the nurse likely preparing to teach the patient about?",
        "options": {
            "A": "Liraglutide (Victoza).",
            "B": "Exenatide (Byetta).",
            "C": "Dulaglutide (Trulicity).",
            "D": "Pramlintide (Symlin)."
        },
        "correctAnswer": "C",
        "rationale": "Dulaglutide (Trulicity) is a GLP-1 receptor agonist administered once weekly. Liraglutide (Victoza) and exenatide (Byetta) are typically administered once daily or twice daily, respectively. Pramlintide (Symlin) is an amylin analog, not a GLP-1 agonist, and is administered before major meals.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient is admitted with a diagnosis of pheochromocytoma. The nurse understands that medical management prior to surgical resection focuses on controlling which life-threatening symptom?",
        "options": {
            "A": "Profound hypoglycemia.",
            "B": "Severe hypertension.",
            "C": "Hypothermia and bradycardia.",
            "D": "Severe fluid volume deficit."
        },
        "correctAnswer": "B",
        "rationale": "Pheochromocytoma is a tumor of the adrenal medulla that secretes excessive catecholamines (epinephrine, norepinephrine), leading to severe, often paroxysmal hypertension. Pre-operative medical management is crucial to block the effects of these hormones, primarily with alpha-blockers (e.g., phenoxybenzamine) and then beta-blockers, to control blood pressure and prevent a hypertensive crisis during surgery. The other options are not primary manifestations or management priorities for pheochromocytoma.",
        "section": "Advanced Concepts: Adrenal Disorders"
    },
    {
        "questionText": "A nurse is reviewing a patient's medication list for potential drug interactions with insulin. Which medication class is known to *increase* blood glucose levels and might necessitate an increase in insulin dosage?",
        "options": {
            "A": "ACE inhibitors (e.g., lisinopril).",
            "B": "Sulfonylureas (e.g., glipizide).",
            "C": "Oral contraceptives.",
            "D": "Thyroid hormones (e.g., levothyroxine)."
        },
        "correctAnswer": "C",
        "rationale": "Certain medications can antagonize the effects of insulin and raise blood glucose levels. Oral contraceptives are known to cause insulin resistance and can increase blood glucose, potentially requiring an increase in insulin dose. ACE inhibitors can potentiate insulin's effects. Sulfonylureas lower blood glucose. Thyroid hormones, if the patient is hypothyroid, can affect glucose, but it's not a direct hyperglycemic interaction with insulin in the same way as oral contraceptives or glucocorticoids.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "A patient with Type 1 Diabetes on a basal-bolus regimen is experiencing recurrent nocturnal hypoglycemia. To differentiate between the Somogyi effect and the Dawn phenomenon, the nurse should advise the patient to:",
        "options": {
            "A": "Skip their evening basal insulin dose.",
            "B": "Measure their blood glucose at 3:00 AM.",
            "C": "Increase their bedtime snack.",
            "D": "Check their blood glucose immediately upon waking."
        },
        "correctAnswer": "B",
        "rationale": "The critical differentiator between the Somogyi effect (nocturnal hypoglycemia followed by rebound hyperglycemia) and the Dawn phenomenon (early morning hyperglycemia without prior hypoglycemia) is the overnight blood glucose level. A 3:00 AM blood glucose check will reveal whether the patient is experiencing hypoglycemia (Somogyi) or stable/rising glucose (Dawn phenomenon). This specific measurement guides the subsequent insulin adjustment.",
        "section": "Advanced Concepts: Insulin Therapy"
    },
    {
        "questionText": "A 40-year-old female patient presents with fatigue, cold intolerance, weight gain, and constipation. Lab results show a TSH of 9.5 mU/L and a free T4 of 0.7 ng/dL. The nurse anticipates a prescription for levothyroxine. What is the most important teaching point regarding this medication?",
        "options": {
            "A": "This medication will provide immediate relief of all your symptoms.",
            "B": "Take this medication with food to prevent stomach upset.",
            "C": "It is essential to take this medication on an empty stomach, consistently at the same time each morning, separated from other medications and supplements.",
            "D": "You will only need to take this medication until your symptoms resolve, then you can stop."
        },
        "correctAnswer": "C",
        "rationale": "Levothyroxine has specific administration requirements for optimal absorption: it should be taken on an empty stomach (typically 30-60 minutes before breakfast), consistently at the same time each day, and separated from calcium, iron, antacids, and other medications by at least 4 hours. Option A is incorrect as effects are gradual. Option B is incorrect as food impairs absorption. Option D is incorrect as it's typically lifelong therapy for primary hypothyroidism.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient on long-term prednisone therapy is hospitalized. The nurse notices the patient's blood pressure is consistently elevated (e.g., 160/90 mmHg) despite a normal baseline and the development of peripheral edema. Which physiological effect of prednisone is primarily responsible for these findings?",
        "options": {
            "A": "Direct cardiac stimulation.",
            "B": "Inhibition of ADH release.",
            "C": "Mineralocorticoid effects (sodium and water retention).",
            "D": "Vasodilation and increased vascular permeability."
        },
        "correctAnswer": "C",
        "rationale": "Prednisone, a synthetic glucocorticoid, possesses significant mineralocorticoid activity, similar to aldosterone. This leads to increased reabsorption of sodium and water in the renal tubules, resulting in fluid retention, edema, and subsequent elevation of blood pressure. It does not primarily stimulate the heart, inhibit ADH (which would cause fluid loss), or cause vasodilation.",
        "section": "Advanced Concepts: Adrenal Hormones"
    },
    {
        "questionText": "A nurse is teaching a patient about medications for diabetes. The nurse explains that patients taking which class of oral antidiabetic agents are most likely to experience hypoglycemia as a monotherapy and should therefore be educated on carrying a rapid-acting glucose source?",
        "options": {
            "A": "Biguanides (e.g., metformin).",
            "B": "DPP-4 inhibitors (e.g., sitagliptin).",
            "C": "SGLT2 inhibitors (e.g., empagliflozin).",
            "D": "Sulfonylureas (e.g., glipizide)."
        },
        "correctAnswer": "D",
        "rationale": "Sulfonylureas (e.g., glipizide, glyburide, glimepiride) stimulate the pancreas to release insulin regardless of current blood glucose levels, making them the class of oral antidiabetics with the highest risk of causing hypoglycemia as monotherapy. Other classes generally have a low risk of hypoglycemia when used alone.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with hypothyroidism is prescribed levothyroxine. Six weeks after starting the medication, the patient reports that she is still feeling tired and constipated. Her TSH level is 7.5 mU/L (normal 0.5-5.0 mU/L). The nurse anticipates which change in the patient's medication regimen?",
        "options": {
            "A": "Decreasing the dose of levothyroxine.",
            "B": "Increasing the dose of levothyroxine.",
            "C": "Adding a second thyroid hormone, such as liothyronine.",
            "D": "Discontinuing levothyroxine and exploring other causes of fatigue."
        },
        "correctAnswer": "B",
        "rationale": "A TSH level of 7.5 mU/L is still elevated, indicating that the patient is still hypothyroid and that the current dose of levothyroxine is insufficient to achieve a euthyroid state. The nurse should anticipate an increase in the levothyroxine dose. Decreasing the dose would worsen the hypothyroidism. Adding a second thyroid hormone or discontinuing the medication is not indicated when TSH is still high on current therapy.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient is taking propylthiouracil (PTU) for hyperthyroidism. The nurse teaches the patient about potential adverse effects and the need for regular monitoring. Which laboratory parameter is a priority for the nurse to monitor for a serious, rare, and potentially fatal adverse effect of PTU?",
        "options": {
            "A": "Serum creatinine.",
            "B": "Liver function tests (ALT, AST).",
            "C": "Hemoglobin and hematocrit.",
            "D": "Electrolyte panel."
        },
        "correctAnswer": "B",
        "rationale": "Propylthiouracil (PTU) carries a black box warning for severe liver injury and acute liver failure, which can be fatal. Therefore, monitoring liver function tests (ALT, AST, bilirubin) is a critical nursing responsibility. While PTU can cause agranulocytosis (requiring CBC monitoring), severe hepatotoxicity is a unique and prominent risk associated with PTU over methimazole.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed exenatide (Byetta), an injectable GLP-1 receptor agonist. The nurse teaches the patient about administration. Which instruction is correct?",
        "options": {
            "A": "Inject this medication once daily before breakfast.",
            "B": "Inject this medication subcutaneously into the abdomen, thigh, or upper arm within 60 minutes before the morning and evening meals.",
            "C": "This medication can be mixed with insulin in the same syringe.",
            "D": "Inject this medication intramuscularly into the deltoid."
        },
        "correctAnswer": "B",
        "rationale": "Exenatide (Byetta) is administered subcutaneously within 60 minutes before the morning and evening meals. It should not be mixed with insulin or given intramuscularly. While some GLP-1 agonists are once-daily or once-weekly, Byetta is typically twice daily.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient is diagnosed with adrenal insufficiency. The nurse anticipates an order for fludrocortisone. What is the primary reason for administering this medication?",
        "options": {
            "A": "To suppress the immune system and reduce inflammation.",
            "B": "To replace the deficient mineralocorticoid hormone, aldosterone.",
            "C": "To stimulate cortisol production from the adrenal glands.",
            "D": "To increase calcium absorption from the gut."
        },
        "correctAnswer": "B",
        "rationale": "Fludrocortisone is a synthetic mineralocorticoid used to replace the deficient aldosterone in adrenal insufficiency. Its primary action is to promote sodium and water reabsorption and potassium excretion in the kidneys, thereby regulating fluid and electrolyte balance and blood pressure. Glucocorticoids suppress immunity, ACTH stimulates cortisol, and calcitriol increases calcium absorption.",
        "section": "Chapter 49: Thyroid, Parathyroid, and Adrenal Disorders"
    },
    {
        "questionText": "A nurse is conducting medication reconciliation for a patient admitted to the hospital. The patient reports taking 'a water pill' (furosemide) and a 'thyroid pill' (levothyroxine). The nurse notes a new order for calcium carbonate twice daily. What is the nurse's priority action regarding these medications?",
        "options": {
            "A": "Administer all medications as ordered, ensuring the patient takes the calcium with food.",
            "B": "Question the order for calcium carbonate due to its interaction with levothyroxine.",
            "C": "Administer the levothyroxine at night to avoid interaction with furosemide.",
            "D": "Teach the patient to crush the levothyroxine and mix it with orange juice for better absorption."
        },
        "correctAnswer": "B",
        "rationale": "Calcium-containing products (like calcium carbonate) can significantly bind to and impair the absorption of levothyroxine. These medications should be separated by at least 4 hours. The nurse's priority is to question the new order for calcium carbonate to ensure a proper administration schedule is established, preventing therapeutic failure of the levothyroxine. Administering all together (A) is incorrect. Furosemide doesn't have a critical interaction with levothyroxine in this manner. Crushing levothyroxine and mixing with juice is incorrect and impairs absorption.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is on an insulin pump. The patient complains of feeling unwell and notices their blood glucose is 280 mg/dL, despite the pump delivering basal insulin. The nurse also notes ketones are present in the urine. What is the most likely issue requiring immediate intervention?",
        "options": {
            "A": "The patient is experiencing the Dawn phenomenon, requiring a higher basal rate.",
            "B": "The pump infusion set may be kinked or dislodged, leading to an interruption in insulin delivery.",
            "C": "The patient is having a mild allergic reaction to the insulin, requiring antihistamines.",
            "D": "The blood glucose reading is likely erroneous; recheck in 30 minutes."
        },
        "correctAnswer": "B",
        "rationale": "The presence of hyperglycemia and ketones in a Type 1 diabetic on an insulin pump strongly suggests a lack of insulin. The most common cause of this in pump users is an issue with the infusion set (e.g., kinked tubing, dislodged cannula, air bubble in tubing), which interrupts insulin delivery and can rapidly lead to DKA. This requires immediate intervention (checking the set, potentially giving a manual injection, and notifying the provider). Dawn phenomenon doesn't explain ketones, and an allergic reaction doesn't cause hyperglycemia/ketones.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient is taking digoxin for heart failure and a loop diuretic (furosemide) for edema. They are newly prescribed calcitriol for a vitamin D deficiency related to chronic kidney disease. The nurse must monitor for which serious drug-drug/drug-lab interaction?",
        "options": {
            "A": "Increased risk of hypokalemia due to calcitriol and furosemide.",
            "B": "Digoxin toxicity due to calcitriol-induced hypercalcemia.",
            "C": "Increased furosemide effectiveness leading to severe dehydration.",
            "D": "Reduced calcitriol absorption due to digoxin."
        },
        "correctAnswer": "B",
        "rationale": "Calcitriol increases calcium absorption. Hypercalcemia, which can result from calcitriol therapy, potentiates the effects of digoxin and increases the risk of digoxin toxicity, even at therapeutic digoxin levels. This is a critical and potentially fatal interaction. Furosemide causes hypokalemia, but calcitriol doesn't primarily affect potassium in this way. Calcitriol wouldn't increase furosemide effectiveness, and digoxin doesn't affect calcitriol absorption.",
        "section": "Advanced Concepts: Drug Interactions"
    },
    {
        "questionText": "A nurse is assessing a patient with Type 2 Diabetes who takes glipizide. The patient reports consuming a few alcoholic beverages at a social event and now feels flushed, nauseated, and has palpitations. The nurse recognizes this as a 'disulfiram-like reaction'. What is the most appropriate nursing action?",
        "options": {
            "A": "Administer an antidote to alcohol.",
            "B": "Administer dextrose to prevent hypoglycemia.",
            "C": "Provide comfort measures and educate the patient on avoiding alcohol with glipizide.",
            "D": "Call a rapid response team immediately."
        },
        "correctAnswer": "C",
        "rationale": "Sulfonylureas like glipizide can cause a disulfiram-like reaction (flushing, nausea, palpitations, headache) when consumed with alcohol. While uncomfortable, it is typically not life-threatening unless severe or combined with significant hypoglycemia. The most appropriate nursing action is to provide comfort measures for the symptoms and to reinforce the critical teaching to avoid alcohol while on this medication. An antidote is not available or necessary, and a rapid response team is not indicated for this non-life-threatening reaction unless other severe symptoms (e.g., severe hypotension, altered consciousness) develop.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed empagliflozin. The nurse teaches the patient about the importance of maintaining adequate hydration. What is the primary reason for this instruction with this medication?",
        "options": {
            "A": "To prevent kidney stones, which are a common side effect.",
            "B": "To minimize the risk of volume depletion and hypotension.",
            "C": "To enhance the drug's effectiveness in lowering blood glucose.",
            "D": "To dilute the concentration of glucose in the urine and prevent infection."
        },
        "correctAnswer": "B",
        "rationale": "Empagliflozin (an SGLT2 inhibitor) causes glucose and sodium to be excreted in the urine, leading to an osmotic diuresis. This increased fluid loss can result in intravascular volume depletion, orthostatic hypotension, and dizziness, especially in elderly patients or those on diuretics. Maintaining adequate hydration helps to mitigate these risks. While increased urine glucose can lead to UTIs/yeast infections, and hydration might indirectly help, the primary reason for emphasizing hydration is to prevent symptomatic hypovolemia and hypotension.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is found unconscious and unresponsive. Their skin is cool and clammy. The nurse checks a fingerstick blood glucose and it reads 'LOW' (meter cannot read). What is the nurse's priority action?",
        "options": {
            "A": "Call the patient's family to inquire about their last meal.",
            "B": "Administer intramuscular glucagon or intravenous dextrose immediately.",
            "C": "Prepare to administer IV regular insulin.",
            "D": "Transport the patient to the radiology department for imaging."
        },
        "correctAnswer": "B",
        "rationale": "The patient's presentation (unconscious, cool/clammy skin, 'LOW' blood glucose) indicates severe hypoglycemia, which is a medical emergency. The priority is to rapidly raise the blood glucose. Since the patient is unconscious and cannot take oral glucose, parenteral options (IM glucagon if no IV access, or IV dextrose if IV access is present) are the immediate life-saving interventions. The other options are either irrelevant, dangerous, or would delay critical treatment.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A nurse is reviewing the medication orders for a newly admitted patient. The patient's diagnosis is 'Rule out Diabetes Insipidus'. Which medication, if ordered, would the nurse question?",
        "options": {
            "A": "Hydrochlorothiazide.",
            "B": "Desmopressin.",
            "C": "Furosemide.",
            "D": "Amiloride."
        },
        "correctAnswer": "B",
        "rationale": "Diabetes Insipidus is a condition of ADH deficiency (or kidney resistance to ADH), leading to excessive dilute urine output. Desmopressin (DDAVP) is a synthetic ADH analogue and the primary treatment for diabetes insipidus. If the diagnosis is 'rule out', meaning it's not confirmed and might be another condition, administering desmopressin could be inappropriate or mask the true diagnosis. Thiazide diuretics (like hydrochlorothiazide) are sometimes used in nephrogenic DI, but desmopressin is the direct ADH analogue.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed a new oral medication, dulaglutide (Trulicity). The nurse teaches the patient that this medication should be administered:",
        "options": {
            "A": "Daily by mouth, with the largest meal.",
            "B": "Once weekly by subcutaneous injection, on the same day each week.",
            "C": "Twice daily by intramuscular injection.",
            "D": "As an oral tablet, once monthly."
        },
        "correctAnswer": "B",
        "rationale": "Dulaglutide (Trulicity) is a GLP-1 receptor agonist that is administered once weekly by subcutaneous injection. It does not need to be taken with food and can be given at any time of day on the chosen day of the week. This unique dosing frequency is a key teaching point.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is taking metformin and develops new onset right flank pain, hematuria, and dysuria. The nurse recognizes these symptoms may be related to a rare adverse effect of an SGLT2 inhibitor. If this patient were also taking empagliflozin, the nurse would be concerned about which complication?",
        "options": {
            "A": "Acute kidney injury.",
            "B": "Urinary tract infection.",
            "C": "Kidney stones (nephrolithiasis).",
            "D": "Pyelonephritis."
        },
        "correctAnswer": "C",
        "rationale": "SGLT2 inhibitors increase glucose and sodium excretion in the urine. While UTIs (B) are a common side effect, new onset flank pain and hematuria are highly suggestive of kidney stones (nephrolithiasis). Although not a primary mechanism, there have been reports and theoretical concerns about increased risk of kidney stones with SGLT2 inhibitors due to changes in urine composition. Acute kidney injury (A) is a broader term, and pyelonephritis (D) is a UTI that would typically present with fever and more systemic symptoms, though it's still possible.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with long-term primary adrenal insufficiency (Addison's disease) is preparing for discharge. The nurse emphasizes the importance of wearing a medical alert bracelet. What is the primary reason for this instruction?",
        "options": {
            "A": "To alert emergency personnel about their need for lifelong glucose monitoring.",
            "B": "To inform healthcare providers about their risk for a hypertensive crisis.",
            "C": "To ensure emergency medical personnel are aware of their need for immediate steroid replacement during stress.",
            "D": "To prevent accidental administration of medications that lower cortisol."
        },
        "correctAnswer": "C",
        "rationale": "Patients with adrenal insufficiency are at risk for life-threatening adrenal crisis (hypotension, shock, hypoglycemia) during periods of stress, illness, or injury. A medical alert bracelet ensures that emergency medical personnel are immediately aware of their condition and the critical need for prompt intravenous glucocorticoid administration (stress dosing) to prevent or treat an adrenal crisis. While other aspects of their care are important, preventing adrenal crisis is paramount.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 2 Diabetes has been prescribed acarbose. The nurse advises the patient to take this medication:",
        "options": {
            "A": "Once daily at bedtime.",
            "B": "Immediately before or with the first bite of each main meal.",
            "C": "30 minutes before breakfast on an empty stomach.",
            "D": "Only when blood glucose levels are above 200 mg/dL."
        },
        "correctAnswer": "B",
        "rationale": "Acarbose is an alpha-glucosidase inhibitor that works by delaying carbohydrate digestion in the small intestine. To be effective, it must be present in the GI tract when carbohydrates are consumed. Therefore, it should be taken immediately before or with the first bite of each main meal. Taking it at other times or only when glucose is high would limit its effectiveness.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is caring for a patient admitted with a severe head injury who has developed polyuria (urine output 600 mL/hour) and polydipsia, along with hypernatremia (Na 155 mEq/L). The nurse suspects Central Diabetes Insipidus. Which medication would the nurse anticipate the provider ordering?",
        "options": {
            "A": "Furosemide (Lasix).",
            "B": "Dextrose 5% in water (D5W).",
            "C": "Desmopressin (DDAVP).",
            "D": "Normal Saline (0.9% NaCl)."
        },
        "correctAnswer": "C",
        "rationale": "Central diabetes insipidus is caused by a deficiency in ADH. The symptoms (polyuria, polydipsia, hypernatremia in the setting of head injury) are classic. Desmopressin (DDAVP) is a synthetic ADH analogue that replaces the deficient hormone, leading to water reabsorption and correction of symptoms. Furosemide would worsen polyuria. D5W is hypotonic and used for free water deficit but DDAVP addresses the underlying problem. Normal saline would contribute to hypernatremia if not used carefully.",
        "section": "Advanced Concepts: Pituitary Hormones"
    },
    {
        "questionText": "Which of the following classes of oral antidiabetic medications has a mechanism of action that directly targets insulin resistance in peripheral tissues like muscle and fat, as well as in the liver?",
        "options": {
            "A": "Sulfonylureas.",
            "B": "Meglitinides.",
            "C": "Thiazolidinediones (TZDs).",
            "D": "DPP-4 inhibitors."
        },
        "correctAnswer": "C",
        "rationale": "Thiazolidinediones (TZDs), such as pioglitazone and rosiglitazone, are known as insulin sensitizers. Their primary mechanism of action is to improve insulin sensitivity in peripheral tissues (muscle, fat) and the liver, allowing the body's own insulin to work more effectively. Sulfonylureas and meglitinides stimulate insulin secretion. DPP-4 inhibitors enhance incretin hormones.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A 68-year-old patient with Type 2 Diabetes is admitted with a severe infection. Her blood glucose levels are elevated (300-400 mg/dL), and she is confused. She is currently on metformin and glipizide. What is the most appropriate initial change to her diabetes management plan?",
        "options": {
            "A": "Increase the dose of her oral metformin and glipizide.",
            "B": "Discontinue all antidiabetic medications and manage with diet only.",
            "C": "Initiate continuous intravenous insulin infusion for tight glycemic control.",
            "D": "Administer an oral glucose tablet to prevent further confusion."
        },
        "correctAnswer": "C",
        "rationale": "During severe illness and stress, oral antidiabetic medications are often insufficient and may even be contraindicated (e.g., metformin in acute illness/renal impairment). The patient's high glucose and confusion suggest significant hyperglycemia or even hyperosmolar hyperglycemic state (HHS). Continuous intravenous insulin infusion provides the most rapid, precise, and flexible glucose control in a critically ill patient. Increasing oral medications is inappropriate, discontinuing them is dangerous, and an oral glucose tablet would worsen hyperglycemia.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with primary hyperparathyroidism (high PTH, high calcium) is scheduled for a parathyroidectomy. Prior to surgery, the nurse anticipates the administration of which medication to lower serum calcium levels?",
        "options": {
            "A": "Calcitriol.",
            "B": "Calcium carbonate.",
            "C": "Bisphosphonates (e.g., pamidronate).",
            "D": "Fludrocortisone."
        },
        "correctAnswer": "C",
        "rationale": "In symptomatic hypercalcemia (especially pre-operatively for hyperparathyroidism), medications like bisphosphonates (e.g., pamidronate, zoledronic acid) are used to lower serum calcium by inhibiting osteoclast activity and bone resorption. Calcitriol and calcium carbonate would increase calcium. Fludrocortisone is a mineralocorticoid, unrelated to calcium regulation.",
        "section": "Advanced Concepts: Parathyroid Disorders"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is on an insulin pump. The patient complains of increased hunger and shakiness an hour after their bolus dose for lunch. The nurse observes diaphoresis and irritability. What is the most likely cause of these symptoms?",
        "options": {
            "A": "Insufficient basal insulin.",
            "B": "Insulin resistance.",
            "C": "Onset of hypoglycemia due to meal bolus timing or carbohydrate miscalculation.",
            "D": "Dawn phenomenon."
        },
        "correctAnswer": "C",
        "rationale": "The symptoms of hunger, shakiness, diaphoresis, and irritability are classic signs of hypoglycemia. Occurring an hour after a meal bolus, it strongly suggests that the bolus dose was too high for the carbohydrate intake, or the timing was off, leading to a rapid drop in blood glucose. Insufficient basal insulin or insulin resistance would lead to hyperglycemia. Dawn phenomenon occurs in the early morning.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "Which of the following is a key adverse effect that requires regular ophthalmologic examinations in patients on long-term corticosteroid therapy (e.g., prednisone)?",
        "options": {
            "A": "Retinal detachment and vision loss.",
            "B": "Development of cataracts and glaucoma.",
            "C": "Optic neuritis and blindness.",
            "D": "Diabetic retinopathy."
        },
        "correctAnswer": "B",
        "rationale": "Long-term use of corticosteroids is a known risk factor for the development of cataracts (especially posterior subcapsular cataracts) and glaucoma (increased intraocular pressure). Regular ophthalmologic examinations are necessary to monitor for these sight-threatening complications.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed a DPP-4 inhibitor, sitagliptin. The nurse explains to the patient that this medication has a lower risk of hypoglycemia compared to sulfonylureas because it:",
        "options": {
            "A": "Causes significant weight loss, improving insulin sensitivity.",
            "B": "Only works to stimulate insulin release when blood glucose levels are elevated.",
            "C": "Promotes the excretion of glucose in the urine, regardless of insulin levels.",
            "D": "Primarily reduces glucose absorption from the intestine."
        },
        "correctAnswer": "B",
        "rationale": "DPP-4 inhibitors like sitagliptin are considered 'glucose-dependent' insulin secretagogues. They work by enhancing the effects of incretin hormones, which only stimulate insulin release and suppress glucagon when blood glucose levels are high. This mechanism makes them less likely to cause hypoglycemia when used as monotherapy compared to sulfonylureas, which stimulate insulin release regardless of glucose levels. Option A is true for GLP-1 agonists, not DPP-4. Option C describes SGLT2 inhibitors. Option D describes alpha-glucosidase inhibitors.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A nurse is teaching a patient with Type 1 Diabetes how to adjust their insulin dosage based on carbohydrate intake. The patient is prescribed insulin aspart with a carbohydrate-to-insulin ratio of 15:1 (1 unit of insulin for every 15 grams of carbohydrates). If the patient plans to eat a meal with 60 grams of carbohydrates, how many units of insulin aspart should they administer?",
        "options": {
            "A": "2 units.",
            "B": "4 units.",
            "C": "6 units.",
            "D": "8 units."
        },
        "correctAnswer": "B",
        "rationale": "To calculate the insulin dose: (Total Carbohydrates in meal) / (Carbohydrate-to-Insulin Ratio) = Insulin Dose. So, 60 grams / 15 grams/unit = 4 units of insulin aspart.",
        "section": "Dosage Calculation"
    },
    {
        "questionText": "A patient is prescribed levothyroxine for hypothyroidism. The nurse instructs the patient to report which symptom, as it may indicate an excessive dose?",
        "options": {
            "A": "Bradycardia and constipation.",
            "B": "Cold intolerance and weight gain.",
            "C": "Nervousness, tremors, and tachycardia.",
            "D": "Fatigue and dry skin."
        },
        "correctAnswer": "C",
        "rationale": "Nervousness, tremors, and tachycardia are classic symptoms of hyperthyroidism (thyrotoxicosis). If a patient on levothyroxine experiences these, it suggests the dose is too high, leading to iatrogenic hyperthyroidism. The other options (bradycardia, constipation, cold intolerance, weight gain, fatigue, dry skin) are symptoms of hypothyroidism, suggesting the dose might be too low or ineffective.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is teaching a patient about managing hypoglycemia. The patient, who is conscious, asks what to do if their blood glucose drops to 60 mg/dL. What is the nurse's best response?",
        "options": {
            "A": "Inject 1 unit of glucagon subcutaneously.",
            "B": "Eat a complex carbohydrate like a slice of whole-wheat toast.",
            "C": "Consume 15 grams of a fast-acting carbohydrate, like 4 ounces of fruit juice, and recheck in 15 minutes.",
            "D": "Go to sleep and allow your body to naturally correct the low blood sugar."
        },
        "correctAnswer": "C",
        "rationale": "For a conscious patient with mild to moderate hypoglycemia (blood glucose <70 mg/dL), the 'Rule of 15' is applied: consume 15 grams of a rapid-acting carbohydrate (e.g., 4 oz juice, glucose tablets), wait 15 minutes, and recheck blood glucose. Repeat if necessary. Glucagon is for unconscious patients. Complex carbohydrates are too slow. Sleeping risks worsening hypoglycemia.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed liraglutide (Victoza), an injectable GLP-1 receptor agonist. The nurse teaches the patient that this medication should be stored:",
        "options": {
            "A": "At room temperature for up to 3 months once opened.",
            "B": "In the freezer until ready for use.",
            "C": "In the refrigerator until first use, then at room temperature for a specified period (e.g., 30 days).",
            "D": "Only in the refrigerator, and discarded 7 days after first use."
        },
        "correctAnswer": "C",
        "rationale": "Many injectable medications, including GLP-1 receptor agonists, follow similar storage guidelines as insulin pens. Unopened pens are stored in the refrigerator. Once opened (or first used), they are typically stored at room temperature (below 86°F or 30°C) and must be discarded after a specific period (e.g., 30 days for Victoza), even if some medication remains. Freezing is incorrect. Storage duration once opened varies by specific drug, but the principle is cold before opening, room temp after, for a limited time.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is evaluating a patient with Type 1 Diabetes who uses an insulin pump and has an A1C of 9.8%. The patient states they administer boluses for meals and corrections but often forget to check their blood glucose between meals. Which nursing diagnosis is most appropriate?",
        "options": {
            "A": "Ineffective Health Management related to insufficient knowledge of insulin pump therapy.",
            "B": "Risk for Unstable Blood Glucose Level related to inadequate adherence to glucose monitoring regimen.",
            "C": "Deficient Knowledge regarding insulin action and timing.",
            "D": "Imbalanced Nutrition: Less than Body Requirements related to uncontrolled diabetes."
        },
        "correctAnswer": "B",
        "rationale": "An A1C of 9.8% indicates poor long-term glycemic control. The patient's statement about forgetting to check blood glucose between meals directly points to a lack of consistent monitoring, which is crucial for effective insulin pump management and overall glycemic control. This directly impacts the stability of their blood glucose. While knowledge deficits might exist, the direct issue stated is adherence to monitoring, leading to unstable glucose. Ineffective health management is a broad diagnosis but 'Risk for Unstable Blood Glucose Level' is more specific to the stated problem.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "A 72-year-old patient with Type 2 Diabetes and a history of kidney stones is prescribed empagliflozin. The nurse emphasizes the importance of maintaining high fluid intake. What is the primary rationale for this advice in this specific patient?",
        "options": {
            "A": "To increase the effectiveness of empagliflozin in lowering blood glucose.",
            "B": "To prevent dehydration and potential acute kidney injury, especially with increased urinary glucose excretion.",
            "C": "To prevent urinary tract infections by flushing out bacteria.",
            "D": "To dilute the urine and reduce the risk of kidney stone formation, given the patient's history."
        },
        "correctAnswer": "D",
        "rationale": "Empagliflozin causes increased glucose excretion in the urine, which can alter urine composition. While adequate hydration is generally important to prevent dehydration (B) and can help with UTIs (C), for a patient with a history of kidney stones, maintaining high fluid intake is crucial to dilute the urine and reduce the concentration of stone-forming solutes (like calcium and oxalate), thereby mitigating the risk of recurrent nephrolithiasis. This is a specific concern for SGLT2 inhibitors and a patient with this history.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient is prescribed desmopressin for nocturnal enuresis. The nurse should instruct the patient to avoid which type of fluid intake with the medication?",
        "options": {
            "A": "Large amounts of water before bedtime.",
            "B": "Milk products in the evening.",
            "C": "Carbonated beverages.",
            "D": "Grapefruit juice."
        },
        "correctAnswer": "A",
        "rationale": "Desmopressin reduces urine production by acting as a synthetic ADH. If large amounts of water are consumed with desmopressin, especially before bedtime, it can lead to excessive water retention, dilutional hyponatremia, and potentially water intoxication (symptoms include headache, nausea, confusion, seizures). Therefore, fluid intake should be restricted, particularly around the time of administration for nocturnal enuresis.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with long-standing Type 2 Diabetes is admitted with Hyperglycemic Hyperosmolar State (HHS). Which finding is a key diagnostic criterion for HHS that differentiates it from Diabetic Ketoacidosis (DKA)?",
        "options": {
            "A": "Presence of metabolic acidosis.",
            "B": "Significant ketonuria or ketonemia.",
            "C": "Profound dehydration and hyperosmolarity without significant ketosis.",
            "D": "Blood glucose level typically between 250-400 mg/dL."
        },
        "correctAnswer": "C",
        "rationale": "HHS is characterized by extremely high blood glucose levels (often >600 mg/dL), severe dehydration, marked hyperosmolarity, and *minimal or absent ketosis and acidosis*. DKA, in contrast, involves significant ketosis and metabolic acidosis. Therefore, the absence of significant ketosis and acidosis, despite profound dehydration and hyperglycemia, differentiates HHS from DKA. A blood glucose of 250-400 mg/dL is typical of DKA, not HHS.",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A 60-year-old patient with hypothyroidism has been taking levothyroxine for 10 years. She now develops new onset atrial fibrillation. The nurse anticipates the provider will likely:",
        "options": {
            "A": "Increase her levothyroxine dose to normalize heart rhythm.",
            "B": "Add a potassium supplement to her regimen.",
            "C": "Assess her TSH level and potentially decrease her levothyroxine dose.",
            "D": "Switch her to a different form of thyroid hormone replacement."
        },
        "correctAnswer": "C",
        "rationale": "Atrial fibrillation (Afib) is a known cardiovascular complication of overtreatment with levothyroxine, leading to iatrogenic hyperthyroidism. Even subclinical hyperthyroidism (suppressed TSH with normal free T4) can increase Afib risk in older adults. The nurse should anticipate assessing the TSH level and potentially decreasing the levothyroxine dose to prevent further cardiac complications, not increase it. Potassium is unrelated to Afib caused by thyroid hormone excess.",
        "section": "Nursing Process: Clinical Judgment"
    },
    {
        "questionText": "Which type of insulin forms a precipitate after subcutaneous injection, allowing for its prolonged action?",
        "options": {
            "A": "Insulin lispro.",
            "B": "Insulin regular.",
            "C": "Insulin NPH.",
            "D": "Insulin glargine."
        },
        "correctAnswer": "D",
        "rationale": "Insulin glargine (Lantus) is formulated at an acidic pH (pH 4.0) to be soluble. After subcutaneous injection into the neutral pH of the body, it forms microprecipitates. These microprecipitates slowly dissolve, releasing insulin steadily over 24 hours without a pronounced peak. NPH is an insulin-protamine complex, making it cloudy and intermediate-acting, but glargine's unique mechanism is the pH-dependent precipitation.",
        "section": "Advanced Concepts: Insulin Therapy"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is prescribed a new oral antidiabetic medication that works by activating PPAR-gamma receptors, leading to improved insulin sensitivity. The nurse recognizes this as a medication from which class?",
        "options": {
            "A": "Biguanides.",
            "B": "Sulfonylureas.",
            "C": "Thiazolidinediones (TZDs).",
            "D": "GLP-1 Receptor Agonists."
        },
        "correctAnswer": "C",
        "rationale": "Thiazolidinediones (TZDs) like pioglitazone and rosiglitazone are selective agonists for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) nuclear receptor. Activation of this receptor leads to gene transcription changes that improve insulin sensitivity in target tissues (fat, muscle, liver). This is their unique mechanism of action.",
        "section": "Advanced Concepts: Oral Antidiabetics"
    },
    {
        "questionText": "A nurse is preparing to administer NPH insulin 10 units and Regular insulin 6 units. The patient is also on a separate prescription for insulin glargine 18 units. Which of the following is the correct administration plan?",
        "options": {
            "A": "Mix NPH and Regular in one syringe, then mix glargine in another syringe and give two separate injections.",
            "B": "Mix NPH and Regular in one syringe (Regular first), and administer glargine as a separate injection.",
            "C": "Mix all three insulins in one syringe, then administer as one injection.",
            "D": "Administer each insulin as a separate injection (three total injections)."
        },
        "correctAnswer": "B",
        "rationale": "Regular and NPH insulin are compatible and can be mixed in the same syringe (clear/Regular first, then cloudy/NPH). Insulin glargine, however, is incompatible with all other insulins and must *always* be administered as a separate injection. Therefore, two injections are needed: one with the mixed Regular/NPH, and a separate one for glargine.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with Addison's disease is prescribed hydrocortisone. The nurse advises the patient that they should generally take this medication:",
        "options": {
            "A": "Once daily at bedtime to ensure overnight adrenal support.",
            "B": "In divided doses, with the largest dose in the morning and smaller doses in the afternoon/evening, to mimic the body's natural diurnal rhythm.",
            "C": "Only when feeling stressed or ill to avoid adverse effects.",
            "D": "With milk to prevent osteoporosis."
        },
        "correctAnswer": "B",
        "rationale": "To best mimic the body's natural circadian rhythm of cortisol production, hydrocortisone replacement therapy is typically administered in divided doses, with the largest dose in the morning (e.g., 2/3 of total daily dose) and smaller doses in the late afternoon/early evening (e.g., 1/3 of total daily dose). This helps provide adequate coverage during periods of activity while avoiding excess at night. Taking only PRN or only at bedtime is incorrect.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with hypothyroidism is prescribed levothyroxine. The nurse teaches the patient about potential drug-food interactions. Which food, if consumed close to the medication, would most significantly impair its absorption?",
        "options": {
            "A": "Grilled chicken.",
            "B": "A large bowl of oatmeal.",
            "C": "A cup of coffee.",
            "D": "Fresh fruit salad."
        },
        "correctAnswer": "C",
        "rationale": "Coffee has been shown to significantly reduce levothyroxine absorption. While all foods can theoretically impact absorption to some extent, strong interactions like those with coffee, calcium, iron, and antacids are clinically significant. Therefore, levothyroxine should be taken with water only, on an empty stomach, at least 30-60 minutes before breakfast.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with diabetes is considering starting an intensive exercise regimen. The nurse explains that exercise can increase insulin sensitivity and lower blood glucose. For a patient taking a sulfonylurea (e.g., glipizide), what is the most important education point regarding exercise?",
        "options": {
            "A": "Exercise will negate the need for the sulfonylurea, so it can be temporarily stopped.",
            "B": "Exercise can increase the risk of hypoglycemia, so monitor blood glucose closely and carry a quick source of carbohydrates.",
            "C": "Exercise will cause hyperglycemia, requiring an increased dose of glipizide.",
            "D": "Exercise has no significant impact on blood glucose when taking oral medications."
        },
        "correctAnswer": "B",
        "rationale": "Exercise increases glucose utilization and improves insulin sensitivity, leading to a reduction in blood glucose. For patients on medications that stimulate insulin secretion (like sulfonylureas), this can significantly increase the risk of hypoglycemia during or after exercise. Patients must be taught to monitor their blood glucose frequently and carry a rapid-acting carbohydrate source to treat potential lows. Exercise does not negate the need for the medication, nor does it cause hyperglycemia.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A nurse is administering a dose of insulin detemir (Levemir) to a patient with Type 2 Diabetes. The nurse understands that this insulin is characterized by:",
        "options": {
            "A": "A rapid onset and short duration, used for mealtime coverage.",
            "B": "An intermediate onset and peak, typically mixed with regular insulin.",
            "C": "A prolonged action with a relatively flat profile, providing basal insulin coverage.",
            "D": "An ultra-rapid onset, suitable for continuous subcutaneous insulin infusion pumps."
        },
        "correctAnswer": "C",
        "rationale": "Insulin detemir (Levemir) is a long-acting basal insulin. It has a prolonged duration of action with a relatively flat, peakless profile, providing continuous basal insulin coverage for up to 24 hours. It is not rapid-acting, intermediate, or typically used in pumps.",
        "section": "Chapter 50: Antidiabetics"
    },
    {
        "questionText": "A patient with hyperthyroidism is prescribed methimazole. The nurse teaches the patient about possible adverse effects. Which adverse effect would indicate a severe allergic reaction and require immediate medical attention?",
        "options": {
            "A": "Mild rash and itching.",
            "B": "Joint pain.",
            "C": "Swelling of the face, tongue, or throat with difficulty breathing.",
            "D": "Hair loss."
        },
        "correctAnswer": "C",
        "rationale": "Angioedema (swelling of the face, tongue, or throat) with difficulty breathing is a sign of a severe, potentially life-threatening allergic reaction (anaphylaxis) or a serious hypersensitivity reaction to methimazole. This requires immediate medical attention. Mild rash, joint pain, and hair loss can be adverse effects but are not as immediately life-threatening.",
        "section": "Safety/Nursing Judgment: Point of Care"
    },
    {
        "questionText": "A 50-year-old patient with no history of diabetes is undergoing a stress test. Prior to the test, a glucose value of 180 mg/dL is noted. The nurse understands that this transient hyperglycemia may be due to:",
        "options": {
            "A": "A new diagnosis of Type 1 Diabetes.",
            "B": "Stress-induced hyperglycemia from catecholamine release.",
            "C": "Severe hypoglycemia causing a rebound effect.",
            "D": "Impaired insulin absorption."
        },
        "correctAnswer": "B",
        "rationale": "Physical and emotional stress (such as a stress test) can cause the release of counter-regulatory hormones like catecholamines (epinephrine, norepinephrine), cortisol, and glucagon. These hormones promote glucose production and reduce insulin sensitivity, leading to temporary stress-induced hyperglycemia even in non-diabetic individuals. It's not necessarily a diagnosis of diabetes, a rebound effect (unless there was a prior unrecorded hypoglycemic event), or an absorption issue.",
        "section": "Advanced Concepts: Pathophysiology"
    },
    {
        "questionText": "A patient with Type 2 Diabetes is receiving a new prescription for canagliflozin (Invokana). The nurse teaches the patient about the potential for genitourinary side effects. Which symptoms should the nurse instruct the patient to report?",
        "options": {
            "A": "Increased frequency of urination and thirst.",
            "B": "Genital itching, burning, or discharge, and painful urination.",
            "C": "Weight gain and peripheral edema.",
            "D": "Hypoglycemia symptoms like shakiness and sweating."
        },
        "correctAnswer": "B",
        "rationale": "SGLT2 inhibitors like canagliflozin cause glucose to be excreted in the urine (glucosuria), which creates an environment conducive to the growth of bacteria and yeast. This leads to an increased risk of genital mycotic infections (yeast infections, presenting as itching, burning, discharge) and urinary tract infections (presenting as painful urination, urgency, frequency). Increased urination and thirst are expected effects, not symptoms to report in this context. Weight gain/edema are more with TZDs, and hypoglycemia is low risk as monotherapy.",
        "section": "Patient Teaching"
    },
    {
        "questionText": "A patient with Type 1 Diabetes is admitted with a new onset of severe fatigue, weight loss, and frequent episodes of hypoglycemia, requiring less insulin than usual. The nurse notes new hyperpigmentation of the skin. The nurse suspects the patient may be developing a co-existing endocrine disorder. Which disorder is most likely?",
        "options": {
            "A": "Hyperthyroidism.",
            "B": "Cushing's Syndrome.",
            "C": "Addison's Disease.",
            "D": "Pheochromocytoma."
        },
        "correctAnswer": "C",
        "rationale": "Autoimmune conditions often cluster. Patients with Type 1 Diabetes are at increased risk for other autoimmune endocrine disorders. The symptoms of severe fatigue, weight loss, unexplained hypoglycemia (requiring less insulin), and hyperpigmentation (due to increased ACTH and MSH) are classic signs of primary adrenal insufficiency (Addison's disease). Hyperthyroidism would cause weight loss but also hyperglycemia and hypermetabolism. Cushing's causes hyperglycemia and weight gain. Pheochromocytoma causes hypertension.",
        "section": "Advanced Concepts: Pathophysiology"
    }
];

    // --- SCRIPT LOGIC ---
    let finalQuizData = [];
    let currentQuestionIndex = 0;
    let userAnswers = {};
    let timeSpentOnQuestions = {};
    let timeFlaggedQuestions = new Set();
    let flaggedForReview = new Set();
    let overallTimerInterval;
    let timeLeft = 35 * 60; // 35 minutes
    let questionStartTime;
    const TIME_THRESHOLD = 90; // 90 seconds for a question to be auto-flagged for review
    let isPaused = false;

    // DOM Element references
    const initialScreen = document.getElementById('initial-screen');
    const startBtn = document.getElementById('start-btn');
    const quizForm = document.getElementById('quiz-form');
    const questionContainer = document.getElementById('question-container');
    const navigationBtn = document.getElementById('navigation-btn');
    const timerDisplay = document.getElementById('timer-display');
    const flagCheckbox = document.getElementById('flag-for-review');
    const resultsArea = document.getElementById('results-area');
    const resultsSummary = document.getElementById('results-summary');
    const resultsDetails = document.getElementById('results-details');
    const studyFocusContainer = document.getElementById('study-focus');
    const pauseBtn = document.getElementById('pause-btn');
    const pauseOverlay = document.getElementById('pause-overlay');
    const printBtn = document.getElementById('print-btn');
    const printableStudyGuide = document.getElementById('study-guide-printable');

    // Function to remove duplicates and prepare quiz data
    function prepareQuizData() {
        const uniqueQuestions = [];
        const seenQuestions = new Set();

        fullQuizData.forEach(q => {
            const questionIdentifier = JSON.stringify({
                text: q.questionText,
                options: q.options,
                correct: q.correctAnswer
            });
            if (!seenQuestions.has(questionIdentifier)) {
                uniqueQuestions.push(q);
                seenQuestions.add(questionIdentifier);
            }
        });

        const dosageQuestions = uniqueQuestions.filter(q => q.section && q.section.includes("Dosage Calculation"));
        const standardQuestions = uniqueQuestions.filter(q => !q.section || !q.section.includes("Dosage Calculation"));

        function shuffleArray(array) {
            for (let i = array.length - 1; i > 0; i--) {
                const j = Math.floor(Math.random() * (i + 1));
                [array[i], array[j]] = [array[j], array[i]];
            }
        }

        shuffleArray(dosageQuestions);
        shuffleArray(standardQuestions);

        // Ensure we always have at least 3 dosage questions if available, up to a max
        const selectedDosage = dosageQuestions.slice(0, Math.min(dosageQuestions.length, 5)); // Increased to allow for more dosage questions
        const numStandardQuestions = 30 - selectedDosage.length;
        const selectedStandard = standardQuestions.slice(0, numStandardQuestions);

        finalQuizData = [...selectedStandard, ...selectedDosage];
        shuffleArray(finalQuizData);
    }

    function startQuiz() {
        prepareQuizData();

        if (finalQuizData.length === 0) {
            questionContainer.innerHTML = `<p class="question-text">There are no questions loaded in this quiz.</p>`;
            initialScreen.classList.add('hidden');
            quizForm.classList.remove('hidden');
            timerDisplay.textContent = "Quiz Not Started";
            return;
        }

        initialScreen.classList.add('hidden');
        quizForm.classList.remove('hidden');
        navigationBtn.classList.remove('hidden');
        pauseBtn.classList.remove('hidden');
        startOverallTimer();
        displayCurrentQuestion();
    }

    function togglePause() {
        isPaused = !isPaused;
        if (isPaused) {
            clearInterval(overallTimerInterval);
            pauseOverlay.style.display = 'flex';
            quizForm.style.visibility = 'hidden';
            navigationBtn.style.visibility = 'hidden';
        } else {
            startOverallTimer();
            pauseOverlay.style.display = 'none';
            quizForm.style.visibility = 'visible';
            navigationBtn.style.visibility = 'visible';
        }
    }

    function startOverallTimer() {
        clearInterval(overallTimerInterval);
        overallTimerInterval = setInterval(() => {
            if (timeLeft <= 0) {
                submitQuiz();
                return;
            }
            timeLeft--;
            const minutes = Math.floor(timeLeft / 60);
            const seconds = timeLeft % 60;
            timerDisplay.textContent = `Time Left: ${String(minutes).padStart(2, '0')}:${String(seconds).padStart(2, '0')}`;
        }, 1000);
    }

    function displayCurrentQuestion() {
        questionStartTime = new Date();
        const qData = finalQuizData[currentQuestionIndex];
        const isSATA = Array.isArray(qData.correctAnswer);
        const isTyped = qData.section === 'Dosage Calculation' && !qData.options;

        let questionBodyHTML = '';
        if (qData.scenario) {
            questionBodyHTML += `<div class="question-scenario">${qData.scenario}</div>`;
        }
        questionBodyHTML += `<p class="question-text">${qData.questionText}</p>`;

        let contentHTML = '';
        if(isTyped) {
            const userAnswer = userAnswers[currentQuestionIndex] || '';
            contentHTML = `<div class="options-container"><input type="text" id="dosage-input" class="text-answer-input" placeholder="Enter numerical answer..." value="${userAnswer}"></div>`;
        } else {
            let optionsHTML = '';
            for (const key in qData.options) {
                let checked = '';
                const currentAnswers = userAnswers[currentQuestionIndex];
                if (currentAnswers) {
                    if (isSATA && Array.isArray(currentAnswers) && currentAnswers.includes(key)) {
                        checked = 'checked';
                    } else if (!isSATA && currentAnswers === key) {
                        checked = 'checked';
                    }
                }
                optionsHTML += `<label><input type="${isSATA ? 'checkbox' : 'radio'}" name="answer" value="${key}" ${checked}> ${key}: ${qData.options[key]}</label>`;
            }
            contentHTML = `<div class="options-container">${optionsHTML}</div>`
        }

        questionContainer.innerHTML = `
            <div class="question-header">Question ${currentQuestionIndex + 1} of ${finalQuizData.length}${isSATA ? ' (Select All That Apply)' : ''}</div>
            ${questionBodyHTML}
            ${contentHTML}
        `;
        flagCheckbox.checked = flaggedForReview.has(currentQuestionIndex);
        navigationBtn.textContent = (currentQuestionIndex === finalQuizData.length - 1) ? "Submit Quiz" : "Next Question";
    }

    function saveAnswerAndState() {
        const qData = finalQuizData[currentQuestionIndex];
        if (!qData) return;

        const isTyped = qData.section === 'Dosage Calculation' && !qData.options;

        if (isTyped) {
            const inputElement = document.getElementById('dosage-input');
            userAnswers[currentQuestionIndex] = inputElement.value.trim();
        } else {
            const isSATA = Array.isArray(qData.correctAnswer);
            const selectedOptions = document.querySelectorAll('input[name="answer"]:checked');
            userAnswers[currentQuestionIndex] = isSATA
                ? Array.from(selectedOptions).map(cb => cb.value)
                : (selectedOptions.length ? selectedOptions[0].value : null);
        }

        const timeSpent = Math.round((new Date() - questionStartTime) / 1000);
        timeSpentOnQuestions[currentQuestionIndex] = (timeSpentOnQuestions[currentQuestionIndex] || 0) + timeSpent;
        if (timeSpent > TIME_THRESHOLD) {
            timeFlaggedQuestions.add(currentQuestionIndex);
        }
        if (flagCheckbox.checked) {
            flaggedForReview.add(currentQuestionIndex);
        } else {
            flaggedForReview.delete(currentQuestionIndex);
        }
    }

    function handleNavigation() {
        saveAnswerAndState();
        if (currentQuestionIndex < finalQuizData.length - 1) {
            currentQuestionIndex++;
            displayCurrentQuestion();
        } else {
            submitQuiz();
        }
    }

    function submitQuiz() {
        clearInterval(overallTimerInterval);
        saveAnswerAndState();
        quizForm.classList.add('hidden');
        navigationBtn.classList.add('hidden');
        pauseBtn.classList.add('hidden');
        timerDisplay.textContent = "Quiz Finished";
        displayResults();
    }

    function checkAnswerCorrectness(qData, userAnswer) {
        if (qData.section === 'Dosage Calculation' && !qData.options) {
            // For dosage calculation, compare numerical values, allowing for slight floating point variations
            const expected = parseFloat(qData.correctAnswer);
            const actual = parseFloat(userAnswer);
            return !isNaN(actual) && Math.abs(actual - expected) < 0.001; // Tolerance for floating point
        }
        if (Array.isArray(qData.correctAnswer)) { // SATA
            const sortedUserAnswer = userAnswer ? [...userAnswer].sort() : [];
            const sortedCorrectAnswer = [...qData.correctAnswer].sort();
            return JSON.stringify(sortedUserAnswer) === JSON.stringify(sortedCorrectAnswer);
        }
        return userAnswer === qData.correctAnswer;
    }

    function displayResults() {
        resultsArea.classList.remove('hidden');
        let correctCount = 0;
        let incorrectCount = 0;

        finalQuizData.forEach((qData, index) => {
            if (checkAnswerCorrectness(qData, userAnswers[index])) {
                correctCount++;
            } else {
                incorrectCount++;
            }
        });

        const score = (correctCount / finalQuizData.length) * 100;
        resultsSummary.innerHTML = `<h2>Quiz Complete!</h2><p>Your Score: <strong>${score.toFixed(1)}%</strong> (${correctCount} out of ${finalQuizData.length} correct)</p>`;

        let detailsHTML = '';
        finalQuizData.forEach((qData, index) => {
            const userAnswer = userAnswers[index];
            const isCorrect = checkAnswerCorrectness(qData, userAnswer);
            const isTyped = qData.section === 'Dosage Calculation' && !qData.options;

            let questionHeaderText = qData.questionText;
            if (qData.scenario) {
                questionHeaderText = `<div class='question-scenario'>${qData.scenario}</div>` + questionHeaderText;
            }

            let resultBodyHTML = '';
            if(isTyped){
                const userAnswerDisplay = userAnswer || "No answer";
                const userClass = isCorrect ? 'correct' : 'incorrect';
                resultBodyHTML += `<div class="typed-answer-result"><p>Your Answer: <span class="user-answer ${userClass}">${userAnswerDisplay}</span></p>`;
                if (!isCorrect) {
                    resultBodyHTML += `<p>Correct Answer: <span class="correct-answer-text">${qData.correctAnswer}</span></p>`;
                }
                resultBodyHTML += `</div>`;
            } else {
                let optionsList = '<ul>';
                for (const key in qData.options) {
                    let li_class = '';
                    const isCorrectOption = Array.isArray(qData.correctAnswer) ? qData.correctAnswer.includes(key) : key === qData.correctAnswer;
                    const isUserSelection = Array.isArray(userAnswer) ? (userAnswer && userAnswer.includes(key)) : key === userAnswer;

                    if (isCorrectOption) li_class = 'correct-answer-label';
                    if (isUserSelection && !isCorrectOption) li_class = 'incorrect-answer-label';
                    if (!isUserSelection && isCorrectOption && !isCorrect) li_class += ' missed-correct-answer-label';

                    optionsList += `<li class="${li_class}">${key}: ${qData.options[key]}</li>`;
                }
                optionsList += '</ul>';
                resultBodyHTML = optionsList;
            }

            let rationaleHTML = '';
            // Rationale always shown now for learning purposes
            let rationaleClasses = 'rationale';
            if (timeFlaggedQuestions.has(index)) rationaleClasses += ' time-flagged-rationale';
            if (flaggedForReview.has(index)) rationaleClasses += ' flagged-rationale';
            rationaleHTML = `<div class="${rationaleClasses}"><strong>Rationale:</strong> ${qData.rationale.replace(/\n/g, '<br>')}<span class="time-spent-info">You spent ${timeSpentOnQuestions[index] || 0} seconds on this question. ${flaggedForReview.has(index) ? '(You flagged this for review)' : ''}</span></div>`;

            detailsHTML += `<div class="result-question"><p><strong>Question ${index + 1}: ${questionHeaderText}</strong></p>${resultBodyHTML}${rationaleHTML}</div>`;
        });
        resultsDetails.innerHTML = detailsHTML;
        generateStudyFocus();

        if (incorrectCount > 0 || flaggedForReview.size > 0 || timeFlaggedQuestions.size > 0) { // Show print button if anything to study
            generatePrintableStudyGuide();
            printBtn.classList.remove('hidden');
        }
    }

    function generateStudyFocus() {
        const topicCounts = {};
        finalQuizData.forEach((qData, index) => {
            const isCorrect = checkAnswerCorrectness(qData, userAnswers[index]);
            const isTimeFlagged = timeFlaggedQuestions.has(index);
            const isUserFlagged = flaggedForReview.has(index);

            if (!isCorrect || isTimeFlagged || isUserFlagged) {
                const topic = qData.section;
                topicCounts[topic] = (topicCounts[topic] || 0) + 1;
            }
        });

        const sortedTopics = Object.entries(topicCounts).sort((a, b) => b[1] - a[1]);
        let focusHTML = '<h3>Personalized Study Focus Guide</h3>';
        if (sortedTopics.length > 0) {
            focusHTML += '<p>Based on your performance, focus your review on these topics:</p><ul>';
            sortedTopics.forEach(topic => {
                focusHTML += `<li><strong>${topic[0]}</strong> (${topic[1]} item${topic[1] > 1 ? 's' : ''} noted)</li>`;
            });
            focusHTML += '</ul>';
        } else {
            focusHTML += '<p>Excellent work! No specific weak areas were identified.</p>';
        }
        studyFocusContainer.innerHTML = focusHTML;
    }

    function generatePrintableStudyGuide() {
        let printHTML = '<h1>Lower Respiratory Disorders - Study Guide</h1>';
        finalQuizData.forEach((qData, index) => {
            const isCorrect = checkAnswerCorrectness(qData, userAnswers[index]);
            const isTimeFlagged = timeFlaggedQuestions.has(index);
            const isUserFlagged = flaggedForReview.has(index);

            if (!isCorrect || isTimeFlagged || isUserFlagged) { // Only include incorrect or flagged questions in print
                const userAnswer = userAnswers[index];
                const isTyped = qData.section === 'Dosage Calculation' && !qData.options;
                let userAnswerText = 'No answer selected.';
                let correctAnswerText = '';

                let questionContentForPrint = qData.questionText;
                if (qData.scenario) {
                    questionContentForPrint = `Scenario: ${qData.scenario}\nQuestion: ${qData.questionText}`;
                }

                if (isTyped) {
                    userAnswerText = userAnswer || 'No answer';
                    correctAnswerText = qData.correctAnswer;
                } else {
                    if (Array.isArray(qData.correctAnswer)) { // SATA
                        userAnswerText = userAnswer && userAnswer.length > 0 ? userAnswer.map(key => `${key}: ${qData.options[key]}`).join('<br>') : 'No answer selected.';
                        correctAnswerText = qData.correctAnswer.map(key => `${key}: ${qData.options[key]}`).join('<br>');
                    } else { // MC
                        userAnswerText = userAnswer ? `${userAnswer}: ${qData.options[userAnswer]}` : 'No answer selected.';
                        correctAnswerText = `${qData.correctAnswer}: ${qData.options[qData.correctAnswer]}`;
                    }
                }

                printHTML += `
                    <div class="study-guide-item">
                        <h3>Question ${index + 1}: ${questionContentForPrint.replace(/\n/g, '<br>')}</h3>
                        <p><strong>Your Answer:</strong><br>${userAnswerText}</p>
                        <p><strong>Correct Answer:</strong><br>${correctAnswerText}</p>
                        <div class="print-rationale">
                            <strong>Rationale:</strong> ${qData.rationale.replace(/\n/g, '<br>')}
                        </div>
                    </div>
                `;
            }
        });
        printableStudyGuide.innerHTML = printHTML;
    }


    // Event Listeners
    startBtn.addEventListener('click', startQuiz);
    pauseBtn.addEventListener('click', togglePause);
    printBtn.addEventListener('click', () => {
        window.print();
    });

    quizForm.addEventListener('submit', (event) => {
        event.preventDefault();
        handleNavigation();
    });
</script>

</body>
</html>